Join MikeLigalig.com!

Why Just Read When You Can Join, Post, and Read!

Menu

Show posts

This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.

Show posts Menu

Messages - Press Release

#1501
For the month of December, Top Dog Express Car Wash will host a Make-A-Wish fundraiser at all locations to help the organization fulfill life-changing wishes for children who are currently battling one or more such illnesses. Top Dog Express Car Wash is inviting its local communities to help Make-A-Wish make every child's wish come true this holiday season through their combined efforts.

ORLANDO, FLA. (PRWEB) NOVEMBER 26, 2020
Every 20 minutes, a child is diagnosed with a critical illness. For the month of December, Top Dog Express Car Wash will host a Make-A-Wish fundraiser at all locations to help the organization fulfill life-changing wishes for children who are currently battling one or more such illnesses. 10 wishes are granted through the organization each day thanks to donations. Top Dog Express Car Wash is inviting its local communities to help Make-A-Wish make every child's wish come true this holiday season through their combined efforts.
"We enthusiastically support Make-A-Wish's mission to change the lives of these children. We're so thrilled to be partnering with such an incredible organization to host this fundraising event. Every child battling critical illness deserves to have a wish granted every day," said Tom Welter, CEO of Clean Streak Ventures, which is the owner of Top Dog Express Car Wash. "We invite you to join us for this important event and help us make a difference."
From November 30th – December 31st, visit Top Dog Express Car Wash and easily make $1 donations to Make-A-Wish at any pay station prior to washing.
"There's no better way to give back this holiday season than by helping kids who are fighting a battle for their health and wellbeing feel loved, appreciated, and supported. Thank you in advance for your contributions and participation. We're looking forward to seeing how our community will turn out for this ongoing fundraising opportunity," said Welter.
Top Dog Express Car Wash is a subsidiary of Clean Streak Ventures, a Florida-based company operating various car wash locations across the U.S., including 17 express car wash locations in Florida. Their growing family of brands includes Top Dog Express Car Wash in central Florida, Bay Breeze Car Wash & Lube in Tampa and Clean Machine Car Wash in Naples. The company focuses on providing the best customer service experience and the highest quality washes within the industry. Clean Streak Ventures is actively seeking opportunities to grow their footprint through acquisitions and new developments in their existing markets and in new ones. Their growth strategy is centered on people and service, and they aim to add value without disrupting companies' culture or essence.
About Top Dog Express Car Wash
Top Dog Express Car Wash offers central Florida's premier express wash options, with oil changes also available at its Altamonte Springs location. They provide an exceptional customer experience, state-of-the-art wash technology, and high-performance wash packages designed to help each car shine every day.
For more information, please follow Top Dog Express Car Wash on social media or visit topdogexpresscarwash.com or http://www.wish.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1502
Glasses USA, a leading online retailer of Eyeglasses, receives another best-in-class 5-star rating from TopConsumerReviews.com.

OVERLAND PARK, KAN. (PRWEB) NOVEMBER 26, 2020
TopConsumerReviews.com once again awarded their highest five-star rating to Glasses USA, an industry leader among stores offering Eyeglasses.
In today's increasingly busy world, who wants to spend time shopping for eyeglasses? The visit to the optometrist already takes an hour (or longer!), and it can be challenging to take time away from work and other responsibilities to go out and buy glasses with the new prescription. Fortunately, there are numerous eyewear retailers that eliminate all of the hassle of in-person shopping, with cutting-edge tools to help customers buy their eyeglasses online. These tools include the ability to "try on" frames using the camera from a mobile phone, to take all of the required measurements for the best fit, and so forth. And, online retailers of eyeglasses tend to have an inventory that goes well beyond what can be found at a brick-and-mortar store, with options for every budget and style.
"Glasses USA continues to stand out among online retailers of Eyeglasses," confirmed Brian Dolezal of TopConsumerReviews.com, LLC. "Shoppers are amazed by their inventory of nearly 1,500 frames, and by the ease of finding the right shape, style and price on Glasses USA's well-designed website. Customers can use a 'virtual mirror' to see how the eyeglasses will look on their face, and this retailer even has a smartphone app that can determine the prescription on an existing pair of glasses! Glasses USA is extremely customer-friendly, offering price matching, student discounts, and a 14-day full refund policy. For all of these reasons and more, Glasses USA earns another first-place ranking among online retailers of Eyeglasses in 2020."
To find out more about Glasses USA and other retailers of Eyeglasses, including reviews and comparison rankings, please visit the Eyeglasses category of TopConsumerReviews.com at https://www.topconsumerreviews.com/eyeglasses/.
About Glasses USA
Glasses USA operates in over 92 countries, making affordable glasses accessible for anyone in need of vision correction. Their customer-centric philosophy puts a team of dedicated experts and experienced customer service representatives at their customers' disposal around the clock, 365 days a year, along with a risk-free shopping guarantee. Glasses USA has helped over 2 million eyes see better.
About TopConsumerReviews.com
TopConsumerReviews.com, LLC is a leading provider of reviews and rankings for thousands of consumer products and services. Eyeglasses to Jewelry Stores and Home Gyms, TopConsumerReviews.com delivers in-depth product evaluations in order to make purchasing decisions easier.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1503
TORONTO (PRWEB) NOVEMBER 26, 2020
New research from Canada's leading online insurance brokerage PolicyAdvisor.com finds more than three-quarters of Canadians are feeling anxious about their financial future due to the economic effects of COVID-19, but not at the expense of their life insurance coverage. The company's Canadian Life Insurance Landscape: Pandemic Checkup sought to determine consumer attitudes and buying behaviour towards life insurance coverage considering COVID-19's impact on their lives.
As families start their holiday shopping and 2021 budgets, it is clear that life and health insurance is one place where they are not cutting corners. While 77% of respondents said they would be cutting discretionary expenses like entertainment and eating out, only 13% said they were looking to reduce any of their life insurance premiums.
In fact, 64% of Canadians thought life insurance was one of the most important types of coverage to have during the current global pandemic; and 63% think that owning life insurance is more important to them now than before COVID-19.
"The results confirmed what we were seeing on a daily basis," said Jiten Puri, founder and CEO of PolicyAdvisor.com. "There has been an urgency to get life insurance coverage now that many people know how quickly they may need it."
All told, 44% of Canadians plan to or already have purchased more life insurance coverage because of COVID-19. The biggest reason preventing respondents from buying more life insurance at this time is their perceived inability to buy it online. The cost of life insurance, and its complexity, closely followed.
"The sad truth is that many Canadians still feel in the dark when it comes to comparing and buying life insurance, especially in the age of social distancing. With a digital broker, you can do your life insurance application online, with easy-to-understand product descriptions, and transparent price comparisons," said Puri.
The time commitment, medical testing requirements, and absence of an advisor they could trust were also cited as reasons some Canadians weren't yet ready to purchase the life insurance coverage they needed. Puri stresses there is a clear need for consumer education. Online insurance tools allow Canadian consumers to remedy most – if not all – of the setbacks they face in their search for coverage. Over half of the respondents (52%) said online fulfillment would make them more likely to purchase life insurance.
Additionally, 65% of Canadians say they rely on their group benefits for life insurance coverage, with 38% citing the work insurance plan as their sole life insurance policy. Recent research from the Conference Board of Canada suggests that 12% of companies making layoffs due to COVID-19 don't plan on extending workplace benefits to laid-off employees, which could leave some Canadian households with a significant insurance shortfall.
About PolicyAdvisor.com
PolicyAdvisor.com is an innovative Canadian online insurance broker providing a digital solution to an archaic industry, combining modern technology, intuitive design and real-world expertise to make insurance buying simpler, straightforward and stress-free.


START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1504
NASHVILLE, TENN. (PRWEB) NOVEMBER 27, 2020
This collaboration with GIVN, the nation's leading social impact beverage brand and makers of GIVN Water, the premium spring water that provides one day of clean water to people in need for every bottle sold, will help provide clean water to communities around the globe. The partnership brings together two brands that stand for human rights and believe that the everyday hero can positively impact the world.
"I'm honored to partner with a brand that not only produces a great product but has a charitable backbone." Shares Pope. "Safe, clean water is every human being's right to have. I hope my partnership with GIVN helps provide that for many more people in need."
John Houseal, GIVN Water Co-Founder & CEO, stated that "We are thrilled to be partnering with Cassadee. Her commitment to using her strong voice to stand up for social justice human rights issues inspires us. We are excited to welcome her to the team and her forward thinking to the GIVN clean water movement. Most of all, together we will make meaningful and positive impact for people in need."
GIVN Water is a premium North American spring water, made with recycled materials that enables everyone to Thirst for More. The company recently reached 4 Million Days of clean water provided to people in need. In over 3,000 retail locations nationally, GIVN Water consumers can quench their thirst for more while enjoying some seriously good water.
###
ABOUT GIVN:
GIVN Goods, maker of GIVN Water and GIVN Apparel, is a Certified B-Corporation dedicated to turning everyday purchases into meaningful good and has been recognized year over year as a Best for the World Honoree. To date, GIVN retailers and consumers have provided over 4 million days of clean water to people in need around the world. GIVN Water is available on Amazon.com and in over 3,000 retail locations across the United States. In 2019 GIVN Water committed to converting all bottles to made from reused materials, including recycled plastic and aluminum. Visit http://www.givnwater.com for more information. GIVN is a registered trademark of GIVN Goods, Inc. B-Corporation is a registered trademark of B Lab.


START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1505
Beverly Hills-based plastic surgeon Dr. J comments on a recent article that the case of little Mickele Allen reminds him of his own experience performing emergency plastic surgery on a little boy following a dog-attack in Peru.

BEVERLY HILLS, CALIF. (PRWEB) NOVEMBER 27, 2020
A November 23 article on WABC Eyewitness News reports on the case of five-year-old Mickele Allen, who was attacked by five pit bull terriers in his native Jamaica. Fortunately, the boy was rescued by his brother and local doctors, but still badly injured with numerous disfiguring injuries. Mickele was taken to a hospital in the Bronx, New York, where he was seen to by the plastic surgeon who had raised the money to pay for the surgery. The young boy is now reported to be making excellent progress. Beverly Hills plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known to his patients as Dr. J, says that the case is an outstanding reminder of the less often discussed area of reconstructive plastic surgery that is simply about allowing patients to live normal lives.
Dr. J notes that the news story contains echoes of his experience several years while on a trip to Peru to perform pro-bono work for the charitable organization, Operation Smile. The widely respected NGO provides free plastic surgery services to children in less developed areas of the world. While most of the procedures Dr. J worked on involved correcting such common but debilitating childhood deformities as cleft lips, he notes that there was one¬ occasion where his work was far more dramatic. In this instance, a small local boy needed emergency treatment after being attacked by a feral dog. Once the child was stabilized, it was clear that, in addition to lifesaving procedures, the small boy was going to need emergency plastic surgery if he was going to have a normal life. Fortunately, Dr. J was there and was able to see to the boy's needs. Dr. J says that, if a qualified plastic surgeon had not been there, there was a good chance the child would have been saddled with major disfigurements indefinitely.
Dr. J notes that, while most people think of procedures like breast augmentation or facial rejuvenation when they hear about plastic surgery, the specialty came into its own correcting serious disfigurements sustained by World War I soldiers. Dr. J notes that plastic surgery is one of the most challenging and dynamic of all medical specialties and that – whether the procedure is reconstructive or purely elective and cosmetic – it boils down to helping people develop the confidence they need to make the most from their lives.
Interested readers who would like to find out if a plastic surgery or cosmetic procedure is right for them can call (310) 228-3151 to learn more. Dr. J's qualifications as a Beverly Hills plastic surgeon, double-board certified by both the American Board of Plastic Surgery and the American Board of Surgery can be seen on his website



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1506
SAN ANTONIO (PRWEB) NOVEMBER 27, 2020
UT Health San Antonio's Sam and Ann Barshop Institute for Longevity and Aging Studies announced Nov. 27 that enrollment is open for a new clinical trial called PREVENTABLE. The study will investigate whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor, can help adults age 75 and older maintain health by preventing dementia, disability and heart disease.
The study, which aims to be one of the largest ever conducted in older adults, will include more than 20,000 participants across the U.S., including 450 from San Antonio. The study will randomize participants without heart disease or dementia to receive either atorvastatin or placebo. The placebo looks like the study drug but has no medicine in it. Researchers will follow participants for up to five years and test their memory, thinking and physical abilities, and monitor them for events such as heart attacks or strokes.
Study participation will be easy and efficient. Researchers will follow participants using electronic health records and Medicare data, and with study visits over the telephone. Study drug will be shipped directly to participants' homes every three months.
The Barshop Institute at UT Health San Antonio is one of the first PREVENTABLE study sites to be activated, said principal investigator Nicolas Musi, MD, institute director and professor of medicine in the university's Joe R. and Teresa Lozano Long School of Medicine.
"We really don't know how these drugs work in older adults," Dr. Musi said. "Most, if not all, of the studies of statins have been done in much younger people, in their 50s and 60s, but studies in adults over 75 are rare."
About one in three people in the U.S. over the age of 75 without heart disease are taking statins. In addition to learning whether statins can prolong health in older adults, the PREVENTABLE study will help clarify which older adults should not be taking statins.
"Participants don't have to have a history of high cholesterol," Dr. Musi, an endocrinologist, said. "This study is conducted to see if this medicine, regardless of cholesterol level, is able to improve cognition and brain function, prevent dementia, improve physical function, and prevent cardiovascular disease and strokes."
"Persons with a history of heart disease, stroke or dementia are not eligible for the study, but people with diabetes are eligible," Dr. Musi said. "So are patients with mild cognitive impairment."
The National Institutes of Health, which is funding the study, is interested in San Antonio as a center of minority participant recruitment. "The PREVENTABLE study is not exclusively for the Hispanic population, but this group is of special interest to us," Dr. Musi said.
Interested people may call the Barshop Institute clinical research line at (210) 450-0020.
# # #
The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school's clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer's disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.
The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country's leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways "We make lives better," visit http://www.uthscsa.edu.
Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
To see how we are battling COVID-19, read inspiring stories on Impact.

"Most, if not all, of the studies of statins have been done in much younger people, in their 50s and 60s, but studies in adults over 75 are rare." -- Nicolas Musi, MD, UT Health San Antonio



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1507
CARSON CITY, NEV. (PRWEB) NOVEMBER 27, 2020
Inventiv is proud to announce updates to its free patenting software ProvisionalBuilder to draft provisional applications. Geared to inventors with no prior experience with the patent system, ProvisionalBuilder provides a structured process through a series of pages or tabs that moves the inventor through the major sections of the Provisional Patent Application. When the inventor completes the disclosure, the software analyzes the draft and spots common potential issues to fix.
Inventiv has also developed a series of FAQs and educational content and links for inventors to get help from various resources, including the Patent Office inventor assistance center and pro-bono programs from law schools. These tools make the IP system accessible to every dreamer, innovator, and inventor. Inventiv is also working on localizing our free resources and software in developed and developing countries for inventors who seek to understand and participate in the evolving, global intellectual property system of the 21st Century.
Inventiv thanks its volunteers for supporting Inventiv in helping innovators and inventors worldwide, rich or poor. We believe that innovations will bring greater wealth to the world and will improve everyone's life.
To get and learn more about the software, visit our website at http://www.inventiv.org

Individual innovators are vital to the patent system. Respect for individual inventors, rich or poor, is the key to our IP system



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1508
CABO SAN LUCAS, MEXICO (PRWEB) NOVEMBER 27, 2020
Coming from a successful inaugural event, the International Center for Breathwork will hold its second annual presentation of The Breathing Festival online from Feb. 11-28, 2021.
Planned for three long weekends in February—Feb. 11-14; Feb. 18-21 and Feb. 25-28—the festival will showcase empowering sessions with over 50 of the world's leading breathwork practitioners. The event boasts 12 days filled with lectures, experiential breathing sessions; breathing tools, tips, tricks and hacks for daily life; conscious music and cutting-edge breathing technology. Confirmed speakers are on the website and the full schedule will be announced in January.
Visit our festival page to see all of our presenters whose teaching methods include Rebirthing, Holotropic, Transformational, Neurodynamic, Breath Holding, Buteyko, Ecstatic, Shamanic, Biodynamic, Vivation and Breath of Love, to name a few.
"The mission of the festival is to encourage all people to become more aware of their own breathing and then to learn how to breathe in different ways to achieve very specific and often remarkable results," said Dan Brulé, co-founder of The Breathing Festival. "Our theme is: 'Change Your Breath. Change Your World.' We want to show people how they can use conscious breathing to improve nearly any part of their life."
According to ICFB, conscious breathing, or breathwork, can help boost a person's low energy or mood and increase concentration and productivity. It can also provide fast-acting and lasting relief for stress, trauma, pain, anxiety and depression. Breathwork is used by top athletes and elite military to improve performance and unlock higher potential.
"The Breathing Festival and the International Center for Breathwork marry my deepest yearning to connect people with my desire to spread healing and love and my passion for creating experiences through events," said Nicole Price, co-founder and CEO of The Breathing Festival. "I am so excited about the possibilities. I love that our 2021 virtual event will touch hundreds of thousands of people, maybe millions, and my vision is clear of the day we will come together in Cabo to breathe in person as humans raising the vibration of our planet."
In addition to the activities, the festival will host The Second Annual Tribute to Leonard Orr, prolific writer, spiritual teacher, philosopher, and the father of the modern breathwork movement and the creator of the Rebirthing conscious breathing technique. Because of Orr and his contributions to society, millions of people around the world have embraced breathwork as a lifestyle path.
Tickets start at only $11 for a full 12 days of access to all of the sessions streaming during the festival. Tickets can be purchased by visiting thebreathingfestival.com.
A very limited quantity of VIP tickets are available for people who want to interact personally with the presenters in live online Q+A chat sessions each festival day.
For more information, visit thebreathingfestival.com.
About the International Center for Breathwork:
The International Center for Breathwork was started by Dan Brulé, VJ Odedra, Nicole Price and Marc Taylor as a place to welcome and support all styles, types, modalities, practices, flavors and kinds of breathwork and to spread the practice of these simple yet often unknown concepts throughout the world. Born in 2020 during the global pandemic, it arose from a desire to show people simple ways to shift our lives into better places by changing the way we breathe.
Our world is under tremendous stress and many things are changing. Breathing techniques are the most effective, accessible and natural tools for navigating and integrating those changes. Some techniques lead to more mindfulness, which leads to more awareness, which gives you more influence in your world. Other techniques increase or decrease energy, release blocked emotions, develop the self, increase emotional intelligence, and reclaim the energy lost from chronic pain. The ICFB is the largest gathering place for these many diverse styles of breathing and makes them all available through The Breathing Festival and its membership program.
The Breathing Festival was created as a way to share breathwork in a fun, exciting, mainstream event that is accessible to as many people as possible. The virtual festival in 2021 gives us the opportunity to reach people in every single corner of the globe. That's our vision and we've got a lot of amazing people working with us to achieve it. We dream about healing the world by healing ourselves and we use our breath to do that. ###


START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1509
This message is awaiting approval by a moderator.
COLUMBUS, OHIO (PRWEB) NOVEMBER 27, 2020
ARC Healthcare launches Fourleaf a "one-click" contract management, and enrollment automation platform, eliminating the leading inefficiencies in Medical Payor provider enrollment.
ARC Healthcare LLC, an innovative Healthcare processes and technology consulting firm that has developed technology to unify the collection process of contracting, credentialing, rosters, provider data to replace the manually-intensive provider enrollment process with a simplified, end-to-end solution. ARC Healthcare has worked with clients across the country and witnessed firsthand the laborious, costly, and intensive tasks Health plans are challenged with to build rapid, comprehensive, and quality networks to service their patients. Many challenges are faced while trying to build a comprehensive and quality network to service patients.
Health plans as well as Providers may lack the time and resources needed to analyze internal processes or have limited funding to develop robust automation and advanced IT solutions. As a result, both Payors and Providers are stuck working in spreadsheets, manually completing forms, and contracting by mail which is costly, burdensome, highly time consuming and error prone. Provider contracting, credentialing and enrollment requires a multi-faceted approach and is the foundation for Payor success. The routine monthly updates made to providers' information and data sets, including new providers, terminations, and location changes, can be tedious to manage and warrants process workflow. Incorrect entry of provider data that route to directories causes inconsistencies, causes confusion, claim delays, member access issues, and even worse, fines and compliance problems. These manual processes lead to duplicative processes, administrative complaints, employee turnover, and higher costs.
ARC Healthcare's solution, Fourleaf, is a cost-effective solution, and fully automates the manual processes of provider enrollment – creating process, and saves customers from repetitive tasks, unnecessary staffing, and excessive spend. By streamlining the provider's paper-driven enrollment processes, Fourleaf eliminates inaccurate dataset errors, and provides easy to use, comprehensive reporting. To succeed, Payors must have a secure, cloud-based, and uniformed solution to manage provider data, automate contracting and enrollment, collect and house documents, and quickly locate documents to comply with audits and State compliance requests.
The Fourleaf Solution
Fourleaf is a unified system designed to collect and manage provider data in a secured cloud infrastructure. The efficiency of time and financial resources is always at the forefront of any solution - and Fourleaf delivers. Integrating automated contracting, document management, task management, and roster ingestion allows Health plans to quickly report on Network Adequacy, allows for automatic data transfers and integrations of contracted information into core systems like claims and authorizations. Provider directories can be generated, and network adequacy reports delivered in a seamless all-in-one system. Other automated reports to conduct internal audits of staff productivity and task completion are at management's fingertips. Unlike other systems on the market, Fourleaf also offers customization to ensure all provider data points are covered to meet your needs.
About ARC Healthcare, LLC
ARC Healthcare, LLC was formed in 2012 to serve organizations in improving contracting processes, keeping them compliant with government guidelines on network adequacy, and ensuring provider data is accurate and easily analyzed. We are a premier firm that delivers an array of services, including healthcare provider recruitment, contracting, software development, call center, staffing, and consulting support resources.
"Our mission at ARC Healthcare is to bring top-quality, meaningful and secure solutions to our customers. Our overarching goal is to bring streamlined solutions to our customers, with an easy to use, all in one system. The days of providers emailing handwritten agreements, with missing information, and unsecured social security numbers across the internet are gone. We are so pleased to be at the forefront of such a meaningful solution," says Amanda C. Ratliff, CEO,
ARC Healthcare. ARC Healthcare, LLC is a certified Woman Owned Small Business (WOSB) and Women-Owned Diverse Supplier (WBENC).
#cloudsolutions #documentmanagement #Networkdevelopment #contracting #managedcare #automation #healthcare #taskmanagement #electronicsignature #providerdirectory #providerenrollment #credentialing #roster
#providercredentialing


START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1510
CHICAGO (PRWEB) NOVEMBER 27, 2020
Transpara, the leading Artificial Intelligence support system for breast cancer screening that uses deep learning algorithms to automatically detect potential breast cancer in 2D and 3D mammograms, has achieved another first in its class!
Transpara led the way being the first to use a unique scoring breast AI system for breast cancer risk. It is the first and remains the only DEEP LEARNING system to be FDA cleared for use on both 2D and 3D mammograms and now is first of its kind to help radiologists read more than 1 million mammograms.
"This is a major milestone in our mission to help radiologists improve survival rates for breast cancer, a disease that is growing relentlessly around the world," said Nico Karssemeijer, CEO for ScreenPoint Medical. "Despite the challenges presented by COVID in 2020, Transpara installations continue to prove successful in more and more countries."
"AI is obviously an important weapon being adopted to fight breast cancer even during these trying times. It is also becoming increasingly obvious that not all breast AI is the same. Our focus is to provide robust clinical evidence around the globe, and we can only do this with the help and support of our clinical partners. With this said, Transpara is being featured in an incredible 6 Scientific presentations with data from 5 different countries at this year's virtual RSNA."
"These studies for BOTH 2D AND 3D mammography look at how Transpara can improve accuracy, reduce interval cancers and help to reduce radiologist's workload. I'm not going to give the game away; you'll have to wait to listen to the presentations, but the results are powerful," said Professor Karssemeijer.
ScreenPoint Medical is also introducing new developments, including additional technology to ease integration of Transpara further in any mammography reading environment.
Here is the list of presentations at RSNA featuring Transpara:
A.J.T. Wanders, W. Mees, N. Janssen, A. Rodriguez-Ruiz, I. Sechopoulos, J.K. van Rooden, Ritse M. Mann. The potential of AI for improving early detection in breast cancer screening to reduce interval cancer rates
C. Balta, N. Janssen, A. Rodriguez-Ruiz, C. Mieskes, N. Karssemeijer, S. H. Heywang-Köbrunner. Using AI to triage which screening mammograms benefit from a double reading strategy
S. J. Vinnicombe, O. Parr, R. Sidebottom, D. Godden, E. Cornford, I. D. Lyburn. What impact could AI based computer aided detection have on the number and biological relevance of interval cancers in a population based screening programme?
C. Balta, N. Janssen, A. Rodriguez-Ruiz, C. Mieskes, N. Karssemeijer, S. H. Heywang-Köbrunner. Can AI help to increase the PPV of screen-recalled biopsies on calcifications?
M. Pinto, A. Rodriguez-Ruiz, K. Pedersen, S. Hofvind, R. Mann, S. Kappler, J. Wicklein, I. Sechopoulos. Impact of AI decision support on breast cancer screening interpretation with single-view wide-angle DBT
S. Romero Martín, J. Luis Raya Povedano, E. Elías Cabot, A. Gubern-Merida, A. Rodríguez-Ruiz, M. Álvarez Benito. Using autonomous AI to reduce the workload of breast cancer screening with breast tomosynthesis: a retrospective validation
Note to Editors
ScreenPoint Medical BV.
ScreenPoint Medical is the leading developer of AI driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations.
Transpara is an AI solution for breast cancer screening, that uses deep learning algorithms to automatically detect lesions suspicious for breast cancer in 2D and 3D mammograms. The software categorises mammograms on a 10-point scale indicating the risk that cancer is present. This Exam Score can be used to help radiologists prioritise patients for further investigation. Decision support marks for calcifications and soft tissue lesions are provided to support radiologists with image interpretation. Studies have shown that Transpara matches the performance of radiologists ,2,3, thus acting as a second opinion which increases diagnostic confidence and accuracy ,3. It is FDA cleared for 2D and 3D mammography.
ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, two internationally respected experts in breast imaging, machine learning and computer aided detection. (diagnosis?)
The company's Head Office is in Nijmegen, The Netherlands.
1"Stand-alone artificial intelligence for breast cancer detection in mammography: Comparison with 101 radiologists", Rodriguez-Ruiz et al, JNCI: Journal of the National Cancer Institute, djy222, https://doi.org/10.1093/jnci/djy222, 2019
2"Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System" Rodríguez-Ruiz et al, Radiology 290:2, 305-314, 2019.
3FDA approval number K193229
For more information, please email info@screenpointmed.com or visit the website http://www.screenpoint-medical.com or http://www.transparabreastcare.com


START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1511
This message is awaiting approval by a moderator.
Ziegler, a specialty investment bank, is pleased to announce its role in advising CareFirst BlueCross BlueShield (CareFirst) in the acquisition of University of Maryland Health Partners (UMHP) and University of Maryland Health Advantage (UMHA) from The University of Maryland Medical System (UMMS). UMMS is a university-based regional care health system focused on serving the health care needs of Maryland residents, bringing innovation, discovery, and research to the healthcare system and educating the state's future physician and health care professionals through its partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the State, the health system's 28,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations at 13 hospitals. UMHP is a 47,000 member Managed Medicaid plan, operating in 21 of 24 Maryland counties through a network of 38 hospitals, 14 FQHCs and over 10,000 physicians. UMHA is a 6,000 member Dual Special Needs (DSNP) Medicare Advantage plan which operates in 15 of 24 Maryland counties with a similar network to UMHP. UMMS acquired UMHP and UMHA in a 2015 transaction with Riverside Health, Inc. in order to align its operations vertically into the payor space.

CHICAGO (PRWEB) NOVEMBER 27, 2020
Ziegler, a specialty investment bank, is pleased to announce its role in advising CareFirst BlueCross BlueShield (CareFirst) in the acquisition of University of Maryland Health Partners (UMHP) and University of Maryland Health Advantage (UMHA) from The University of Maryland Medical System (UMMS). UMMS is a university-based regional care health system focused on serving the health care needs of Maryland residents, bringing innovation, discovery, and research to the healthcare system and educating the state's future physician and health care professionals through its partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the State, the health system's 28,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations at 13 hospitals. UMHP is a 47,000 member Managed Medicaid plan, operating in 21 of 24 Maryland counties through a network of 38 hospitals, 14 FQHCs and over 10,000 physicians. UMHA is a 6,000 member Dual Special Needs (DSNP) Medicare Advantage plan which operates in 15 of 24 Maryland counties with a similar network to UMHP. UMMS acquired UMHP and UMHA in a 2015 transaction with Riverside Health, Inc. in order to align its operations vertically into the payor space.
In its 83rd year of service, CareFirst, an independent licensee of the Blue Cross and Blue Shield Association, is a not-for-profit health care company which, through its affiliates and subsidiaries, offers a comprehensive portfolio of health insurance products to 3.4 million individuals and groups in Maryland, the District of Columbia and Northern Virginia. In 2018, CareFirst invested $43 million to improve overall health, and increase the accessibility, affordability, safety and quality of health care throughout its market areas.
"The University of Maryland Medical System and CareFirst have always been strong allies and the acquisition of UMHP and UMHA further solidifies that alignment," said Mohan Suntha, MD, MBA, President and CEO of UMMS. "More importantly, it ensures our Medicaid and Medicare enrollees have uninterrupted access to comprehensive health coverage and care through partnership with a Maryland-based, not-for-profit health plan. Delivering high quality, compassionate care is fundamental to the missions both UMMS and CareFirst serve and we are confident that UMHP and UMHA enrollees will benefit from CareFirst's expertise in the market."
"This partnership brings the best capabilities of CareFirst and UMMS together in a new model and is part of our broader efforts designed to deliver care focused on value and improved health outcomes. Our work with the UMMS team will provide opportunities for deeper collaboration and innovation designed to bring our shared communities greater value, expanded access to high quality care, better consumer experiences, and more equitable care for all Maryland residents," said CareFirst President & CEO Brian D. Pieninck.
Chris Hendrickson, Managing Director, in Ziegler's Healthcare Corporate Finance practice, stated, "CareFirst has built an outstanding reputation as the largest health insurer in the Mid-Atlantic region, with the largest network of physicians in its area, leading customer support and member engagement capabilities, and innovative programs including its Patient Centered Medical Home Program (PCMH). These transactions allow it to expand beyond its core strength in commercial insurance to the government space."
CareFirst is bringing UMHP and UMHA into its not-for-profit organizational structure to better align with its mission. CareFirst is integrating UMMS' staff and infrastructure with CareFirst operations over a multi-year transition period.
Ziegler's Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.
For more information about Ziegler, please visit us at http://www.ziegler.com.
About Ziegler:
Ziegler is a privately held investment bank, capital markets and proprietary investments firm. Specializing in the healthcare, senior living and education sectors, as well as general municipal and structured finance, enables Ziegler to generate a positive impact on the clients and communities it serves. Headquartered in Chicago with regional and branch offices throughout the United States, Ziegler provides its clients with capital raising, strategic advisory services, equity and fixed income sales & trading and research. To learn more, visit http://www.ziegler.com.
Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client's experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.
# # #

Chris Hendrickson, Managing Director, in Ziegler's Healthcare Corporate Finance practice, stated, "CareFirst has built an outstanding reputation as the largest health insurer in the Mid-Atlantic region, with the largest network of physicians in its area...



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1512
LOS ANGELES, CA (PRWEB) NOVEMBER 27, 2020
Designed and Engineered in the USA, the reusable QuantaDose UVC test card uses photochromatic WPV (Word Power Visibility) technology to provide reliable UVC intensity readings in 15 seconds with instant notification of optimal UV-C germicidal wavelengths. The QuantaDose UVC intensity test card relies on calibrated word legibility starting > 300 µW/cm² when the word "ULTRAVIOLET" first becomes legible during exposure to optimal UVC germicidal wavelengths.
"The COVID-19 pandemic changed the way American's spent Thanksgiving yesterday. The outbreak has also changed what people are rushing to buy today that weren't on last year's Black Friday and Cyber Monday's shopping list," said CTO John Coates. 
Coates stated that QuantaDose UVC light test cards are one of those innovative items that made the #1 bestsellers list on Amazon even before the holiday rush. Millions of people depend on unregulated UVC devices dominated by third-party sellers on mainstream shopping sites. Unfortunately, the charlatan sellers use much cheaper components that can't provide the UVC disinfecting power many manufacturers claim.  QuantaDose UVC light test cards are very easy-to-use, credit card-sized UVC Indicators that can increase the efficiency of the UVC light disinfection processes by helping consumers to quickly visualize what is most effective, instantly ruling out most all falsely advertised UV sterilization products," he said.
QuantaDose created a specially formulated ink chemistry sensitive to only optimal UVC, which will not fluoresce to ordinary visible light or UVA and UVB. This ensures the transparent letters UV-C only illuminate bright fluorescent green under germicidal UV wavelengths between 222-280nm.  QuantaDose provides consumers with the quickest verification method to avoid an increasing number of fraudulent UVC light products that flood the consumer market.
According to Katie Webb, CEO of Quanta X Technology, the QuantaDose team prides itself on rapidly fine-tuning its product line, including designs for very high power UVC devices and the development of Far-UV analytes.
"We have been busy, already on the 3rd edition of QuantaDose UV test cards. We are focused on making QuantaDose the most helpful tool; QuantaDose is quickly innovating in quantum confinement effects and molecular fluorescence material designs that haven't advanced much in 20 years.  This has led to a new QuantaDose product launched every 45 days.  It is inspiring to be able to produce the best tools to help people make the best choices when trusting UVC as part of their disinfection routine," she said.  
HOW TO USE QUANTADOSE UVC TEST CARD
STEP 1) Top Light Sensor Test Wavelength of UV Exposure: When exposed to optimal UVC germicidal wavelengths, the QuantaDose UVC test card undergoes an instant color change to a green glow where fluorescence is directly related to energy values of UV wavelength received. Fluorescence stops when excited electrons release all photos within nanoseconds after exposure.
STEP 2) Bottom Light Sensor Test Intensity of UV Exposure: When exposed to confirmed mercury-line UVC wavelengths, the QuantaDose test card first displays the word "ULTRAVIOLET " at approximately > 300 µW/cm² a gradual color change is directly related to the energy value received. Temporary photochromic dosimeter color is used to check intensity after exposure and should be checked immediately after the test for the most accurate intensity results. The test is completed in 15 secs; remove the card from the source!
With QuantaDose, you're not just purchasing a product- you're making an investment in protecting love-ones from bad actors and fraudulent UVC products being sold almost everywhere online. For more information, call 800.713.9004 or visit quantadose.com. For the fastest QuantaDose UVC test card delivery, Amazon offers free same-day delivery on QuantaDose UVC test cards for prime members in most areas in the USA.


START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1513
This message is awaiting approval by a moderator.
Jumpstart Foundry, a healthcare-focused private investment firm headquartered in Nashville, announced today its second round of 2020 portfolio selections. The Fall 2020 selection of portfolio companies consists of 5 healthcare startups chosen from a pool of more than 200 applicants, which brings the total number of seed-stage investments to 108 for the TN firm.

NASHVILLE, TENN. (PRWEB) NOVEMBER 30, 2020
Jumpstart Foundry, a healthcare-focused private investment firm headquartered in Nashville, announced today its second round of 2020 portfolio selections. The Fall 2020 selection of portfolio companies consists of 5 healthcare startups chosen from a pool of more than 200 applicants, which brings the total number of seed-stage investments to 108 for the TN firm.
Ranked as one of the most active venture capital investors in Tennessee, Jumpstart Foundry annually makes 20-25 standard investments of $150,000 via convertible SAFE notes into innovative companies in the health space. These companies are expected to have a tremendous impact in the health domain while driving strong financial returns for Jumpstart's investors.
"We received a record number of applications this year and were able to be incredibly selective in our approach," said Eller Mallchok, Jumpstart Foundry's Managing Director. "Of course, I was pleased with the quantity of applications, but the quality was also impressive. There is no lack of supply of healthcare innovation, and Jumpstart is here to help them grow."
The Jumpstart Foundry Fall 2020 cohort of portfolio companies include various novel healthcare applications such as malnutrition diagnosis, behavioral health solutions, AI-powered labor management, and care management. All five companies will participate in a virtual onboarding orientation to connect with Jumpstart's network of industry experts and will be indoctrinated into The Jumpstart Refinery, Jumpstart's exclusive digital community, designed to connect the Jumpstart Foundry network and support growth acceleration.
"It has been an interesting and exciting year to be in venture capital – particularly in healthcare innovation. We are excited to welcome these new companies from diverse backgrounds across the country into the Jumpstart Foundry family," said Jumpstart Foundry COO Dr. Brian Dougherty.
In a time of great uncertainty, Jumpstart Foundry remains committed to making investments that support healthcare innovation. The Nashville-based venture capital firm is excited to MAKE SOMETHING BETTER in health as they prepare to deploy more capital in 2021.
About Jumpstart Foundry:
Jumpstart Foundry is a seed-stage healthcare innovation fund with one goal: Make Something Better. Jumpstart Foundry invests $150K in 15-20 healthcare startups from around the country each year. Jumpstart then guides and supports entrepreneurs through a systemized, step-by-step process to help each business reach success. The JSF fund has over 100 companies in its portfolio and was reported as Tennessee's most active venture capital firm in January 2020 by CB Insights.
For questions or additional information, please contact:
Richard Amoako
Content Marketing Manager | Jumpstart Foundry
richard@jsf.co
423-676-5282



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1514
This message is awaiting approval by a moderator.
Jim joins Capio with over 30 years' experience within the healthcare receivables management industry.

ATLANTA (PRWEB) NOVEMBER 30, 2020
Capio is pleased to welcome Jim Pender in the role of Vice President, National Accounts. Jim joins us with over 30 years' experience within the healthcare receivables management industry. Most recently, Jim served as the Vice President of Sales and Marketing for Medi-Centrix. Jim will be responsible for identifying new opportunities and supporting our existing national provider clients.
Jim brings a wealth of experience and knowledge to this role. Prior to joining Capio, he held leadership positions at EOS, McKesson, and Outsourcing Solutions, Inc. He began his career in operations at OSI prior to advancing into client management and sales roles.
"Jim is joining our team at Capio during a unique time. Despite the challenges of Covid-19, we are witnessing rapid growth as healthcare providers continue to rely on Capio to assist in their cash acceleration efforts," noted Dan Kutchel, Capio's Chief Sales officer. He added, "Our team is the best in the industry, and we are thrilled to have Jim join us. Jim's integrity, vast knowledge of the healthcare revenue cycle, deep personal connections, and past successes will allow him to excel in his new role."
Jim is active in several professional associations including Healthcare Finance Management Association (HFMA) on both a national and local level. Jim is also a member American Association of Healthcare Administrative Management, Medical Group Management Association, American Medical Group Association, Community Oncology Alliance and American Society of Anesthesiologists.
About Capio
Capio assists healthcare providers and physician organizations increase cashflow, while also lowering their bad debt expense. To date, Capio has acquired and provided consumer services with over $30B in patient accounts receivable, via partnerships alongside more than 450 provider clients across the United States. To learn more about Capio, please visit http://www.capiopfw



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1515
DigitalOne is offering Cranberry Peak ezCDS service as part of its DigitalOne Platform

CAMBRIDGE, MASS. (PRWEB) NOVEMBER 30, 2020
Cranberry Peak, a leading provider of AI, conversational interfaces and clinical decision support (CDS) technology announced today that it has formed a strategic partnership with DigitalOne. Cranberry Peak's clinical decision service, ezCDS has been integrated with DigitalOne's Orders Communicator, and is available to more than 100,000 providers currently connected through the DigitalOne Platform.
ezCDS is a CMS-qualified clinical decision support mechanism (CDSM) for the Appropriate Use Criteria (AUC) Program, supporting the implementation of Protecting Access to Medicare Act of 2014 (PAMA). Specifically, under this program, ordering physicians will be required to consult a CDSM for advanced diagnostic imaging orders. In addition to facilitating evidence-based medicine and standards of care at the point of care, ezCDS is also transforming user experience in healthcare and reducing physician burnout by introducing the first AI digital assistant serving ordering physicians, with voice and conversational interface. ezCDS supports modern interoperability standards with FHIR and CDS Hooks state of the art technology.
"With the integration of ezCDS into the DigitalOne Platform, our clients now have an intuitive solution to address CDS requirements that fits seamlessly into their workflow," said N Gulati, Sr Partner at DigitalOne. "With this partnership, imaging providers are now able to offer an easy to use solution to their referrer community to perform CDS consultations for advanced imaging orders across all referral channels even if the referring EMR doesn't offer CDS capability natively."
Cranberry Peak's Founder and CEO, Neculai Archip, PhD, MBA, said, "We have been working with the DigitalOne team for a while, and we are impressed by their effectiveness. In particular, the technical integration between our CDS service and DigitalOne platform was extremely smooth. DigitalOne's engineering team is top notch and has completed the technical integration within 3 weeks."
"Our companies are continuously optimizing our combined solution to best serve our users. Therefore, we are confident that this partnership will be successful for healthcare providers and positively impact the healthcare industry," Dr. Archip goes on to say.
Visit Cranberry Peak at https://www.cranberrypeak.com and DigitalOne at http://www.digitalonereports.net to learn more about this new partnership and how it can help you meet both current and future healthcare demands. During the week of November 30, 2020, Cranberry Peak is hosting online presentations on its website.
About Cranberry Peak
Cambridge, MA-based Cranberry Peak Corp. is a leader in AI, conversational interfaces and clinical decision support technology. In addition to enabling evidence-based medicine and standards of care, at the point of care, with the goal of improving healthcare delivery, Cranberry Peak is also aiming at reducing physician burnout.
For more information https://www.cranberrypeak.com or email contact@cranberrypeak.com
About DigitalOne
DigitalOne offers leading Interoperability Solutions that help Imaging Providers better serve their referring community while eliminating the time and expense associated with building point-to-point interfaces. The DigitalOne Platform that includes Orders Caddy, Desktop Delivery, EMRConnect, Zero Footprint Image Viewer, Orders Communicator and Patient Portal, deliver multiple convenient channels for referring providers to submit referrals and receive timely results into their EMR - securely, reliably and effectively.    
For more information https://www.digitalonereports.net or email info@digitalonereports.net

The technical integration between our CDS service and DigitalOne platform was extremely smooth. DigitalOne's engineering team is top notch and has completed the technical integration within 3 weeks.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1516
SmartBRAIN by MD Logic Health is the newest in our line of cognitive support supplements.

MIAMI, FLA. (PRWEB) NOVEMBER 30, 2020
MD Logic Wellness, last week announced that it has launched SmartBRAIN by MD Logic Health, a nutritional supplement featuring Acetyl-L-Carnitine, Phosphatidylserine, and Alpha GPC. It is known that as we age, our mental performance sees a noticeable decline in its normal functioning. While growing evidence and studies have revealed that exercise, genetics, and other lifestyle factors may impact our brain health and mental performance, new research reveals that nutrition can play a positive role in supporting healthy brain function, focus, concentration, and clarity. SmartBRAIN formula includes Phosphatidylserine, a phospholipid abundant in the brain. Phosphatidylserine improves neuron survival and supports the mechanisms needed for the formation of memories and learning.
Scott Emmens, Co-Founder of MD Logic Wellness commented, "As a busy entrepreneur, husband and father being able to maintain focus and recall throughout a long day is essential to maximize business and personal success. SmartBRAIN's stimulant-free formula allows me to seamlessly pivot from project to project without the jitters caffeine can cause. SmartBRAIN supports my natural neurotransmitters to keep me sharp and supplies Phosphatidylserine to support memory. We are very proud to introduce SmartBRAIN by MD Logic Health as the newest in our line of cognitive support supplements."
All MD Logic Health products are manufactured in the USA. We source only the purest and most effective ingredients which are quarantined and tested to meet approved specifications prior to being released for use. We strive to create effective and high-quality products based on clinical studies and scientific research. We are committed to delivering premium supplements to support a healthy lifestyle. Each MD Logic Health supplement is formulated with a specific purpose in mind. We believe that overall health and wellness can be improved by supplementing a healthy diet. MD Logic Health provides options that are gluten-free, vegetarian, dairy, and GMO-free with no artificial colors or flavors. For more information about SmartBRAIN and our other products please visit us at https://www.mdlogichealth.com or call 877-629-8711.
About MD Logic Wellness
MD Logic Health was created and founded by passionate health and wellness advocates. Our mantra is Spirit, Mind, Body, and Planet. Our quality is at the core of who we are and what we offer. Our purity and efficacy come from the superior ingredients used in every MD Logic Health product. Individual dietary and non-dietary ingredients are tested for identity, strength, purity, and composition compliance to ensure maximum effectiveness prior to use.
We currently have three distinct product lines to create a 360-degree ecosystem to link all potential customers. The Professional Line is sold exclusively to Health Care Providers, the MD Logic Health line is sold directly to consumers and the Essential line is sold to retail stores for core nutritional products.
"We believe health and well-being is the foundation to achieve your best life. Our mission is to connect our community to their health through superior dietary supplements, education, and health professional guidance. We believe our customers deserve the highest quality products, service, and support. MD Logic Health connects health care professionals and patients in their mutual pursuit of optimal wellbeing."
Availability
SmartBRAIN by MD Logic Health is now available online at our website https://www.mdlogichealth.com and on Amazon at https://www.amazon.com/MD-Logic-Health-SmartBRAIN/dp/B08NXX36BQ/
Contact
Jyoti Hardat, Director of Marketing
jhardat@mdlogichealth.com
+1(877) 629-8711 x700

We are very proud to introduce SmartBRAIN by MD Logic Health as the newest in our line of cognitive support supplements.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1517
Olive Fertility Centre voted Best Fertility Clinic in Vancouver in the Georgia Straight Best of Vancouver Awards 2020 - for the sixth year in a row - and voted in the top three for Best Local Employer

VANCOUVER, BRITISH COLUMBIA (PRWEB) NOVEMBER 30, 2020
Vancouver Canada-Olive Fertility Centre is proud to announce that they have been voted Best Fertility Clinic in Vancouver in the Georgia Straight Best of Vancouver Awards 2020.
We want to express our gratitude to all our wonderful patients who chose Olive to help them create their families and voted us the Best Fertility Centre in Vancouver for the sixth year in a row. We are also thrilled to have been voted in the top three for Best Local Employer.
"We are absolutely thrilled to have received Best Fertility Centre and Best Local Employer as it recognizes the level of care we provide for our patients and the kind of work environment we want for our staff. We really feel it is only by taking care of the people who work here that we can provide the excellent patient-centered care we are known for," says Olive Fertility co-director, Dr Beth Taylor. "The fact that Olive Fertility has among the best pregnancy success rates in Canada is due to our award-winning lab, internationally acclaimed team of fertility experts, and outstanding staff. Everyone at Olive, from the receptionists at the front desk to the patient care coordinators, nurses, embryologists and doctors, strives to ensure that patients have the best experience possible."
The rate of infertility in Canada has doubled over the last 20 years according to a Stats Canada report, in part because more women are delaying pregnancy until they are in their 30's and even 40's. "Frequently women don't know that fertility declines more quickly after 35 and that a woman over 35 and her partner should have a full fertility workup if they haven't conceived after six months of unprotected intercourse," says Dr Taylor. "The biological clock starts ticking much more quickly at this age. So, the sooner a problem is diagnosed, the more quickly the treatment can start."
Recent advances in fertility treatment and preimplantation genetic testing have improved the chances of achieving a pregnancy and having a healthy baby even for women over the age of 38.
Fertility evaluation and testing is fully covered by MSP in British Columbia with a referral from a family physician or a doctor at a walk-in clinic.
Olive would also like to congratulate Acubalance Wellness Centre for receiving the Georgia Straight Best of Vancouver Acupuncture, Naturopathic and Integrative clinic.
Located in Vancouver, BC, Olive Fertility Centre is one of Canada's leading fertility clinics, offering an award-winning IVF lab, personal care teams, 70+ years of combined experience, and innovative programs including specialized genetic testing, egg freezing, and prenatal NIPT testing.

We are absolutely thrilled to have received Best Fertility Centre and Best Local Employer as it recognizes the level of care we provide for our patients and the kind of work environment we want for our staff.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1518
MarvelXACT PEEKsil can be used in all HPLC/UHPLC applications

ROHNERT PARK, CALIF. (PRWEB) DECEMBER 01, 2020
IDEX Health & Science, industry leader in fluidic connections for life science applications, has launched the new MarvelXACT PEEKsil Connection Systems. Employing patented MarvelXACT connections technology, these new bioinert tubing and fitting connection systems are designed to be compatible with low flow applications at high pressures that require low contamination and minimal flow resistance. The new connection systems have an extremely smooth internal diameter and provide a secure dead volume connection which helps avoid carryover and blockage.
"MarvelXACT PEEKsil can be used in all HPLC/UHPLC applications and as a replacement for PEEK and SST tubing especially where chemical compatibility and low absorption is required" said Audrey Schrock, Sr. Product Manager, Valves and Column Hardware. "We are enabling more robust low-flow analysis data for applications that are highly sensitive and require chemical inertness," continued Schrock.
Other bioinert products supplied by IDEX Health & Science include: MarvelX and MarvelXACT connection technology, 1mm columns, bioinert PEEK-Lined Stainless-Steel Column Hardware and a novel flat film degasser.
About IDEX Health & Science, LLC
IDEX Health & Science, LLC is the global leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, solutions, and expertise. As one of the few companies in the world with component, sub-system, and application level experts, IDEX Health & Science helps instrument developers solve the most demanding fluidic and optical challenges in a wide array of applications. At IDEX Health & Science we believe partnership will change the way the world innovates, leading to new technologies that improve our health, protect our planet, and enrich our lives. For more information visit: http://www.idex-hs.com

MarvelXACT PEEKsil can be used in all HPLC/UHPLC applications and as a replacement for PEEK and SST tubing especially where chemical compatibility and low absorption is required" said Audrey Schrock, Sr. Product Manager, Valves and Column Hardware. "We are enabling more robust low-flow analysis data



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1519
Children's National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids.

SALT LAKE CITY (PRWEB) NOVEMBER 30, 2020
Children's National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids. The innovation, insta-3D imaging from company nView medical, is designed to make 3D images available in the operating room quickly and safely. The 3D images provide surgeons with better visualization, allowing them to continue improving patient care and outcomes.
Matthew Oetgen, M.D., division chief of Orthopaedic Surgery at Children's National, is overseeing the first use of this 3D imaging technology in orthopaedic procedures.
"Having a technology like this available in the operating room will potentially help make our surgeries even more precise with 3D imaging available quickly," says Dr. Oetgen. "We anticipate this improved precision will lead to better outcomes and added value to what we do for our patients."
Cristian Atria, nView medical's CEO, commented for the first case.
"Seeing our imaging technology provide critical information during a kid's surgery reminds us what the purpose of nView medical is all about," says Cristian. "I would like to thank the surgeons, our backers, the team, and our clinical partners for making this first surgery a success. I couldn't be more enthusiastic for what's ahead!"
The potential of nView medical's insta-3D imaging is especially exciting for Children's National as nView medical is a 2019 Winner of the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) competition "Make Your Medical Device Pitch for Kids!" NCC-PDI is led by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National and the A. James Clark School of Engineering at the University of Maryland with support from partners MedTech Innovator, BioHealth Innovation, and design firm Archimedic.
NCC-PDI is one of five members in the FDA's Pediatric Device Consortia Grant Program created to support the development and commercialization of medical devices for children in areas of critical need where innovation can significantly improve children's health care.
"Children deserve to benefit from our most advanced medical technologies and we know that improvements in pediatric care can make a positive difference over the lifetime of a child," says Kolaleh Eskandanian, Ph.D., M.B.A, P.M.P, vice president and chief innovation officer at Children's National and principal investigator of NCC-PDI. "Pediatric hospitals must lead the way in supporting innovation for children's care. That's why, through NCC-PDI and our innovation institute, Children's National helps to provide promising new pediatric devices with resources and expertise that support their journey to the market."
-
About nView medical:
nView medical, based in Salt Lake City, UT, is a startup whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Capital Consortium for Pediatric Device Innovation, MedTech Innovator, HealthTech Arkansas, Dr. Kevin Foley, MD, and Fusion Fund (Palo Alto, CA).
About Children's National Hospital
Children's National Hospital, based in Washington, D.C., celebrates 150 years of pediatric care, research and commitment to community. Volunteers opened the hospital in 1870 with 12 beds for children displaced after the Civil War. Today, 150 years stronger, it is among the nation's top 10 children's hospitals. It is ranked No. 1 for newborn care for the fourth straight year and ranked in all specialties evaluated by U.S. News & World Report. Children's National is transforming pediatric medicine for all children. In 2020, construction will be complete on the Children's National Research & Innovation Campus, the first in the nation dedicated to pediatric research. Children's National has been designated twice as a Magnet hospital, demonstrating the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C., metropolitan area, including the Maryland and Northern Virginia suburbs. Children's National is home to the Children's National Research Institute and Sheikh Zayed Institute for Pediatric Surgical Innovation and is the nation's seventh-highest NIH-funded children's hospital. It is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels.

We anticipate this improved precision will lead to better outcomes and added value to what we do for our patients.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1520
Beginning in March of 2020, older adults were cut off from their families. Senior living companies of all types were caught in the triple bind of no-visitors, worsening worker shortage and the spread of Covid-19 to their residents. The pandemic caused older adults to defer health appointments and interactions with others, resulting in the usage of telehealth and other technologies like Zoom and FaceTime to skyrocket. Many of the technology stopgaps will become part of permanent change in how seniors connect, how businesses serve them, and what innovations matter most. Aging and Health Technology Watch covers these topics in its newest research report , "The Future of Remote Care Technology and Older Adults 2020."

PORT SAINT LUCIE, FLA. (PRWEB) NOVEMBER 30, 2020
The current status and future potential are discussed in the new report The Future of Remote Care Technology and Older Adults 2020 from Aging and Health Technology Watch. The report is based on interviews with experts from 30 organizations across healthcare and technology. Insights and report advice span telehealth, wearables, AI, smart home, and voice products and services.
Says Mary Furlong: "Laurie Orlov continues to deliver thought leadership and guidance that will help shape the longevity market in these difficult times."
Tech industry veteran Laurie M. Orlov launched the market research company in 2009 with a blog, advisory services, and industry information which can be found at http://www.ageinplacetech.com.

The home will be come the hub for life and care.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1521
Prescott's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

PRESCOTT, ARIZ. (PRWEB) DECEMBER 01, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Prescott, AZ for 2021. The informational guide recognizes the top 16 rehab facilities based on cost, treatment options, location, accompanying services and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Prescott, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Prescott with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Prescott. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Prescott, AZ please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-prescott-az/
2021 Best Rehab Facilities in Prescott, AZ (in alphabetical order)
Blueprints for Recovery
225 Grove Avenue
Prescott, AZ 86301
928-723-4600
Canyon Crossing Recovery
819 West Gurley Street
Prescott, AZ 86305
800-651-7254
Compass Recovery Center
711 South Granite Street
Prescott, AZ 86303
800-216-1840
Decision Point Center
505 Whipple Street
Prescott, AZ 86301
928-778-4600
Embark Recovery
3727 Karicio Lane
Prescott, AZ 86303
928-250-0447
Granite Mountain Behavioral Healthcare
8705 East Eastridge Drive
Prescott Valley, AZ 86314
877-389-0412
Holdfast Recover
1470 West Gurley Street
Prescott, AZ 86305
800-680-7738
Northern Arizona Center for Addiction
195 Plaza Drive
Prescott, AZ 86303
928-615-6006
Prescott House
214 North Arizona Avenue
Prescott, AZ 86301
866-425-4673
Recovery In The Pines
919 12th Place, Suite 13
Prescott, AZ 86305
844-762-3748
Reflections Recovery Center
957 Black Drive
Prescott, AZ 86305
866-418-1213
Reflections Recovery Center
957 Black Drive
Prescott, AZ 86305
866-418-1213
Royal Life Centers at Chapter 5
818 W. Gurley Street
Prescott, AZ 86301
877-732-6837
Silver Sand Recovery
3636 Crossings Drive
Prescott, AZ 86305
833-723-0387
StoneRidge Center for Brain and Addiction Treatment
5940 East Copper Hill Drive, Suites B & E
Prescott Valley, AZ 86314
928-583-7799
Viewpoint Dual Recovery
702 W. Hillside Avenue
Prescott, AZ 86301
855-746-3633
West Yavapai Guidance
642 Dameron Drive
Prescott, AZ 86301
928-445-5211
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1522
Even the healthiest of adults are affected by the physical and mental effects of aging because of the inherent nature of the process. With this in mind, Market America | SHOP.COM is here to talk about aging well and two ways to appreciate your second act even more!

GREENSBORO, N.C. (PRWEB) NOVEMBER 30, 2020
The holidays are here and it's the perfect time to give thanks for what's most important in our lives. As we age, certain things take on more meaning and importance. Often, what becomes most important are the very things that money can't buy – the love of family and friends and the time we spend together with the ones we love becomes priceless. American activist, editor and writer, Frances Lear, may have said it best when she said "I believe the second half of one's life is meant to be better than the first half. The first half is finding out how you do it. And the second half is enjoying it." With this in mind, Market America | SHOP.COM is here to talk about aging well and two ways to appreciate your second act even more!
Referred to as the "gray tsunami," the U.S. Census reports that baby boomers (born from 1946 to 1964) have changed the face of our country for more than 70 years and are continuing to do so as they become seniors. An estimated 73 million baby boomers account for the second-largest age group, only to be outnumbered by the millennials (born from 1982 to 2000). By 2030, all boomers will be at least age 65.
No matter what your age, it's important to take care of yourself by eating the right foods, exercising regularly and visiting your personal healthcare physician for an annual checkup. Even the healthiest of adults, however, are affected by the physical and mental effects of aging because of the inherent nature of the process. So, the next time you go in for your annual checkup, consider talking with your doctor about nutrients and what you should be eating to get the right amount of nutrients for your age. Why? Consider this. The National Institute of Health (NIH) has shared research demonstrating that because older adults' abilities to absorb and use many nutrients become less efficient, the nutrient requirements can actually increase. This may mean that while you are focused on maintaining an alert mind and an active body, the level of nutrients it can take to get you there may be more than you realize!
That's where two supplements may help you as you age – Prime Ultimate Longevity Formula by Isotonix and Isotonix Essentials Anti-Aging. Both can help with the physical and mental effects of aging and both are in an isotonic delivery system. More on what an isotonic delivery system is in a moment.
1.    Prime Ultimate Longevity Formula by Isotonix
Prime Ultimate Longevity Formula by Isotonix specifically addresses the select needs of mature adults. While other products might focus on a particular area of aging, Prime Ultimate Longevity Formula by Isotonix is designed for the aging adult who wants to maintain both an alert mind and active body. Prime Ultimate Longevity Formula by Isotonix is formulated with natural ingredients, including huperzine A (which aids in improving and enhancing memory and cognitive function) and branched-chain amino acids (which promote muscle retention). Benefits may include:*

Supporting cognitive performance

Helping to reduce muscle fatigue

Aiding in improving and enhancing memory

Promoting healthy muscle retention and use

2.    Isotonix Essentials Anti-Aging
Although a healthy diet is essential to getting the nutrients the body needs to look and feel well, taking daily supplements can be a good way support optimal health. We too often accept lower energy and strength as we mature, however, supplements can add the needed vitamins and minerals to balance the demands of the body and brain as we get older. Isotonix Essentials Anti-Aging can help you maintain the vitality of your body as you gracefully move up in years. It features a dynamic, custom blend of antioxidants, botanicals and minerals designed to provide the vitamins and minerals you need as your body ages. Our Anti-Aging formula helps support brain and cognitive health, provides a strong antioxidant defense and provides daily nutrients to support healthy aging. It also helps support skeletal and muscular health.* Benefits may include:

Providing daily nutrients to support healthy aging.

Promoting muscle health and strength

Helping with energy and stamina

Helping to support brain/cognitive health

Isotonic, which means "same pressure," bears the same chemical resemblance of the body's blood, plasma and tears. All fluids in the body have a certain concentration, referred to as osmotic pressure. The body's common osmotic pressure, which is isotonic, allows a consistent maintenance of the body's tissues. In order for a substance to be absorbed and used in the body's metabolism, it must be transported in an isotonic state. Both Prime Ultimate Longevity Formula by Isotonix and Isotonix Essentials Anti-Aging are isotonic solutions, meaning that the body has less work to do in obtaining maximum absorption. The isotonic state of the suspension allows nutrients to pass directly into the small intestine and be rapidly absorbed into the bloodstream. With Isotonix products, little nutritive value is lost, making the absorption of nutrients highly efficient while delivering maximum results.*
Finally, when it comes to defeating age, Sophia Loren says each of us already has what we need. "There is a fountain of youth: it is your mind, your talents, the creativity you bring to your life and the lives of people you love. When you learn to tap this source, you will truly have defeated age."
*These statements have not been evaluated by the Food and Drug Administration. This product(s) is not intended to diagnose, treat, cure or prevent any disease.
Market America | SHOP.COM is a global product brokerage and internet marketing company that specializes in one-to-one marketing and is the creator of The Shopping Annuity.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1523
Mediaplanet's Lung Health campaign, found within USA TODAY and online, aims to raise awareness on chronic lung diseases affecting nearly 37 million Americans

NEW YORK (PRWEB) NOVEMBER 30, 2020
Lung disease is the third-leading cause of death in the United States, affecting nearly 37 million Americans living with some form of chronic lung disease. Despite these daunting figures, we are heading toward a brighter future for lung health, due to advancements in early detection and treatment. Mediaplanet's new November edition of the 'Lung Health' campaign will reach both patients and professionals, alerting them to the innovative tools now available.
In partnership with the respiratory community's leaders, this campaign educates readers on some of the most serious lung issues including lung cancer, pulmonary fibrosis, asthma, and cystic fibrosis. It also calls special attention to lung diseases in the age of COVID-19 and how every individual can take preventative measures to protect their lungs.
The print component of "Lung Health" is distributed within the November 25th regional circulation of USA Today with a circulation of approximately 200,000 copies and an estimated readership of 600,000 within the New York, Los Angeles, San Francisco, and Washington D.C./Baltimore markets. The digital component is distributed nationally, through a cast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, click here.
This edition of "Lung Health" was made possible with the support of the American Thoracic Society, Lung Cancer Foundation of America, Go2 Foundation for Lung Cancer, Pulmonary Fibrosis Foundation (PFF), Allergy and Asthma Network, Personalized Medicine Coalition, Cancer Treatment Centers of America, Rock CF, Association of Community Cancer Centers, Bellerophon Therapeutics, GRAIL, Boehringer Ingelheim Pharmaceuticals and SunRADON.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Isabelle Garrity
Isabelle.garrity@mediaplanet.com
646 - 518- 5421



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1524
Mediaplanet and SunRADON have joined forces in advocating for lung health

NEW YORK (PRWEB) NOVEMBER 30, 2020
Mediaplanet is proud to announce the launch of this November's Lung Health campaign. The campaign brings together patients, healthcare providers, advocates to spread awareness of chronic lung disease as well as recent innovation in prevention, diagnostics, and treatment for these devastating respiratory conditions. The campaign also takes a dive into importance of lung cancer prevention, and how some companies are dedicated to helping prevent lung cancer.
One leading company is SunRADON, a top provider of professional Radon Detection and Indoor Air Quality (IAQ) monitors. The company has recently launched lüft, the world's first smart, plug-in Indoor Air Quality and Radon Monitor. This is a welcome innovation in the fight against radon-induced lung cancer.
lüft was created to provide consumers an effective and easy method to track Indoor Air Quality, including detection of Radon, a feature often lacking in today's IAQ monitors yet crucial in protecting lung health. "Radon is the #1 cause of lung cancer among non-smokers, and responsible for more deaths every year than all other home related deaths combined. Yet long term radon measurements are not included in standard IAQ monitors! It's because radon detection requires specialized know-how and technology, which SunRADON has mastered for 30+ years while serving professional radon inspectors and mitigators worldwide," explains SunRADON CEO Dr. Kai Wundke.
Through lüft, SunRADON is helping a wide variety of customers, whether at home, school, the office or a healthcare facility, to accurately monitor indoor air quality on a long-term basis. lüft not only monitors radon levels but also dangerous chemicals such as formaldehyde, carbon dioxide equivalent, temperature, pressure, and humidity. lüft is unique in that it packs state-of-the-art radon detection into an IoT-enabled plug-in device. It also allows users to share data with their indoor air quality professionals to provide expert services should need arise.
"lüft is not just another IAQ monitor, but an integrated, smart IAQ system with the benefit of also detecting radon, the most dangerous Indoor Air Quality problem of them all," adds Dr. Wundke. The lüft monitor is available for purchase on sunradon.com or amazon.com.
The print component of Lung Health is distributed within the November edition of USA TODAY in LA, Boston, New York, Chicago, Houston, Seattle, Las Vegas, D.C Baltimore, and Pittsburgh/Cleveland markets. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: https://www.futureofpersonalhealth.com/campaign/lung-health/
The campaign was made possible with the support of SunRADON, as well as the American Thoracic Society, Lung Cancer Foundation of America, Go2 Foundation for Lung Cancer, Boehringer Ingelheim, Bellerophon Therapeutics and GRAIL.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Isabelle Garrity
Isabelle.garrity@mediaplanet.com
646-518-5421



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1525
Clearwater's leading provider of Cryoskin and Verju fat reduction technologies announces curated event series to give clients safe and local access to even more wellness

CLEARWATER, FLA. (PRWEB) NOVEMBER 30, 2020
Trim Studio is dedicated to helping clients achieve their goals through leading-edge technologies for fat reduction, cellulite treatment and skin toning without painful procedures, side effects or downtime. Their ongoing wellness event series will focus on therapies which support body contouring results and overall well being. For more information, visit their website.
"Throughout this year, we knew we'd need to get creative with how we make wellness resources available to our clients. The 'quarantine 15' joke is all too real for so many of us, and we feel lucky to work in a setting that allows for safe execution of events and one-on-one treatments at a safe social distance," says Corina Froese, co-founder of Trim Studio.
Trim Studio was set to host their second annual Brunch and Yoga event in the spring of 2020 when pandemic-related circumstances made it impossible. After canceling, they shifted gears to smaller pop-up style events with a more intimate feel. Even with smaller events, Trim Studio intends to pack them with a punch of beneficial wellness and science-backed adjunct therapies.
In September, the Clearwater wellness boutique welcomed healthcare providers for vitamin injections and hormone wellness consultations. In November, an ozone sauna was made available to clients during a two day pop-up event which sold out in under 48 hours. In December, the Studio will be in Tampa for a one day event offering discounted body treatments and anti-aging CryoFacials at Femme Akoi Beauty Studio on Nebraska Avenue in Tampa.
"We absolutely love working with local wellness businesses that share our common goal to help clients improve their lifestyle and feel better. Though circumstances limited us a little bit in 2020, it also allowed us time to step back and reflect on how we might help our clients achieve more and better results—this is something that is always top of mind, and we definitely have some exciting news and changes to reveal in the new year!"
Trim Studio's non-invasive Verju laser is FDA-cleared for reduction of cellulite, fat and overall body circumference. Verju is the world's first green body contouring laser of its kind and the only body contouring device on the market with proven efficacy by way of a double-blind, multi-site and placebo-controlled clinical study in which clients saw a four-inch average loss after completion of a treatment program. The Studio also offers Cryoskin 3.0 technology which affords clients the opportunity to spot reduce stubborn body fat through cryolipolysis (fat freezing) as well as to reduce the appearance of cellulite and smooth facial wrinkles.
Trim Studio's technologies are appropriate for body types ranging from athletic to clinically obese. For more information or to request a consultation contact them by calling 727-288-4329.
###
ABOUT TRIM STUDIO
Trim Studio is a wellness boutique located in Clearwater, Florida specializing in non-surgical body sculpting. Utilizing technologies such as Cryoskin 3.0 for cryolipolysis (fat freezing), skin toning, cellulite smoothing and facial rejuvenation as well as Verju (photoporosis) for fat and cellulite reduction, Trim Studio is dedicated to changing the body contouring game with effective tools for real, observable fat loss and improvements to skin's elasticity and tone. For more information, please visit http://www.TrimStudioFL.com or visit the Studio on social media at @TrimStudioFL!
MEDIA CONTACT
Corina Froese
corina@dandelioncreativeco.com
727-441-1711



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1526
President & Founder of HR Maximizer Inc is now a member of the Forbes Business Council. Forbes Business Council is an Invitation-Only Communities For Successful Executives And Entrepreneurs

HOUSTON (PRWEB) NOVEMBER 30, 2020
Rollis Fontenot III of HR Maximizer Inc accepted into Forbes Business Council
Forbes Business Council Is an Invitation-Only Community for Successful Business Owners and Leaders
Rollis Fontenot III, president & founder of HR Maximizer Inc, a subscription based recruitment services firm serving clients nationwide, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.
Rollis Fontenot III was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors.
"We are honored to welcome Rollis Fontenot III into the community," said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council. "Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world."
As an accepted member of the Council, Rollis has access to a variety of exclusive opportunities designed to help his reach peak professional influence. he will connect and collaborate with other respected local leaders in a private forum and at members-only events. Rollis will also be invited to work with a professional editorial team to share his expert insights in original business articles on Forbes.com, and to contribute to published Q&A panels alongside other experts.
Finally, Rollis will benefit from exclusive access to vetted business service partners, membership-branded marketing collateral, and the high-touch support of the Forbes Councils member concierge team.
"I am very excited about being a part of this global community of business leaders who are looking to offer their expertise to help others grow. In this way, the rising tide will lift all boats, thereby helping all of us attain our individual goals. I look forward to this opportunity for us to make valuable contributions to this group as we grow together."
ABOUT FORBES COUNCILS
Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive.
To learn more about Forbes Councils, visit forbescouncils.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1527
In this free webinar, the featured speakers will discuss the impact of the RACE for Children Act since it went into effect, from a regulatory, health care professional and industry point of view, both in the USA and globally. They will talk about what a pediatric champion is and why they are needed, and a parent and child's experience of a molecularly targeted therapy.

TORONTO (PRWEB) NOVEMBER 30, 2020
After three years of hard work by multiple diverse stakeholders, and with much anticipation, the RACE for Children Act became effective August 18th, 2020. This landmark legislation aims to dramatically shift the global landscape of clinical research in pediatric oncology and intends to bring new molecularly targeted cancer therapeutics to children, who have not been as greatly impacted by precision medicine over the past few decades compared to adults.
Whether the RACE for Children Act leads to the development of more drugs for children with cancer in the USA, and globally, remains to be seen. What can we learn about the global impact of the RACE for Children Act in the first few months since its implementation? What is needed to ensure its ongoing success?
Regulators, researchers, industry and patient advocates have come together to focus on not only curing childhood cancer but reducing long term side effects. Please join us in hearing from them in this webinar on what the early global impact of the RACE for Children Act looks like, and what is needed to ensure its success, including the critical function of pediatric champions.
Join Dr. Gregory Reaman, Associate Director for Pediatric Oncology, Oncology Center of Excellence, Center for Drug Evaluation and Research, US Food and Drug Administration; Prof. Gilles Vassal, Head of Pediatric Research Program, Gustave Roussy/Université Paris-Saclay and President ITCC, Chair of ACCELERATE; Dr. Anjali Sharma, Pediatric Oncology Development Lead and Early Oncology Development Lead, Amgen; and Dr. Beth Anne Baber, Founder & President, TigoHealth, in a live webinar on Thursday, December 17, 2020 at 10am EST (3pm GMT/UK).
For more information, or to register for this event, visit The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1528
In this complimentary webinar, featured speakers from Medpace and MyoKardia will discuss precision medicine approaches for treating cardiovascular disease and its growing role in clinical trials. A case study of MyoKardia's MAVERICK-HCM trial will be presented, highlighting operational challenges, best practices and lessons learned. Future directions, including mitigations during a pandemic will also be disussed.

TORONTO (PRWEB) NOVEMBER 30, 2020
Despite advances in medical therapeutics, cardiovascular disease (CVD) remains the leading cause of death worldwide. Notably, heart failure and coronary disease continue to present an exorbitant burden on patients and health care. Recently, breakthroughs in precision medicine are creating optimism for a field that has historically witnessed few long-term successes in targeted therapeutic approaches.
Indeed, precision-medicine approaches target the subsets of patients that are most likely to benefit from a drug, including approaches based on mechanism of disease and shared patient characteristics. By matching mechanism of a drug action with specific disease etiology, precision-medicine approaches are starting to turn the page in CVD trials.
Investigational drugs like mavacamten, developed by MyoKardia, offer new hope for patients with hypertrophic cardiomyopathy (HCM), an inherited and often lethal primary myocardial disorder without effective pharmacological options. Indeed, the striking positive results found in obstructive and non-obstructive HCM patients are expected to support a New Drug Application (NDA) filing, thus commencing a new promising chapter in the precision-medicine approach to CVD drug discovery.
Join experts from Medpace and MyoKardia in a live webinar on Tuesday, December 15, 2020 at 12pm EST (5pm GMT/UK).
For more information, or to register for this event, visit From Promise to Reality: MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1529
In this free webinar, the featured speakers will discuss when direct-to-patient is applicable for a trial and whatsponsors should plan for if implementing a direct-to-patient strategy.

TORONTO (PRWEB) NOVEMBER 30, 2020
The current pandemic has had a significant impact on clinical development, calling for the implementation of decentralized trials. With this change, it's now more important than ever to ensure the right Investigational Medicinal Product (IMP) reaches the right patient at the right time.
So how do sponsors go about implementing direct-to-patient models and how do they maintain the chain of custody for the life of an IMP? This insightful webinar will take participants through the what, why and how of performing various direct-to-patient models. Participants will gain knowledge of the important areas to consider before executing, such as:

Additional data requirements needed

What information needs to be held in the Interactive Response Technology (IRT)

What steps can be taken to safeguard trials beyond the pandemic

Join expert speakers from Almac Clinical Technologies, Matt Lowrie, ASQ CQA, QA Manager, Quality Assurance; Abby Sener, Manager, Almac ONE, ACS Project Services; and Kat Williams, Manager, Clinical Project Services, in a live webinar on Tuesday, December 15, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Direct-to-Patient: Implementing Models for Continuous Treatment During the Pandemic And Beyond.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1530
In this free webinar, experts from ICON Medical Imaging and Medidata will discuss how AI needs to have focus in specific areas, as past efforts to do everything have failed. The presenters will talk about narrowing down imaging problem statements to generate better results. How AI and ML can function as "guide rails" for radiologists will also be explored, in addition to areas in which AI and ML can increase (thus saving money) and improve quality (thus saving lives).

TORONTO (PRWEB) NOVEMBER 30, 2020
For the first 125 years of medical imaging, technological advances focused primarily on new modes of imaging as technology progressed from the discovery of the X-ray in 1895 to ultrasounds, MRIs, PET and CT scans in the late 20th century. Now, arguably, the most notable advances are being made in how images from those technologies are securely shared, managed, stored and assessed. These advancements are largely due to the application of artificial intelligence (AI) and machine learning (ML) to imaging systems and data platforms.
Automation is improving virtually every stage of the imaging workflow, but there is a lot of hype concerning AI and ML in the marketplace. Companies have underestimated the challenge that complexity presents, and predictions of the end of radiologists have proven false multiple times.
Join experts from ICON Medical Imaging and Medidata for this webinar on the practical applications for AI and ML in clinical trial imaging and what is possible today. Learn what is available today in the current landscape, its applications for building efficiency and what is coming in the near future to help life science companies transform their clinical trial imaging.
Join Paul McCracken, Vice President, Head of Medical Imaging, ICON Medical Imaging; and Dan Braga, VP, Product Management, Acorn AI Product & Ecosystem, Medidata, in a live webinar on Wednesday, December 16, 2020 at 11am EST (8am PST).
For more information, or to register for this event, visit Imaging AI and Machine Learning — Beyond the Hype.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1531
The company's latest algorithm enhancements to help radiologists distinguish between Coronavirus and other abnormalities such as common pneumonia on chest CT scans

NEW YORK (PRWEB) NOVEMBER 30, 2020
RADLogics today announced the availability of the latest version of the company's AI-Powered COVID-19 CT algorithm. Building on the company's AI-Powered solution that has processed and analyzed hundreds of thousands of suspected Coronavirus cases globally, the latest update delivers a complex deep learning system consisting of several models utilized to detect, localize and segment regions in the lungs infected with COVID-19. With Coronavirus cases again surging across the U.S. along with hospitalizations, AI-Powered solutions are poised to not only alleviate the increased burden associated with COVID-19, but to help support improved outcomes by reducing burnout and errors.
As part of RADLogics' latest version of its algorithm, three different analyses can now be performed simultaneously on raw chest CT image scans including: 1) a lungs region-of-interest are cropped with lung abnormalities detected; 2) the lung lobes are segmented and; 3) if the nodules plug-in is activated, focal Ground Glass Opacities (GGOs) are detected. According to leading physicians, these measurements are key features in determining patient classification into COVID-19 and non-COVID-19 indications. The overall system produces the decision whether the case is suspected for COVID-19 with a confidence level (in percentages). These measurements along with other features are used by radiologists to distinguish between COVID-19 and other abnormalities such as common pneumonia.
"With the U.S. in the midst of an unprecedented rise in COVID-19 infections, with current hospitalizations at an all-time record of more than 90,000 patients, there is an increasing need for AI solutions in medical imaging," said Moshe Becker, CEO and Co-Founder of RADLogics. "Coronavirus-related infection rates are experiencing a sharp increase in most states – from rural communities to urban areas – that have the potential to overwhelm ER, ICU and radiology teams with a surge of patients, and AI-Powered medical imaging analysis solutions are poised to reduce this pressure through improved patient triage, monitoring and management."
Since the pandemic started earlier this year, RADLogics has responded with the deployment of the company's AI-Powered medical image analysis solution worldwide. In accordance with FDA guidance for imaging systems and software to address the COVID-19 public health emergency, RADLogics has made its FDA cleared CT and X-ray solutions available to hospitals and healthcare systems throughout the U.S. for patient triage and management. Designed for easy installation and integration both on-site and via the cloud, RADLogics' algorithms are supported by the company's patented software platform that enables rapid deployment at multiple hospitals, and seamless integration with existing workflows. All of the company's AI-Powered solutions are available worldwide through major OEM distribution partners including Nuance via the AI Marketplace in the U.S. market.
To further validate the ability of AI to distinguish COVID-19 from other respiratory diseases, the company also highlighted a new research paper in preprint entitled "Automated triage of COVID-19 from various lung abnormalities using chest CT features". Led by Professor Hayit Greenspan from Tel Aviv University and members of the RADLogics' algorithm development team, the paper studied a fully automated AI-based system that takes as input chest CT scans and triages COVID-19 cases.
The study explored multiple descriptive features, including lung and infections statistics, texture, shape and location, to train a machine learning based classifier that distinguishes between COVID-19 and other lung abnormalities (including community acquired pneumonia). The research evaluated the system on a dataset of 2,191 CT cases and demonstrated a robust outcome with 90.8 percent sensitivity at 85.4 percent specificity with 94.0 percent ROC-AUC. Results of this study are available on arXiv.org, and it has been submitted for review and potential publication.
RADLogics will be featured this week as part of the RSNA 2020 Imaging AI in Practice demonstration. In addition, RADLogics will be included in the Nuance virtual booth as part of the company's AI Marketplace display. You can also learn more about RADLogics' COVID-19 solutions on the company's website at https://www.radlogics.com/covid-19.
About RADLogics
RADLogics is a healthcare software company developing AI-Powered solutions that support image analysis to improve radiologists' productivity while enhancing patient outcomes. Based in New York, NY, U.S., and Tel Aviv, Israel, RADLogics is one of the pioneers in using AI & machine learning image analysis and advanced big data analytics to search and analyze imaging data from CTs, MRIs, PET scans, and X-rays to help reduce diagnostics turnaround time from hours to minutes by automating detection and report generation functions. The company's patented AI medical image analysis platform enables rapid development of AI algorithms, and provides seamless integration into existing radiology workflow. Visit http://www.radlogics.com to learn more or follow us on LinkedIn or Twitter. To contact RADLogics to request a demonstration or to sign up for our monthly newsletter, please visit https://www.radlogics.com/contact.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1532
Introducing the winners of The Scientist's annual Top 10 Innovations competition. From an ID NOW COVID-19 test to a single-cell intracellular proteome, these new products made 2020 a transformative year in both laboratory and clinical life science.

WILMINGTON, DEL. (PRWEB) DECEMBER 01, 2020
Each year The Scientist strives to identify the latest and greatest tools, technologies, and techniques to hit the life science landscape. For more than a decade, our expert panels of independent judges have weighed submissions of innovative products speeding work in laboratories and facilitating biological discovery. This year's crop of entries to The Scientist's Top 10 Innovations contest reflected the fact that the scientific community, like the whole of society, faced a once-in-a-lifetime challenge in the form of a global infectious disease pandemic. "The COVID-19 pandemic birthed a shared scientific purpose and accelerated innovation in 2020," says Editor-in-Chief Bob Grant. "The winners of this year's competition embody the spirit of togetherness and ingenuity marshalled by the research community in the face of this unprecedented challenge."
The winners of The Scientist's Top 10 Innovations of 2020 contest are:
1) CeliumTM (AbCellera) – This AI-powered data visualization tool can rapidly sift through genetic data to identify antibodies that might work best as potential therapies for various diseases, such as COVID-19.
2) ID NOW COVID-19 Test (Abbott) – This toaster-size device can detect RNA from the SARS-CoV-2 virus, reporting results in less than 15 minutes.
3) TotalSeqTM-C Human Universal Cocktail v1.0 (BioLegend) – Comprising a collection of 130 oligo-linked antibodies for massive screening of the cell-surface proteins of individual cells, this tool is designed for use on a single-cell sequencing platform.
3) GRAFTM (Seven Bridges) – This genomic analysis platform attempts to include all possible iterations of genetic sequences at any given locus, with the goal of capturing more variations and boosting the presence of underrepresented groups in genomic research.
4) TESSA (OXGENE) – This research-grade viral vector aims to improve the efficiency of making adeno-associated virus (AAV) for potential use in gene therapies.
5) BioXpTM 3250 System (Codex DNA) – With this desktop gene synthesizer, researchers can assemble DNA sequences of up to 7,000 base pairs long with the push of a button.
6) Single-Cell Intracellular Proteome (IsoPlexis) – This system uses innovative microfluidics to monitor 30 or more protein pathways at the level of single cells.
7) Surge (GigaGen) – This platform helps researchers tease apart the intricacies of the immune system by using single-cell sequencing to capture and recreate libraries of antibodies from blood donors, including people who have recovered from COVID-19.
8) Chromium Single Cell Multiome ATAC + Gene Expression (10X Genomics) – With the goal of opening a window onto cellular functionality, this platform simultaneously profiles the epigenome and transcriptome of single cells.
9) Visium Spatial Gene Expression Solution (10X Genomics) – This technology exposes 55-micrometer areas at 5,000 locations within a tissue sample to mRNA-binding oligonucleotides, and overlays the resulting gene expression data with histological images, yielding high-resolution gene expression data.
9) OnyxTM Digital Genome Engineering Platform (Inscripta, Inc.) – This benchtop device makes CRISPR scalable and high-throughput using fully automated genome-engineered libraries with hundreds of thousands of single edits in microbial genomes.
10) SLIM (MOBILion) – This instrument brings ion mobility separations to the next level, packing a 13-meter ion path length in a device the size of a briefcase, enabling higher resolution, faster analysis, and simpler workflows in characterizing biologic therapeutics, biomarker discovery, and clinical diagnostics.
Congratulations to this year's winners. Be sure to visit https://the-scientist.com/features/2020-top-10-innovations-68176 where you can read more about the products that earned top spots and see comments from our expert judges.
About The Scientist:
The Scientist is a publication for life science professionals that is dedicated to covering a wide range of biological fields. The Scientist provides print and online coverage of the latest developments in the life sciences, including trends in research, new technology, news, business, and careers. It is read by the science-curious public and leading researchers in industry and academia who value penetrating analyses and broad perspectives on life science topics both within and beyond their areas of expertise. Written by prominent scientists and professional journalists, articles in The Scientist are concise, accurate, accessible, and entertaining.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1533
Chill-Pak ramps up mass production of its ISTA-Qualified ultra-cold thermal shippers to meet market demand for upcoming distribution of Covid-19 vaccines.

SPRINGFIELD, MO. (PRWEB) NOVEMBER 30, 2020
Engineered Packaging, Inc. dba Chill-Pak a leading manufacturer and total solutions provider of sustainable cold-chain thermal packaging solutions for specialty pharmaceutical and life sciences applications announces the availability of its ISTA Qualified thermal insulated shippers designed for COVID-19 vaccines that need to be kept at ultra-low (-89ºC to -70ºC) temperatures over long durations (up to 120-hours).
"During these extraordinary times, state Departments of Health and logistics companies have been looking to us for assistance with specialty thermal coolers capable of meeting the rigorous temperature and duration specifications that Covid-19 vaccines require for storage and distribution to vaccine administration sites," said Julie Kilgore, Vice President of Sales at Chill-Pak. "We use proprietary recyclable polyurethane foam in multiple density formulations allowing us to provide solutions with performance-specific results. It is for this very reason we also have solutions for vaccines that require frozen (-20ºC), refrigerated (2-8ºC) and controlled room temperatures (15-30ºC) which span the entire temperature and duration spectrum."
"From a manufacturing standpoint, three major cornerstones of our company identity are at play: our agility, just-in-time delivery, and mass production capabilities, all of which have allowed us to quickly ramp up to meet the unprecedented demand for vaccines shippers in a matter of days," said Stephen Foster, President at Chill-Pak. "With three decades of engineering and manufacturing experience, our team is prepared to deliver exceptional products to protect these lifesaving vaccines. We are honored to be playing a role as we all collectively battle against this disease."
About Chill-Pak
Engineered Packaging, Inc. dba Chill-Pak is a manufacturer and total solutions provider of sustainable cold-chain thermal packaging solutions for specialty pharmaceutical and Life Sciences applications. We create a positive impact for a better and healthier world through aggressive sustainability, diversity, and inclusion initiatives.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1534
In an era where working from home and virtual classrooms have become the norm, indoor air quality is a necessity more than ever before for households throughout the country

CHICAGO (PRWEB) NOVEMBER 30, 2020
Since the COVID-19 pandemic hit the nation, households around the country and beyond have been spending more than 90% of their time indoors. Homes have become our workplaces, classrooms, restaurants, gyms, and everything in between. With the rise of time spent indoors, the rise of harmful pollutants and germs in the air have also skyrocketed and have been recirculating throughout our houses. Now more than ever, the E·Z Breathe Ventilation System is a necessity to transform the entire home into a healthy living environment and to keep families safe by preventing the spread of harmful airborne particles. E·Z Breathe Basement and Crawlspace Ventilation provides complete home air exchange that improves indoor air quality, reduces indoor humidity and lowers allergen and pollutant levels. Air polluted with mold, allergens, pathogens and other toxins and odor-causing pollutants is vented at the lowest level of the home to the outside in a revolutionary way, introducing and circulating fresher, cleaner air throughout the home.
"With our homes being sources to all our recreational activities, we are now breathing in more toxic air than ever before," said E·Z Breathe Vice President Andre Lacroix. "Because this air is trapped within the confines of our four walls, it continues to circulate and we continue to breathe it in on a daily basis, and over time, these are the harmful toxins that get us sick, especially at an early age."
Fighting pollutants and toxins at an early age, in fact, helps lower the chances of children growing up with asthma and allergies. In fact, the U.S. Environmental Protection Agency reports that 60% of homes and buildings are "sick" meaning they are hazardous to your health to occupy. The E·Z Breathe Ventilation System can improve the indoor air quality with up to an 85% reduction in airborne particulates and common indoor air pollutants. This ventilation system has the ability to help alleviate many common homeowner concerns such as mildew odors, mold growth, pet dander, dust mites, humidity and moisture, pollen, chemical smells, leaving your home feeling fresh and allergen-free for both the work from home parents, as well as children with remote learning.
"Our main focus right now are all the households who are consistently breathing in poor air quality without even realizing it, and starting that conversation with them," said E·Z Breathe President Erika Lacroix. "Once people realize this dire need for clean air within our homes, it is then we are able to showcase just what our products can do to help with our overall health during these unprecedented times."
The U.S. Environmental Protection Agency, or EPA, reports that the air in the average American home is a minimum of five times and, in some cases, up to 100 times more polluted than outdoor air, and building science experts agree that more than 20 gallons of water vapor are absorbed into the average home through basements and/or crawlspaces every single day. Even though it is installed in one room, E·Z Breathe achieves whole-home air exchanges six to ten times daily by gently drawing air throughout the home to replace the stale, polluted air being exhausted. As families continue to shelter in place, and adhere to social distancing guidelines outside of their homes, maintaining a safe haven once inside your home is crucial for short, and long term, health benefits, even after the pandemic.
E·Z Breathe products work for up to 7,000 square feet of living space, and operate efficiently at only $2 to $4 a month; the same as a 40-watt light bulb. Known as a set it, then forget it product, E·Z Breathe are low maintenance and do not require extra attention after installation. Now offering self-installation kits for all DIY homeowners, as home improvement has skyrocketed this past year, those who would feel more comfortable setting up the E·Z Breathe on their own have the ability to now do so. With the holidays just around the corner, patrons also have the opportunity to gift good health and purchase an E·Z Breathe product for themselves and their loved ones.
Following in the footsteps of a 2nd generation, family-owned and operated business that has been providing foundation repair in homes with basements and crawlspaces for over 40 years, E·Z Breathe Ventilation Systems was established as an independent company in 2003. The company's core values include offering world-class customer service to every customer, every time. E·Z Breathe Ventilation Systems and E·Z Breathe Healthy Home Solutions supply products to foundation repair contractors, remodelers, indoor air quality professionals and more. They are proud to include over 100,000 homeowners all over North America into their E·Z Breathe family.
For more information on E·Z Breathe and their product benefits, call 1.866.822.7328 or visit http://www.ezbreathe.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1535
CCam focus, powered by Civicom Marketing Research Services, was a Gold Sponsor and Speaker for the recently held IIEX Health, one in a series of this year's virtual GreenBook events, held on November 5th, 2020.

GREENWICH, CONN. (PRWEB) NOVEMBER 30, 2020
CCam focus, powered by Civicom Marketing Research Services, was a Gold Sponsor and Speaker for the recently held IIEX Health, one in a series of this year's virtual GreenBook events, held on November 5th, 2020.
IIEX is a leading global event series that offers programs that discuss valuable insights trends in the healthcare industry. Part of GreenBook's advocacy to bridge the gap between marketers and consumer insight, it provides a platform for thought leaders to share ideas and methods that can help insights professionals innovate their research and keep them ahead of the game.
This year's event was held virtually to adhere to the protocols of the pandemic while offering the same collaborative and enlightening benefits of attending in-person. Participants received cutting edge ideas from major healthcare and pharmaceutical companies as well as leading research strategists in the community.
In support of the event, CCam focus joined alongside experts as a gold sponsor and speaker. CCam focus delivered a case study with New Perspectives Research, entitled "Five Steps to Successful In-Facility Product Testing Right Now," that showcased the value of a unique hybrid approach (combination of in-person and online) for conducting product testing and how it can be accomplished efficiently using CCam focus technology while still following the requirements of the new norm.
Interested parties can view a recording of a presentation by clicking here.
About Civicom CCam focus - HD 360° Focus Groups With Integrated Video Curation Tools
CCam focus is an HD 360º recording and streaming solution for in-person research, ideal for the new safety protocols. The omnidirectional camera with built-in microphones simultaneously captures a panoramic view as well as full-face video that adjusts when the speaker changes, fully capturing body language and sentiment. CCam focus delivers high definition visuals and superior audio even when the participants are wearing masks or are seated behind plexiglass. The result is omnidirectional viewing of all participants.
Integrated video curation tools assure video deliverables are generated within minutes for review of key moments. Civicom provides personalized service and support for set up, troubleshooting, and assistance throughout every session. CCam focus is also portable for plug and play situations, enabling market researchers to record and stream in-person interviews and focus groups from any location.
This quality focus group solution is part of Civicom Marketing Research Services group, the global industry leader in facilitating web-enabled in-depth interviews and focus groups through web-enabled technology.
For more information, email contact(at)ccamfocus.com or visit https://civicommrs.com/ccamfocus.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1536
The potent mint flavor freshens breath while releasing the immune-benefiting properties of HK L-137, a probiotic originally discovered by Japanese immunologists researching health benefits of sushi and fermentation.* Also known as Immuno-LP20, HK L-137 has demonstrated in human clinical studies to benefit the immune system, respiratory health and overall quality of life.*

VENICE, FLA. (PRWEB) NOVEMBER 30, 2020
Enzymedica, a Florida-based company that produces high quality natural digestive products, announces the launch of its innovative Immune Max Immuno-Biotic Defense Mints. These great tasting and refreshing mints dissolve in the mouth to deliver 12 billion cells of HK Lactobacillus plantarum L-137, also known as of Immuno-LP20, a unique probiotic strain that is clinically studied to support immune and respiratory health.* Stress and fatigue can easily lower immunity, and this formula helps boost the immune and digestive systems by increasing natural killer T-cell activity, which are on the front lines to help protect against seasonal threats.*
The probiotic strain L-137 was originally discovered by Japanese immunologists, working at the prestigious Medical Institute of Bioregulation at Kyushu University, who were testing new substances to improve key markers for immune health. By fermenting fish with lactic acid bacteria to create Narezushi, a precursor to modern sushi, the scientists were able to isolate a novel lactic acid bacterium. It became known as probiotic L-137 and it demonstrated beneficial immune boosting properties, made even more robust through a heat-treatment process that converts the strain to HK L-137. *
The heat-treatment process that converts L-137 to HK L-137 locks the structure of the bacterial cells to their shape at the highest point of activity. This allows the beneficial bacterial cells to work in a human's gastric acid, while also promoting the ability for the probiotic bacterial cells to interact with immune cells in the intestine.* The beneficial properties of HK L-137 are most associated with Lipoteichoic acids, components of the cell wall of the probiotic bacterium. These acids provide nutrition for the body's immune system by boosting the production of interleukin-12, a substance secreted by immune cells that strengthens the body's overall immune defense system. *
Following its initial discovery, human clinical studies have demonstrated that HK L-137 benefits the immune system, respiratory health, and overall quality of life.* Each package of Enzymedica's Immune Max Mints contains 30 fast-acting quick melt mints for $19.99 and can be purchased at https://enzymedica.com/products/immune-max-immuno-biotic-defense-mints?variant=32531305889841.
About Enzymedica
Enzymedica is a Florida-based, natural digestive health company since 1998 that sells to over 30,000 stores worldwide and online. Its top-selling enzyme brand is No. 1 in America. In addition to high quality products, Enzymedica also is dedicated to its People & Planet initiative, which is a core pillar within the company's mission - to leave a legacy that will make the world a better place. The company has received more than 50 industry awards including multiple Better Nutrition Magazine's People's Choice Awards, many Best of Supplements Awards and numerous VITY and Nexty Awards. Visit https://enzymedica.com/ for more information.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Media Contact
Ria Romano, Partner
RPR Public Relations, Inc.
Tel. 786-290-6413



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1537
An important milestone on the way to receiving FDA market clearance.

MILLERSVILLE, MD. (PRWEB) NOVEMBER 30, 2020
EndoVigilant, Inc., a privately held company developing an artificial intelligence (AI) enabled medical imaging platform for endoscopy procedures announced that the pivotal clinical study for its first application using the platform is now in progress at multiple sites across the US. The first application focuses on real-time computer aided detection (CADe) assistance for improving polyp detection during colonoscopies.
Colonoscopy is a gold standard screening test for screening of colon cancer, which continues to be one of the leading causes of cancer related deaths in the US. Even though approximately 18 million colonoscopy procedures are performed annually in the US, adenomatous polyp miss rate as high as 26% often results in missed cancers.
EndoVigilant's first application has been developed to assist gastroenterologists in real-time with polyp detection with the goal of reducing adenomatous polyp miss rate and hence, the occurrence of interval colon cancers. EndoVigilant's software has been developed using state of the art deep learning AI algorithms and is trained on images and videos collected from practicing gastroenterologists from multiple academic and private endoscopy centers across the US. It is interoperable with existing endoscopy systems and can be deployed in a plug-and-play manner without requiring changes or costly upgrades to those systems.
Earlier this year, EndoVigilant reached an agreement with the FDA on the design of its pivotal clinical study. The study is a prospective, multi-center, randomized controlled trial with sites and investigators from both academic and community settings. The study is currently being performed to support the company's planned filing to the FDA to obtain market clearance in the US.
Dr. Shai Friedland, Professor of Medicine at Stanford University, the Principal Investigator for the study commented "AI is a rapidly growing field with multiple medical applications in gastrointestinal endoscopy. EndoVigilant's CADe application for colonoscopy procedures has the potential to improve polyp detection rates, decrease adenomas miss rates in colonoscopy and therefore, reduce the occurrence of interval colon cancers."
"The progress of clinical pivotal study highlights our commitment to demonstrate the clinical benefits of EndoVigilant's CADe application and getting it in the hands of gastroenterologists as soon as possible," stated Vineet Sachdev, CEO and Co-Founder of EndoVigilant. "Based on strong results from pilot studies earlier, we are confident that this pivotal study will show increased adenomatous polyp detection without introducing significant risk when our software is used by gastroenterologists while performing colonoscopy procedures. We expect the pivotal clinical study to complete in Q1 2021."
About EndoVigilant
Headquartered in Maryland, home to one of the largest life sciences clusters in the US, EndoVigilant, Inc., is a privately-held company developing an AI enabled medical imaging platform for endoscopy procedures. The platform's first application is focused on improving colon polyp detection during colonoscopies with additional applications planned for the entire digestive tract. For more information, please visit http://www.endovigilant.com .

Dr. Shai Friedland, Professor of Medicine at Stanford University, the Principal Investigator for the study commented "EndoVigilant's CADe application has the potential to decrease adenomas miss rates in colonoscopy and therefore, reduce the occurrence of interval colon cancers."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1538
Expansive HTE Catalog Standardizes Quality for Leading and Emerging Cannabis Brands with Unwavering Flavor, Consistency and Testing Standards

IRVINE, CALIF. (PRWEB) NOVEMBER 30, 2020
ABSTRAX, an industry leader in the study and production of cannabis and botanically-derived terpenes, has launched the first standardized cannabis live resin High Terpene Extract (HTE) catalog for the California Cannabis, Vape, and Food/Beverage markets after unparalleled research and development efforts.
"This is a thrilling time for ABSTRAX and our customers," says Max Koby, Founding Partner and Chief Executive Officer. "Beyond offering the largest collection of premium botanically-derived terpenes, we also now offer our California partners the most expansive selection of the highest quality cannabis-derived terpenes and live resin extracts. These are reshaping the way brands are developing their product offerings, by providing them the highest quality, active key flavor ingredients to create the optimal strain specific terpene profiles of the most desirable genetics in California."
ABSTRAX offers a superior product to traditional flavor houses and extraction companies for the following reasons:
1. ABSTRAX product developers and scientists utilize proprietary, groundbreaking technologies to identify rare terpenes and aroma compounds that are hugely responsible for giving each strain its unique flavor and effects, whereas other organizations have access to outmoded technologies that don't reveal the specifics of what makes leading strains so delicious and effective.
2. Other extraction companies lack the resources, technology, and testing capabilities to analyze hundreds of compounds to optimize their extraction processes and standardize product formulations.
3. Flavor companies do not have the proper licensing, facilities or technology for cannabis testing, research, extraction and formulation.
4. Other formulators are unable to develop cannabis products and test them to assure both quality and consistency of product formulations.
5. Flavor and aroma manufacturers do not produce products to the safety compliance specifications required by cannabis regulatory agencies including no residual solvents, heavy metals or pesticides.
6. There is limited access to study and extract the freshest samples of the most popular genetics in the world.
"Thanks to an amazing team of passionate researchers and the combination of our terpene manufacturing facility and state of the art licensed cannabis R&D Manufacturing lab (the only of its kind in the world), we've accomplished the feat of identifying more than 400 cannabis-derived terpenes (aroma and flavor compounds) in every sample we analyze. We use these research capabilities to optimize our cannabis terpene extracts, offer unparalleled terpene analysis, and also recreate any cannabis strain from botanically derived ingredients with an unwavering commitment to quality, consistency, and accuracy," says Koby.
ABSTRAX uses 3D metabolite fingerprinting technology to discover and isolate hidden aroma and fragrance compounds that have been missed in previous efforts by other cannabis researchers and flavor houses. The company combines these advanced testing capabilities with its proprietary extraction process to yield the highest quality natural extracts, assuring they preserve and optimize the full spectrum of the terpene flavor profile.
With every product, ABSTRAX creates standardized product data sheets that map the entire profile of over 400 compounds to determine the specific flavor, aroma, strain balance, gas factor, fruit levels and other desirable qualities that help brands create memorable product experiences. Brands can use this technology and data to better educate consumers on the intended flavor and effects of these natural extracts.
"All of our live resin cannabis derived extracts are produced from the most premium strains and fresh frozen plants selected through our advanced research program, designed to discover and share the best cannabis terpene profiles in the world. We are the modern day Terp Hunters grown out of California, which has the most sought-after cannabis profiles and is the industry trendsetter for the entire world. Our research starts with the cannabis flower, but doesn't end until we can offer the most premium terpene flavors from both cannabis and botanically-derived sources," says Koby.
ABSTRAX also creates botanically derived versions of the best cannabis terpene profiles to help brands reproduce a targeted, repeatable and consistent product experience. The "secret sauce" lies in finding the perfect balance between the major and minor terpenes as well as the hidden aroma and flavor compounds. ABSTRAX does this by studying the cannabis flower and live resin extract to create identical botanically-derived terpenes and entourage-driven mental and physical effects.
"For years, we have specialized in cannabis research and extraction to create the most authentic, botanically derived cannabis profiles in the world. Now we are launching our cannabis derived terpene extracts and offering the next generation of Native Series botanical terpenes to recreate the same live resin experience for companies outside California that do not have access to our cannabis terpenes," continued Koby.
For example, ABSTRAX has perfected a vape-ready Jack Herer blend that couldn't be successfully recreated prior to its technological advancements with 3D metabolite fingerprinting. Other flavor houses had attempted to recreate the strain, but fell short because their analysis didn't go deep enough.
"After partnering with Dan Herer to study and extract the original genetics, we discovered there are a few rare compounds (including ß-phellandrene in high concentration, which plays a crucial role in its unique flavor) that were not easily identified until our groundbreaking technologies made it possible," says Koby.
ABSTRAX was able to bring together the exact aroma and flavor compounds (in their specific amounts) and recreate Jack Herer with unwavering precision and consistency. The company helped the Original Jack Herer Brand develop authenticated products including Live Resin Vapes in CA, Distillate Vape with the Native Series terpenes, terpene-infused rolling papers, and most recently a Jack Herer Beer. Now, the Original Jack Herer Brand has the ability to standardize their cannabis extracts, vape formulations, and CPG product applications across the country with other manufacturing partners.
By bringing together the key terpenes and compounds found in the Jack Herer strain, ABSTRAX's blends also ensure consumers will enjoy similar physiological effects achieved when consuming infused products — such as increased energy and creativeness, followed by a relaxed "chilled" feeling as time progresses. This unique experience, known as the entourage effect, is produced by the terpenes and cannabinoids working together.
"It all comes down to our mastery of mapping cannabis terpene profiles from flower through extraction and developing quality centric testing standards to improve our quality metrics and help further educate consumers and empower the industry with scientifically driven data. Our analytical testing program focuses on: (1) The Gas Factor – the components giving cannabis its quintessentially "skunky" smell, (2) The Fruit Factor – the components that contribute to sweet or fruity flavors, (3) Strain Balance — the dispersal of terpenes in a flower, (4) Sensory Panel — describes the flavor and intended effects, and (5) the specific terpene and aroma compounds found within each cannabis strain ranked by concentration. We've mastered each of these and continue to create new advancements in our testing program so that we can assure unwavering consistency and standards for the most accurate recreation of any strain on the market," says Koby.
For ABSTRAX, the release of its HTE catalog has placed the company in the position of standard-bearer for the production of cannabis terpene profiles for the State of California and beyond. "As legalization expands throughout the country and world, we expect our catalog will set the standard for the industry at large," says Koby.
About ABSTRAX
Leveraging its proven background in cannabis research, ABSTRAX is the leader in the research, development, and production of botanically-derived and cannabis-inspired terpenes that create unforgettable sensorial experiences. Headquartered in California, the company owns and operates a state-of-the-art type 7 licensed research and manufacturing lab where it's award-winning product developers and scientists leverage the most advanced strain analysis technology to extract and study aroma compounds via three-dimensional analysis, allowing for each and every compound within a plant to be named and studied. The company has partnered with many of the best cultivators in the industry to study their cannabis profiles and create the world's most advanced terpene formulations. As a result of its efforts, ABSTRAX offers the largest terpene catalogue of the most popular strains - botanically-derived terpene blends and isolates native to cannabis. These ingredients, also known as functional flavors and aromas, are used in vapes, concentrates, edibles, beer, essential oils, fragrances, cosmetics, topicals, tinctures, alcohol, food and beverage, personal care, and more. The company works with internationally recognized brands and provides unparalleled cannabis research, innovation, and custom formulations to create products that engage and thrill consumers. ABSTRAX also devotes significant resources to developing the highest terpene standards and best practices in the industry. The company has developed a robust quality management system including Gas Chromatography analysis and molecular distillation of natural ingredients to achieve the highest purity standards. Investigating and ensuring that ingredients used in its own products, and products within its industry, are safe for consumption. The terpene industry is a rapidly growing segment of the global flavor and fragrance market, which is expected to grow to $35 billion by 2024. This market segment includes the cannabis, CBD, skincare, cosmetics, health and wellness, food and beverage industries. For more information, visit AbstraxTech.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1539
The pharmaceutical excipient powerhouse will highlight advancements in controlled release and pediatric medicine in addition to efforts to tackle other prevalent industry issues

SHANGHAI (PRWEB) NOVEMBER 30, 2020
DuPont Nutrition & Biosciences (DuPont) will use insights to help manufacturers evolve with the biggest trends in the Asia pharma industry, with highlights to the latest offerings at CPhI China 2020 from December 16–18. Attendees who visit DuPont booth E3D26 will get an exclusive look at solutions to many of the industry's most pressing challenges, including taste-masking for pediatric medicines, pharmaceutical ingredients for acid reflux, and controlled release solutions that can significantly enhance manufacturing processes and much more.
DuPont has continuously supported its pharmaceutical customers with its vital expertise, and broad, unique portfolio that helps formulators succeed in manufacturing, regulatory, product design and beyond. As China's pharmaceutical industry continues to expand in profitability and regulatory complexity, DuPont intends to show customers that it has the products and technical know-how to help them keep pace.
Experts will be available to discuss the offerings which include:

- Ensuring compliance among younger patients. No child likes the taste of medicine, which means taste-masking bitter active pharmaceutical ingredients (APIs) is of utmost importance in pediatric care. DuPont offers several solutions, including colloidal Avicel microcrystalline cellulose (MCC), which is ideal for use in oral suspension; and ETHOCEL and Aquacoat, two superior coating polymers that effectively mask unpleasant tastes.

- Optimal ingredients for controlled release. METHOCEL DC2 is a cellulose ether that achieves superior process control with fewer production steps and less waste. With improved flow, faster and consistent tableting speeds, it greatly enhances overall production efficiency.

- Sustainable ingredients that treat acid reflux. Protanal is a tailored innovative solution highly aligned with market trends and can be used as an API in the treatment of acid reflux. Using a patented and environmentally friendly technology, this brown seaweed extract helps to enable enhanced performance.

- Focus on quality beyond manufacturing. Given quality is paramount for our industry, DuPont will discuss its efforts to broaden its quality focus beyond manufacturing to an organizational priority. Efforts also include an extension of its renowned Avicel to reduce technically unavoidable particles (TUPs).

- A whole new range of innovative delivery forms for dietary supplements industry. We offer a vast range of functional ingredients that works well with nutritional ingredients to make a product that meets consumer demands – from clean label, plant-based, consumer-friendly capsules, great tasting gummies and smaller tablets for consumer convenience. Our SeaGel vegetarian softgel technology outperforms its animal-based counterpart, imparting excellent thermal stability and implementing seamlessly into soft capsule equipment.

At the booth, attendees can attend mini talks and discuss with DuPont experts on how they can enable their goals in the pharma and dietary supplements space, including sharing of best practices for each ingredient, application expertise and regulatory knowledge tailored to the Asian market.
"All of these offerings represent our commitment to delivering strategic, high quality customer service to the Asia's pharma industry," explained Frank Zhao, Sales Leader, APAC, Pharma Solutions, DuPont Nutrition & Biosciences. "It's a reflection of our global implementation of Big Q—a Quality culture. We believe our focus on quality will resonate with visitors at CPhI China, who will come away with practical solutions to create viable pharmaceutical products for this expanding market."
To learn more about the broad product portfolio and expertise areas from DuPont Nutrition & Biosciences, visit pharma.dupont.com.
About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
# # #
12/01/2020
DuPont, the DuPont Oval Logo, and all trademarks and service marks denoted with , SM or are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1540
Global developer of innovative Radiology ultrasound machines invites attendees of the RSNA's 106th Scientific Assembly and Annual Meeting to explore personalized and immersive VR experience

MAHWAH, N.J. (PRWEB) NOVEMBER 30, 2020
Mindray, a global leader in the development of healthcare technologies, will attend the Radiological Society of North America's (RSNA) 106th Scientific Assembly and Annual Meeting, November 29 - December 5. During this year's virtual event, Mindray will highlight their comprehensive portfolio of Radiology ultrasound machines through an immersive and interactive virtual reality (VR) platform.
Throughout the last few years, Mindray has achieved consistent growth in a highly competitive marketplace. Due to an incredible value proposition, advanced technologies and industry-leading warranty, Mindray North America was one of only three companies to achieve double-digit growth in their Radiology ultrasound division in 2019. In addition, Mindray was recently awarded a contract in the ultrasound category for the Pediatric Program at Vizient, and excelled in landing strategic partnerships with the top 10 hospitals in the United States. Mindray continues to provide new and improved ways to enhance patient care and manage costs without sacrificing quality.
"With COVID-19 challenging every aspect of healthcare and forcing many to rethink the 'normal' way of doing things, Mindray's mission has become more important than ever before," said Director of Marketing, Ultrasound, Maher Elhihi. "Mindray was founded on the dream of increasing access to outstanding care by providing accessible, relevant medical devices that exceed clinician's expectations and needs. Our team is determined to ensure our frontline heroes and their patients have the tools they need; and while many things have changed in 2020, Mindray's vision has not - we will continue to drive our vision of better healthcare for all forward."
RSNA Virtual Reality Experience
Mindray will be debuting a one-of-a-kind VR experience at RSNA 2020. This virtual format provides healthcare professionals from around the world the opportunity to safely and conveniently explore Mindray's latest solutions from the comfort of their home or office. Once an attendee enters the experience, they will be transported to a "Mindray Hospital" where they can explore Mindray's Radiology ultrasound solutions in the departments in which they are used: Radiology/Imaging and Interventional Radiology. There is no special technology needed; the VR experience is desktop, laptop, tablet and mobile-friendly. Ultrasound team members and experts will be available throughout the duration of the exhibit to address any questions or comments from attendees.
Featured Systems Include:
•Resona 7 Ultrasound System: Mindray's flagship Radiology Ultrasound System delivers crystal clear imaging capabilities with unrivaled detail resolution and image uniformity that is powered by the industry's first virtual beamforming architecture, ZONE Sonography Technology+ (ZST+).
•ZS3 Ultrasound System: Mindray's ZS3 Ultrasound System is a smaller, lightweight System that combines premium performance and mobility for today's demanding ultrasound environments. This unique portable System allows for rapid transition times resulting in increased exam efficiency and patient throughput.
•DC-90 Ultrasound System: Mindray's DC-90 is a versatile, high-performing System designed for a comprehensive range of clinical applications. Exceptional image clarity, combined with advanced technology, aligns with the financial goals of a wide range of institutions.
Mindray's comprehensive suite of Radiology ultrasound solutions includes an industry-leading five-year warranty and investment protection with software updates to keep customers at the forefront of ultrasound technology. Visit Mindray's virtual exhibit through the RSNA website and learn more about the latest innovation and cutting-edge solutions.
About Mindray
Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.
1.    Harder, B./U.S. News & World Report (July 28, 2020). 2020-21 Best Hospitals Honor Roll and Medical Specialties Rankings Retrieved from https://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1541
Early Studies Indicate up to 20 - 24 Percent of Covid-19 Patients Can Experience Myocardial Injury or Heart Failure

NEWARK, CALIF. (PRWEB) NOVEMBER 30, 2020
Ziosoft, a pioneer in 3D/4D AI medical visualization, is featuring its comprehensive suite of advanced visualization and post-processing applications, on a true vendor neutral platform, at RSNA's virtual 2020 exhibition being held November 29 – December 5. Featured this year on the company's flagship Ziostation2 system are a wide-range of applications, which are well suited in the analysis of pathology caused by the Covid-19 virus as the disease affects multiple anatomy, such as respiratory, pulmonary and cardiovascular sites.
Several studies published earlier this year indicate Covid-19 specifically can cause myocardial injury or heart failure in up to 20 - 24 percent of affected patients. Two of these studies found that between 49-52 percent of patients who died from the disease experienced heart failure.
"In addition to respiratory and pulmonary impact, these recent studies demonstrate significant cardiac injury risk as well," said Rajeev Taitriya, vice president of Business Development and Marketing, Ziosoft. "Our Ziostation2 software provides numerous tools for analyzing these symptoms including pulmonary analysis, virtual bronchoscopy, CT cardiac function and MR coronary analysis, in addition to several other visualization and measurement solutions. All are designed to provide comprehensive analysis capabilities to help support diagnostic confidence and help guide therapeutic endeavors."
Ziosoft's platform provides a robust and clinically validated algorithm, which is driven by both a traditional and new era of machine learning, unlocking the potentials of artificial intelligence (AI) for efficient and repeatable outcomes. The company's flagship Ziostation2 is an economical and scalable multi-departmental solution. A full suite of regulatory cleared 2D, 3D, and 4D analytical tools provides consistent functionality across the enterprise, without compromise.
With over 3,000 installations in 2,000 locations throughout more than 30 countries globally, the company is also highlighting PhyZiodynamics in Vivo, which enables virtual dynamic dissection to support precise therapy for organ targeting analyses and Implantations. PhyZiodynamics in Vivo offers an unprecedented "real-time" journey through the body non-invasively, supporting diagnoses and treatment planning for numerous anatomical targets.
"These unprecedented times call for highly sophisticated and comprehensive solutions for imaging visualization and analysis," said Shusuke Chino, co-founder and president, Ziosoft. "We use 20 plus years of medical imaging expertise with deep learning to enable accurate segmentation with easy-to-use intuitive tools for efficient and customizable workflows. This experience has not only brought outstanding 3D/4D to the radiological community, but several other useful tools to support clinicians during this challenging period."

In addition to respiratory and pulmonary impact, these recent studies demonstrate significant cardiac injury risk as well



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1542
Chugg's goal is to improve accessibility for water challenged communities and outdoor enthusiasts around the world.

TORRANCE, CALIF. (PRWEB) NOVEMBER 30, 2020
With the goal of making clean water technology accessible, Chugg is using easy to use UV-C technology to keep your water free of harmful contaminants and germs. Based in California, Chugg is a purpose-driven family business helping bring clean water to our country's most hard-hit communities.
Clean water is a basic necessity, yet millions of people worldwide lack access, including in the USA. Over 2 million Americans don't have access to clean water. With COVID-19 disproportionately affecting lower-income communities, the water issue has grown exponentially worse and, in some cases, is just an afterthought. Thus Chugg was born with a strong conviction to help fight the clean water issue and provide clean water for all.
While Chugg's goal is big, they have decided to start close to home. Chugg is supporting the Navajo Water Project by donating 5% of profits to help with their goal to provide clean water to 100 families this holiday season. According to The Navajo Water Project, 1 in 3 members of the Navajo tribe do not have access to running water in their home and are forced to pay up to 67X more for the water hauled to them vs. piped water.
The Navajo Water Projects Ultimate Goal Is:

To develop new sources where water is pumped, treated, and stored locally.

Deliver water in food-grade trucks to hundreds of families living close to each source.

Provide home water systems that provide 1200 gallons of hot and cold water.

You can learn more about the cause and how we are helping at https://www.drinkchugg.com/
Chugg pledges to help the Navajo Nation one bottle at a time. Every sale will help create a lasting impact for people in need of safe water. Join the movement and use the hashtag #shareachugg
Product and Technology:
With everyone shifting their thinking and cleanliness habits in 2020, Chugg's goal is to give individuals the tools they need to seamlessly transition into a new reality. A simple press of a button utilizes UV light to sanitize the water in your bottle. Specifically, UV-C light exposure is a proven technique to eradicate microorganisms and dechlorinate drinking water[footnote ref]. With its shorter, more intense wavelengths of light, UV-C has the power to deactivate microbes by destroying the genetic material in their DNA, thus stopping viruses from making copies of themselves. At the same time, its UV-A and UV-B counterparts are merely capable of giving you a nice suntan and sunburn, respectively.
Not only can you begin the clean cycle by activating the Gaia Mode, the Chugg bottle has a Gaia+ mode that will automatically cycle every 6 hours so you can have peace of mind as you continue your busy life on the go.
"Come on this adventure with us!"
– The Chugg Team



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1543
Accreditation bodies like A2LA that meet the FDA's requirements for this new program are granted ASCA Recognition, enabling them to assess testing laboratories seeking ASCA accreditation to perform premarket testing for medical device companies.

FREDERICK, MD. (PRWEB) NOVEMBER 30, 2020
A2LA is proud to announce that it has been granted ASCA Recognition by the FDA, making it among the first accreditation bodies accepted as a participant in the ASCA Pilot program. The ASCA Pilot is a cooperative program that relies on participation from accreditation bodies, testing laboratories, medical device manufacturers and FDA staff. Accreditation bodies like A2LA that meet the FDA's requirements for this new program are granted ASCA Recognition, enabling them to assess testing laboratories seeking ASCA accreditation to perform premarket testing for medical device companies. The Pilot is intended to enhance product reviewers' and device manufacturers' confidence in medical device testing, which in turn helps to ensure the widespread accessibility of safe and effective medical devices.
In addition to supporting the FDA's public health mission by providing increased confidence in testing results from ASCA-accredited testing laboratories, the ASCA Pilot is expected to reduce the burden of individual premarket submissions when manufacturers rely on testing completed by ASCA-accredited testing laboratories. The Pilot relies on international conformity assessment standards and a set of FDA-identified ASCA program specifications to create clear and consistently applied criteria for accreditation, which a limited number of qualified accreditation bodies will be recognized to assess. A2LA is among the largest and most trusted accreditation bodies in the United States and applied for ASCA Recognition at the first opportunity. A2LA's commitment to the value and broad applicability of third-party accreditation aligns closely with the FDA's goals in creating this program, and A2LA is eager to serve the medical device testing companies to which this new program applies.
"A2LA is recognized as a leader in the global accreditation industry. With that reputation to uphold, we continually seek opportunities to expand the services we are able to provide our customers and to find ways to serve our community." Said Terrianne Kohr, Accreditation Supervisor at A2LA, and one of the people most closely involved with this new program. "The launch of this new program and cooperation with the FDA is an exciting opportunity for us to realize both of these missions within the medical device field. It is an honor to be among the first accreditation bodies recognized by the FDA to offer assessment services under this Pilot program. We are looking forward to working closely with the FDA and testing laboratories in this endeavor to improve the efficiency of the premarket review process and instill increased confidence in testing results within the industry."
In the coming weeks, A2LA will be issuing guidance on how to apply for accreditation to this program, and will be providing additional information for both laboratories seeking A2LA accreditation for the first time and those who are already accredited by A2LA and are interested in this new program. For any questions about accreditation with A2LA, please call 301-644-3248 or use this link to reach out by email.
About A2LA
A2LA is a non-profit, non-governmental, third-party accreditation body, offering internationally recognized accreditation services to testing and calibration laboratories, inspection bodies, biobanking facilities, stand-alone sampling organizations, proficiency testing providers, reference material producers and product certifiers.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1544
Veteran Scientist Positioned to Lead Origent's Efforts to Optimize and Rescue Clinical Trials

VIENNA, VA. (PRWEB) DECEMBER 01, 2020
Origent Data Sciences, Inc. today announced that its Board of Directors has appointed Dr. David L. Ennist as President and Chief Executive Officer effective immediately. Dr. Ennist has served continuously as Chief Science Officer since Origent's inception in 2013.
Mike Keymer, who has held the role of President & CEO since 2013, will continue to serve on the Board of Directors and remain actively involved in supporting the Origent leadership team, which includes Dr. Ennist and Chief Data Science Officer Danielle Beaulieu.
"We are fortunate to have someone of Dave's caliber and experience to lead Origent," said Keymer. "I have been grateful for his contributions as Chief Science Officer and his counsel during my own tenure as CEO. He is the perfect leader to execute Origent's move into the drug rescue space, as we work with our partners to bring new therapies to the market to treat neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's Disease, Huntington's Disease, Alzheimer's Disease, and others. I look forward to continuing to support and collaborate with Dave during this exciting next stage of Origent's growth."
Fabian Rosado, Chairman of Origent, said, "Origent is indebted to Mike for his contributions as founding CEO of Origent, and his service and dedication over the last seven years. Mike created a culture of integrity, innovation, and earned trust at Origent, and helped the company push the boundaries of machine learning, AI, and computational science in support of drug development and clinical trials. Dr. Ennist will now build on top of the foundation that Mike created as we pursue our mission of rescuing and bringing to market new drug therapies which failed their initial attempts at registration. Origent's future success will depend on our ability to synthesize complex information across data science, medical science, and drug development. Dr. Ennist is perfectly aligned at the intersection of these domains, and has the right operational, scientific, and managerial experience to lead Origent in our next chapter."
Ennist said, "I believe we have a unique opportunity to rejuvenate therapeutics in multiple neurodegenerative indications that have languished in clinical development. I am honored that the Origent board has selected me to lead Origent into its next chapter and am grateful that Mike Keymer will continue to provide sage advice in his role as Director. With our amazing team, I know Origent will continue to be a leader in the application of machine-learning for improving the efficiency of clinical trials."
About Origent Data Sciences
Origent is dedicated to rescuing failed clinical trials and reducing drug development risks through better foresight. Origent's scientists are experts in the development and application of predictive models that are designed to anticipate and predict the dynamics of individual patients. By modeling patient-level dynamics rather than the characteristics of a population, Origent's tools uncover a deep level of insight that provides greater knowledge from clinical trial data. For additional information about Origent, please visit our website at https://www.origent.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1545
UT Health San Antonio's Sam and Ann Barshop Institute is enrolling volunteers for the PREVENTABLE study funded by the U.S. National Institutes of Health. Volunteers must come from the San Antonio area, unless they are able to travel further for a few needed study assessments. PREVENTABLE will look at whether a statin medication, Lipitor, can keep adults 75 and older healthier. Interested people may call the Barshop Institute clinical research line at (210) 450-0020.

SAN ANTONIO (PRWEB) NOVEMBER 27, 2020
UT Health San Antonio's Sam and Ann Barshop Institute for Longevity and Aging Studies announced Nov. 27 that enrollment is open for a new clinical trial called PREVENTABLE. The study will investigate whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor, can help adults age 75 and older maintain health by preventing dementia, disability and heart disease.
The study, which aims to be one of the largest ever conducted in older adults, will include more than 20,000 participants across the U.S., including 450 from San Antonio. The study will randomize participants without heart disease or dementia to receive either atorvastatin or placebo. The placebo looks like the study drug but has no medicine in it. Researchers will follow participants for up to five years and test their memory, thinking and physical abilities, and monitor them for events such as heart attacks or strokes.
Study participation will be easy and efficient. Researchers will follow participants using electronic health records and Medicare data, and with study visits over the telephone. Study drug will be shipped directly to participants' homes every three months.
The Barshop Institute at UT Health San Antonio is one of the first PREVENTABLE study sites to be activated, said principal investigator Nicolas Musi, MD, institute director and professor of medicine in the university's Joe R. and Teresa Lozano Long School of Medicine.
"We really don't know how these drugs work in older adults," Dr. Musi said. "Most, if not all, of the studies of statins have been done in much younger people, in their 50s and 60s, but studies in adults over 75 are rare."
About one in three people in the U.S. over the age of 75 without heart disease are taking statins. In addition to learning whether statins can prolong health in older adults, the PREVENTABLE study will help clarify which older adults should not be taking statins.
"Participants don't have to have a history of high cholesterol," Dr. Musi, an endocrinologist, said. "This study is conducted to see if this medicine, regardless of cholesterol level, is able to improve cognition and brain function, prevent dementia, improve physical function, and prevent cardiovascular disease and strokes."
"Persons with a history of heart disease, stroke or dementia are not eligible for the study, but people with diabetes are eligible," Dr. Musi said. "So are patients with mild cognitive impairment."
The National Institutes of Health, which is funding the study, is interested in San Antonio as a center of minority participant recruitment. "The PREVENTABLE study is not exclusively for the Hispanic population, but this group is of special interest to us," Dr. Musi said.
Interested people may call the Barshop Institute clinical research line at (210) 450-0020.
# # #
The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school's clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer's disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.
The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country's leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways "We make lives better," visit http://www.uthscsa.edu.
Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
To see how we are battling COVID-19, read inspiring stories on Impact.

"Most, if not all, of the studies of statins have been done in much younger people, in their 50s and 60s, but studies in adults over 75 are rare." -- Nicolas Musi, MD, UT Health San Antonio



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1546
Inventiv Foundation Announces an updated Free Smart Software to Draft Patent Applications and provision of educational resources for all inventors. Inventiv, a 501c3 Non-Profit, is the foremost organization for providing education, training, software, and resources on intellectual property (IP) rights to innovators. Our programs offer training on protecting and maximizing the benefits of inventor's rights and state of the art solutions in developing IP rights for inventors who cannot afford legal assistance.

CARSON CITY, NEV. (PRWEB) NOVEMBER 27, 2020
Inventiv is proud to announce updates to its free patenting software ProvisionalBuilder to draft provisional applications. Geared to inventors with no prior experience with the patent system, ProvisionalBuilder provides a structured process through a series of pages or tabs that moves the inventor through the major sections of the Provisional Patent Application. When the inventor completes the disclosure, the software analyzes the draft and spots common potential issues to fix.
Inventiv has also developed a series of FAQs and educational content and links for inventors to get help from various resources, including the Patent Office inventor assistance center and pro-bono programs from law schools. These tools make the IP system accessible to every dreamer, innovator, and inventor. Inventiv is also working on localizing our free resources and software in developed and developing countries for inventors who seek to understand and participate in the evolving, global intellectual property system of the 21st Century.
Inventiv thanks its volunteers for supporting Inventiv in helping innovators and inventors worldwide, rich or poor. We believe that innovations will bring greater wealth to the world and will improve everyone's life.
To get and learn more about the software, visit our website at http://www.inventiv.org



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1547
Coming from a successful inaugural event, the International Center for Breathwork will hold its second annual presentation of The Breathing Festival online from Feb. 11-28, 2021.

CABO SAN LUCAS, MEXICO (PRWEB) NOVEMBER 27, 2020
Coming from a successful inaugural event, the International Center for Breathwork will hold its second annual presentation of The Breathing Festival online from Feb. 11-28, 2021.
Planned for three long weekends in February—Feb. 11-14; Feb. 18-21 and Feb. 25-28—the festival will showcase empowering sessions with over 50 of the world's leading breathwork practitioners. The event boasts 12 days filled with lectures, experiential breathing sessions; breathing tools, tips, tricks and hacks for daily life; conscious music and cutting-edge breathing technology. Confirmed speakers are on the website and the full schedule will be announced in January.
Visit our festival page to see all of our presenters whose teaching methods include Rebirthing, Holotropic, Transformational, Neurodynamic, Breath Holding, Buteyko, Ecstatic, Shamanic, Biodynamic, Vivation and Breath of Love, to name a few.
"The mission of the festival is to encourage all people to become more aware of their own breathing and then to learn how to breathe in different ways to achieve very specific and often remarkable results," said Dan Brulé, co-founder of The Breathing Festival. "Our theme is: 'Change Your Breath. Change Your World.' We want to show people how they can use conscious breathing to improve nearly any part of their life."
According to ICFB, conscious breathing, or breathwork, can help boost a person's low energy or mood and increase concentration and productivity. It can also provide fast-acting and lasting relief for stress, trauma, pain, anxiety and depression. Breathwork is used by top athletes and elite military to improve performance and unlock higher potential.
"The Breathing Festival and the International Center for Breathwork marry my deepest yearning to connect people with my desire to spread healing and love and my passion for creating experiences through events," said Nicole Price, co-founder and CEO of The Breathing Festival. "I am so excited about the possibilities. I love that our 2021 virtual event will touch hundreds of thousands of people, maybe millions, and my vision is clear of the day we will come together in Cabo to breathe in person as humans raising the vibration of our planet."
In addition to the activities, the festival will host The Second Annual Tribute to Leonard Orr, prolific writer, spiritual teacher, philosopher, and the father of the modern breathwork movement and the creator of the Rebirthing conscious breathing technique. Because of Orr and his contributions to society, millions of people around the world have embraced breathwork as a lifestyle path.
Tickets start at only $11 for a full 12 days of access to all of the sessions streaming during the festival. Tickets can be purchased by visiting thebreathingfestival.com.
A very limited quantity of VIP tickets are available for people who want to interact personally with the presenters in live online Q+A chat sessions each festival day.
For more information, visit thebreathingfestival.com.
About the International Center for Breathwork:
The International Center for Breathwork was started by Dan Brulé, VJ Odedra, Nicole Price and Marc Taylor as a place to welcome and support all styles, types, modalities, practices, flavors and kinds of breathwork and to spread the practice of these simple yet often unknown concepts throughout the world. Born in 2020 during the global pandemic, it arose from a desire to show people simple ways to shift our lives into better places by changing the way we breathe.
Our world is under tremendous stress and many things are changing. Breathing techniques are the most effective, accessible and natural tools for navigating and integrating those changes. Some techniques lead to more mindfulness, which leads to more awareness, which gives you more influence in your world. Other techniques increase or decrease energy, release blocked emotions, develop the self, increase emotional intelligence, and reclaim the energy lost from chronic pain. The ICFB is the largest gathering place for these many diverse styles of breathing and makes them all available through The Breathing Festival and its membership program.
The Breathing Festival was created as a way to share breathwork in a fun, exciting, mainstream event that is accessible to as many people as possible. The virtual festival in 2021 gives us the opportunity to reach people in every single corner of the globe. That's our vision and we've got a lot of amazing people working with us to achieve it. We dream about healing the world by healing ourselves and we use our breath to do that. ###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1548
COLUMBUS, OHIO (PRWEB) NOVEMBER 27, 2020
ARC Healthcare launches Fourleaf a "one-click" contract management, and enrollment automation platform, eliminating the leading inefficiencies in Medical Payor provider enrollment.
ARC Healthcare LLC, an innovative Healthcare processes and technology consulting firm that has developed technology to unify the collection process of contracting, credentialing, rosters, provider data to replace the manually-intensive provider enrollment process with a simplified, end-to-end solution. ARC Healthcare has worked with clients across the country and witnessed firsthand the laborious, costly, and intensive tasks Health plans are challenged with to build rapid, comprehensive, and quality networks to service their patients. Many challenges are faced while trying to build a comprehensive and quality network to service patients.
Health plans as well as Providers may lack the time and resources needed to analyze internal processes or have limited funding to develop robust automation and advanced IT solutions. As a result, both Payors and Providers are stuck working in spreadsheets, manually completing forms, and contracting by mail which is costly, burdensome, highly time consuming and error prone. Provider contracting, credentialing and enrollment requires a multi-faceted approach and is the foundation for Payor success. The routine monthly updates made to providers' information and data sets, including new providers, terminations, and location changes, can be tedious to manage and warrants process workflow. Incorrect entry of provider data that route to directories causes inconsistencies, causes confusion, claim delays, member access issues, and even worse, fines and compliance problems. These manual processes lead to duplicative processes, administrative complaints, employee turnover, and higher costs.
ARC Healthcare's solution, Fourleaf, is a cost-effective solution, and fully automates the manual processes of provider enrollment – creating process, and saves customers from repetitive tasks, unnecessary staffing, and excessive spend. By streamlining the provider's paper-driven enrollment processes, Fourleaf eliminates inaccurate dataset errors, and provides easy to use, comprehensive reporting. To succeed, Payors must have a secure, cloud-based, and uniformed solution to manage provider data, automate contracting and enrollment, collect and house documents, and quickly locate documents to comply with audits and State compliance requests.
The Fourleaf Solution
Fourleaf is a unified system designed to collect and manage provider data in a secured cloud infrastructure. The efficiency of time and financial resources is always at the forefront of any solution - and Fourleaf delivers. Integrating automated contracting, document management, task management, and roster ingestion allows Health plans to quickly report on Network Adequacy, allows for automatic data transfers and integrations of contracted information into core systems like claims and authorizations. Provider directories can be generated, and network adequacy reports delivered in a seamless all-in-one system. Other automated reports to conduct internal audits of staff productivity and task completion are at management's fingertips. Unlike other systems on the market, Fourleaf also offers customization to ensure all provider data points are covered to meet your needs.
About ARC Healthcare, LLC
ARC Healthcare, LLC was formed in 2012 to serve organizations in improving contracting processes, keeping them compliant with government guidelines on network adequacy, and ensuring provider data is accurate and easily analyzed. We are a premier firm that delivers an array of services, including healthcare provider recruitment, contracting, software development, call center, staffing, and consulting support resources.
"Our mission at ARC Healthcare is to bring top-quality, meaningful and secure solutions to our customers. Our overarching goal is to bring streamlined solutions to our customers, with an easy to use, all in one system. The days of providers emailing handwritten agreements, with missing information, and unsecured social security numbers across the internet are gone. We are so pleased to be at the forefront of such a meaningful solution," says Amanda C. Ratliff, CEO,
ARC Healthcare. ARC Healthcare, LLC is a certified Woman Owned Small Business (WOSB) and Women-Owned Diverse Supplier (WBENC).
#cloudsolutions #documentmanagement #Networkdevelopment #contracting #managedcare #automation #healthcare #taskmanagement #electronicsignature #providerdirectory #providerenrollment #credentialing #roster
#providercredentialing


START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1549
Transpara breast AI by ScreenPoint Medical has now been used to read over 1 million mammograms

CHICAGO (PRWEB) NOVEMBER 27, 2020
Transpara, the leading Artificial Intelligence support system for breast cancer screening that uses deep learning algorithms to automatically detect potential breast cancer in 2D and 3D mammograms, has achieved another first in its class!
Transpara led the way being the first to use a unique scoring breast AI system for breast cancer risk. It is the first and remains the only DEEP LEARNING system to be FDA cleared for use on both 2D and 3D mammograms and now is first of its kind to help radiologists read more than 1 million mammograms.
"This is a major milestone in our mission to help radiologists improve survival rates for breast cancer, a disease that is growing relentlessly around the world," said Nico Karssemeijer, CEO for ScreenPoint Medical. "Despite the challenges presented by COVID in 2020, Transpara installations continue to prove successful in more and more countries."
"AI is obviously an important weapon being adopted to fight breast cancer even during these trying times. It is also becoming increasingly obvious that not all breast AI is the same. Our focus is to provide robust clinical evidence around the globe, and we can only do this with the help and support of our clinical partners. With this said, Transpara is being featured in an incredible 6 Scientific presentations with data from 5 different countries at this year's virtual RSNA."
"These studies for BOTH 2D AND 3D mammography look at how Transpara can improve accuracy, reduce interval cancers and help to reduce radiologist's workload. I'm not going to give the game away; you'll have to wait to listen to the presentations, but the results are powerful," said Professor Karssemeijer.
ScreenPoint Medical is also introducing new developments, including additional technology to ease integration of Transpara further in any mammography reading environment.
Here is the list of presentations at RSNA featuring Transpara:
A.J.T. Wanders, W. Mees, N. Janssen, A. Rodriguez-Ruiz, I. Sechopoulos, J.K. van Rooden, Ritse M. Mann. The potential of AI for improving early detection in breast cancer screening to reduce interval cancer rates
C. Balta, N. Janssen, A. Rodriguez-Ruiz, C. Mieskes, N. Karssemeijer, S. H. Heywang-Köbrunner. Using AI to triage which screening mammograms benefit from a double reading strategy
S. J. Vinnicombe, O. Parr, R. Sidebottom, D. Godden, E. Cornford, I. D. Lyburn. What impact could AI based computer aided detection have on the number and biological relevance of interval cancers in a population based screening programme?
C. Balta, N. Janssen, A. Rodriguez-Ruiz, C. Mieskes, N. Karssemeijer, S. H. Heywang-Köbrunner. Can AI help to increase the PPV of screen-recalled biopsies on calcifications?
M. Pinto, A. Rodriguez-Ruiz, K. Pedersen, S. Hofvind, R. Mann, S. Kappler, J. Wicklein, I. Sechopoulos. Impact of AI decision support on breast cancer screening interpretation with single-view wide-angle DBT
S. Romero Martín, J. Luis Raya Povedano, E. Elías Cabot, A. Gubern-Merida, A. Rodríguez-Ruiz, M. Álvarez Benito. Using autonomous AI to reduce the workload of breast cancer screening with breast tomosynthesis: a retrospective validation
Note to Editors
ScreenPoint Medical BV.
ScreenPoint Medical is the leading developer of AI driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations.
Transpara is an AI solution for breast cancer screening, that uses deep learning algorithms to automatically detect lesions suspicious for breast cancer in 2D and 3D mammograms. The software categorises mammograms on a 10-point scale indicating the risk that cancer is present. This Exam Score can be used to help radiologists prioritise patients for further investigation. Decision support marks for calcifications and soft tissue lesions are provided to support radiologists with image interpretation. Studies have shown that Transpara matches the performance of radiologists ,2,3, thus acting as a second opinion which increases diagnostic confidence and accuracy ,3. It is FDA cleared for 2D and 3D mammography.
ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, two internationally respected experts in breast imaging, machine learning and computer aided detection. (diagnosis?)
The company's Head Office is in Nijmegen, The Netherlands.
1"Stand-alone artificial intelligence for breast cancer detection in mammography: Comparison with 101 radiologists", Rodriguez-Ruiz et al, JNCI: Journal of the National Cancer Institute, djy222, https://doi.org/10.1093/jnci/djy222, 2019
2"Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System" Rodríguez-Ruiz et al, Radiology 290:2, 305-314, 2019.
3FDA approval number K193229
For more information, please email info@screenpointmed.com or visit the website http://www.screenpoint-medical.com or http://www.transparabreastcare.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1550
This message is awaiting approval by a moderator.
Ziegler, a specialty investment bank, is pleased to announce its role in advising CareFirst BlueCross BlueShield (CareFirst) in the acquisition of University of Maryland Health Partners (UMHP) and University of Maryland Health Advantage (UMHA) from The University of Maryland Medical System (UMMS). UMMS is a university-based regional care health system focused on serving the health care needs of Maryland residents, bringing innovation, discovery, and research to the healthcare system and educating the state's future physician and health care professionals through its partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the State, the health system's 28,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations at 13 hospitals. UMHP is a 47,000 member Managed Medicaid plan, operating in 21 of 24 Maryland counties through a network of 38 hospitals, 14 FQHCs and over 10,000 physicians. UMHA is a 6,000 member Dual Special Needs (DSNP) Medicare Advantage plan which operates in 15 of 24 Maryland counties with a similar network to UMHP. UMMS acquired UMHP and UMHA in a 2015 transaction with Riverside Health, Inc. in order to align its operations vertically into the payor space.

CHICAGO (PRWEB) NOVEMBER 27, 2020
Ziegler, a specialty investment bank, is pleased to announce its role in advising CareFirst BlueCross BlueShield (CareFirst) in the acquisition of University of Maryland Health Partners (UMHP) and University of Maryland Health Advantage (UMHA) from The University of Maryland Medical System (UMMS). UMMS is a university-based regional care health system focused on serving the health care needs of Maryland residents, bringing innovation, discovery, and research to the healthcare system and educating the state's future physician and health care professionals through its partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the State, the health system's 28,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations at 13 hospitals. UMHP is a 47,000 member Managed Medicaid plan, operating in 21 of 24 Maryland counties through a network of 38 hospitals, 14 FQHCs and over 10,000 physicians. UMHA is a 6,000 member Dual Special Needs (DSNP) Medicare Advantage plan which operates in 15 of 24 Maryland counties with a similar network to UMHP. UMMS acquired UMHP and UMHA in a 2015 transaction with Riverside Health, Inc. in order to align its operations vertically into the payor space.
In its 83rd year of service, CareFirst, an independent licensee of the Blue Cross and Blue Shield Association, is a not-for-profit health care company which, through its affiliates and subsidiaries, offers a comprehensive portfolio of health insurance products to 3.4 million individuals and groups in Maryland, the District of Columbia and Northern Virginia. In 2018, CareFirst invested $43 million to improve overall health, and increase the accessibility, affordability, safety and quality of health care throughout its market areas.
"The University of Maryland Medical System and CareFirst have always been strong allies and the acquisition of UMHP and UMHA further solidifies that alignment," said Mohan Suntha, MD, MBA, President and CEO of UMMS. "More importantly, it ensures our Medicaid and Medicare enrollees have uninterrupted access to comprehensive health coverage and care through partnership with a Maryland-based, not-for-profit health plan. Delivering high quality, compassionate care is fundamental to the missions both UMMS and CareFirst serve and we are confident that UMHP and UMHA enrollees will benefit from CareFirst's expertise in the market."
"This partnership brings the best capabilities of CareFirst and UMMS together in a new model and is part of our broader efforts designed to deliver care focused on value and improved health outcomes. Our work with the UMMS team will provide opportunities for deeper collaboration and innovation designed to bring our shared communities greater value, expanded access to high quality care, better consumer experiences, and more equitable care for all Maryland residents," said CareFirst President & CEO Brian D. Pieninck.
Chris Hendrickson, Managing Director, in Ziegler's Healthcare Corporate Finance practice, stated, "CareFirst has built an outstanding reputation as the largest health insurer in the Mid-Atlantic region, with the largest network of physicians in its area, leading customer support and member engagement capabilities, and innovative programs including its Patient Centered Medical Home Program (PCMH). These transactions allow it to expand beyond its core strength in commercial insurance to the government space."
CareFirst is bringing UMHP and UMHA into its not-for-profit organizational structure to better align with its mission. CareFirst is integrating UMMS' staff and infrastructure with CareFirst operations over a multi-year transition period.
Ziegler's Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.
For more information about Ziegler, please visit us at http://www.ziegler.com.
About Ziegler:
Ziegler is a privately held investment bank, capital markets and proprietary investments firm. Specializing in the healthcare, senior living and education sectors, as well as general municipal and structured finance, enables Ziegler to generate a positive impact on the clients and communities it serves. Headquartered in Chicago with regional and branch offices throughout the United States, Ziegler provides its clients with capital raising, strategic advisory services, equity and fixed income sales & trading and research. To learn more, visit http://www.ziegler.com.
Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client's experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.
# # #

Chris Hendrickson, Managing Director, in Ziegler's Healthcare Corporate Finance practice, stated, "CareFirst has built an outstanding reputation as the largest health insurer in the Mid-Atlantic region, with the largest network of physicians in its area...



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1551
QuantaDose was created out of the need for a rapid response reusable UVC test to prevent consumers from falling victim to UV sterilizer scams which are flooding the US market as potential holiday stocking stuffers. QuantaDose instantly informs holiday shoppers if a UV wavelength is truly germicidal and within 15 seconds provides confirmation of >300 µW/cm² UVC intensity for peace of mind that real UVC power is being used for disinfection given the proper time and distance is calculated.

LOS ANGELES, CA (PRWEB) NOVEMBER 27, 2020
Designed and Engineered in the USA, the reusable QuantaDose UVC test card uses photochromatic WPV (Word Power Visibility) technology to provide reliable UVC intensity readings in 15 seconds with instant notification of optimal UV-C germicidal wavelengths. The QuantaDose UVC intensity test card relies on calibrated word legibility starting > 300 µW/cm² when the word "ULTRAVIOLET" first becomes legible during exposure to optimal UVC germicidal wavelengths.
"The COVID-19 pandemic changed the way American's spent Thanksgiving yesterday. The outbreak has also changed what people are rushing to buy today that weren't on last year's Black Friday and Cyber Monday's shopping list," said CTO John Coates. 
Coates stated that QuantaDose UVC light test cards are one of those innovative items that made the #1 bestsellers list on Amazon even before the holiday rush. Millions of people depend on unregulated UVC devices dominated by third-party sellers on mainstream shopping sites. Unfortunately, the charlatan sellers use much cheaper components that can't provide the UVC disinfecting power many manufacturers claim.  QuantaDose UVC light test cards are very easy-to-use, credit card-sized UVC Indicators that can increase the efficiency of the UVC light disinfection processes by helping consumers to quickly visualize what is most effective, instantly ruling out most all falsely advertised UV sterilization products," he said.
QuantaDose created a specially formulated ink chemistry sensitive to only optimal UVC, which will not fluoresce to ordinary visible light or UVA and UVB. This ensures the transparent letters UV-C only illuminate bright fluorescent green under germicidal UV wavelengths between 222-280nm.  QuantaDose provides consumers with the quickest verification method to avoid an increasing number of fraudulent UVC light products that flood the consumer market.
According to Katie Webb, CEO of Quanta X Technology, the QuantaDose team prides itself on rapidly fine-tuning its product line, including designs for very high power UVC devices and the development of Far-UV analytes.
"We have been busy, already on the 3rd edition of QuantaDose UV test cards. We are focused on making QuantaDose the most helpful tool; QuantaDose is quickly innovating in quantum confinement effects and molecular fluorescence material designs that haven't advanced much in 20 years.  This has led to a new QuantaDose product launched every 45 days.  It is inspiring to be able to produce the best tools to help people make the best choices when trusting UVC as part of their disinfection routine," she said.  
HOW TO USE QUANTADOSE UVC TEST CARD
STEP 1) Top Light Sensor Test Wavelength of UV Exposure: When exposed to optimal UVC germicidal wavelengths, the QuantaDose UVC test card undergoes an instant color change to a green glow where fluorescence is directly related to energy values of UV wavelength received. Fluorescence stops when excited electrons release all photos within nanoseconds after exposure.
STEP 2) Bottom Light Sensor Test Intensity of UV Exposure: When exposed to confirmed mercury-line UVC wavelengths, the QuantaDose test card first displays the word "ULTRAVIOLET " at approximately > 300 µW/cm² a gradual color change is directly related to the energy value received. Temporary photochromic dosimeter color is used to check intensity after exposure and should be checked immediately after the test for the most accurate intensity results. The test is completed in 15 secs; remove the card from the source!
With QuantaDose, you're not just purchasing a product- you're making an investment in protecting love-ones from bad actors and fraudulent UVC products being sold almost everywhere online. For more information, call 800.713.9004 or visit quantadose.com. For the fastest QuantaDose UVC test card delivery, Amazon offers free same-day delivery on QuantaDose UVC test cards for prime members in most areas in the USA.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1552
Jumpstart Foundry, a healthcare-focused private investment firm headquartered in Nashville, announced today its second round of 2020 portfolio selections. The Fall 2020 selection of portfolio companies consists of 5 healthcare startups chosen from a pool of more than 200 applicants, which brings the total number of seed-stage investments to 108 for the TN firm.

NASHVILLE, TENN. (PRWEB) NOVEMBER 30, 2020
Jumpstart Foundry, a healthcare-focused private investment firm headquartered in Nashville, announced today its second round of 2020 portfolio selections. The Fall 2020 selection of portfolio companies consists of 5 healthcare startups chosen from a pool of more than 200 applicants, which brings the total number of seed-stage investments to 108 for the TN firm.
Ranked as one of the most active venture capital investors in Tennessee, Jumpstart Foundry annually makes 20-25 standard investments of $150,000 via convertible SAFE notes into innovative companies in the health space. These companies are expected to have a tremendous impact in the health domain while driving strong financial returns for Jumpstart's investors.
"We received a record number of applications this year and were able to be incredibly selective in our approach," said Eller Mallchok, Jumpstart Foundry's Managing Director. "Of course, I was pleased with the quantity of applications, but the quality was also impressive. There is no lack of supply of healthcare innovation, and Jumpstart is here to help them grow."
The Jumpstart Foundry Fall 2020 cohort of portfolio companies include various novel healthcare applications such as malnutrition diagnosis, behavioral health solutions, AI-powered labor management, and care management. All five companies will participate in a virtual onboarding orientation to connect with Jumpstart's network of industry experts and will be indoctrinated into The Jumpstart Refinery, Jumpstart's exclusive digital community, designed to connect the Jumpstart Foundry network and support growth acceleration.
"It has been an interesting and exciting year to be in venture capital – particularly in healthcare innovation. We are excited to welcome these new companies from diverse backgrounds across the country into the Jumpstart Foundry family," said Jumpstart Foundry COO Dr. Brian Dougherty.
In a time of great uncertainty, Jumpstart Foundry remains committed to making investments that support healthcare innovation. The Nashville-based venture capital firm is excited to MAKE SOMETHING BETTER in health as they prepare to deploy more capital in 2021.
About Jumpstart Foundry:
Jumpstart Foundry is a seed-stage healthcare innovation fund with one goal: Make Something Better. Jumpstart Foundry invests $150K in 15-20 healthcare startups from around the country each year. Jumpstart then guides and supports entrepreneurs through a systemized, step-by-step process to help each business reach success. The JSF fund has over 100 companies in its portfolio and was reported as Tennessee's most active venture capital firm in January 2020 by CB Insights.
For questions or additional information, please contact:
Richard Amoako
Content Marketing Manager | Jumpstart Foundry
richard@jsf.co
423-676-5282



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1553
Jim joins Capio with over 30 years' experience within the healthcare receivables management industry.

ATLANTA (PRWEB) NOVEMBER 30, 2020
Capio is pleased to welcome Jim Pender in the role of Vice President, National Accounts. Jim joins us with over 30 years' experience within the healthcare receivables management industry. Most recently, Jim served as the Vice President of Sales and Marketing for Medi-Centrix. Jim will be responsible for identifying new opportunities and supporting our existing national provider clients.
Jim brings a wealth of experience and knowledge to this role. Prior to joining Capio, he held leadership positions at EOS, McKesson, and Outsourcing Solutions, Inc. He began his career in operations at OSI prior to advancing into client management and sales roles.
"Jim is joining our team at Capio during a unique time. Despite the challenges of Covid-19, we are witnessing rapid growth as healthcare providers continue to rely on Capio to assist in their cash acceleration efforts," noted Dan Kutchel, Capio's Chief Sales officer. He added, "Our team is the best in the industry, and we are thrilled to have Jim join us. Jim's integrity, vast knowledge of the healthcare revenue cycle, deep personal connections, and past successes will allow him to excel in his new role."
Jim is active in several professional associations including Healthcare Finance Management Association (HFMA) on both a national and local level. Jim is also a member American Association of Healthcare Administrative Management, Medical Group Management Association, American Medical Group Association, Community Oncology Alliance and American Society of Anesthesiologists.
About Capio
Capio assists healthcare providers and physician organizations increase cashflow, while also lowering their bad debt expense. To date, Capio has acquired and provided consumer services with over $30B in patient accounts receivable, via partnerships alongside more than 450 provider clients across the United States. To learn more about Capio, please visit http://www.capiopfw.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1554
DigitalOne is offering Cranberry Peak ezCDS service as part of its DigitalOne Platform

CAMBRIDGE, MASS. (PRWEB) NOVEMBER 30, 2020
Cranberry Peak, a leading provider of AI, conversational interfaces and clinical decision support (CDS) technology announced today that it has formed a strategic partnership with DigitalOne. Cranberry Peak's clinical decision service, ezCDS has been integrated with DigitalOne's Orders Communicator, and is available to more than 100,000 providers currently connected through the DigitalOne Platform.
ezCDS is a CMS-qualified clinical decision support mechanism (CDSM) for the Appropriate Use Criteria (AUC) Program, supporting the implementation of Protecting Access to Medicare Act of 2014 (PAMA). Specifically, under this program, ordering physicians will be required to consult a CDSM for advanced diagnostic imaging orders. In addition to facilitating evidence-based medicine and standards of care at the point of care, ezCDS is also transforming user experience in healthcare and reducing physician burnout by introducing the first AI digital assistant serving ordering physicians, with voice and conversational interface. ezCDS supports modern interoperability standards with FHIR and CDS Hooks state of the art technology.
"With the integration of ezCDS into the DigitalOne Platform, our clients now have an intuitive solution to address CDS requirements that fits seamlessly into their workflow," said N Gulati, Sr Partner at DigitalOne. "With this partnership, imaging providers are now able to offer an easy to use solution to their referrer community to perform CDS consultations for advanced imaging orders across all referral channels even if the referring EMR doesn't offer CDS capability natively."
Cranberry Peak's Founder and CEO, Neculai Archip, PhD, MBA, said, "We have been working with the DigitalOne team for a while, and we are impressed by their effectiveness. In particular, the technical integration between our CDS service and DigitalOne platform was extremely smooth. DigitalOne's engineering team is top notch and has completed the technical integration within 3 weeks."
"Our companies are continuously optimizing our combined solution to best serve our users. Therefore, we are confident that this partnership will be successful for healthcare providers and positively impact the healthcare industry," Dr. Archip goes on to say.
Visit Cranberry Peak at https://www.cranberrypeak.com and DigitalOne at http://www.digitalonereports.net to learn more about this new partnership and how it can help you meet both current and future healthcare demands. During the week of November 30, 2020, Cranberry Peak is hosting online presentations on its website.
About Cranberry Peak
Cambridge, MA-based Cranberry Peak Corp. is a leader in AI, conversational interfaces and clinical decision support technology. In addition to enabling evidence-based medicine and standards of care, at the point of care, with the goal of improving healthcare delivery, Cranberry Peak is also aiming at reducing physician burnout.
For more information https://www.cranberrypeak.com or email contact@cranberrypeak.com
About DigitalOne
DigitalOne offers leading Interoperability Solutions that help Imaging Providers better serve their referring community while eliminating the time and expense associated with building point-to-point interfaces. The DigitalOne Platform that includes Orders Caddy, Desktop Delivery, EMRConnect, Zero Footprint Image Viewer, Orders Communicator and Patient Portal, deliver multiple convenient channels for referring providers to submit referrals and receive timely results into their EMR - securely, reliably and effectively.    
For more information https://www.digitalonereports.net or email info@digitalonereports.net

The technical integration between our CDS service and DigitalOne platform was extremely smooth. DigitalOne's engineering team is top notch and has completed the technical integration within 3 weeks.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1555
SmartBRAIN by MD Logic Health is the newest in our line of cognitive support supplements.

MIAMI, FLA. (PRWEB) NOVEMBER 30, 2020
MD Logic Wellness, last week announced that it has launched SmartBRAIN by MD Logic Health, a nutritional supplement featuring Acetyl-L-Carnitine, Phosphatidylserine, and Alpha GPC. It is known that as we age, our mental performance sees a noticeable decline in its normal functioning. While growing evidence and studies have revealed that exercise, genetics, and other lifestyle factors may impact our brain health and mental performance, new research reveals that nutrition can play a positive role in supporting healthy brain function, focus, concentration, and clarity. SmartBRAIN formula includes Phosphatidylserine, a phospholipid abundant in the brain. Phosphatidylserine improves neuron survival and supports the mechanisms needed for the formation of memories and learning.
Scott Emmens, Co-Founder of MD Logic Wellness commented, "As a busy entrepreneur, husband and father being able to maintain focus and recall throughout a long day is essential to maximize business and personal success. SmartBRAIN's stimulant-free formula allows me to seamlessly pivot from project to project without the jitters caffeine can cause. SmartBRAIN supports my natural neurotransmitters to keep me sharp and supplies Phosphatidylserine to support memory. We are very proud to introduce SmartBRAIN by MD Logic Health as the newest in our line of cognitive support supplements."
All MD Logic Health products are manufactured in the USA. We source only the purest and most effective ingredients which are quarantined and tested to meet approved specifications prior to being released for use. We strive to create effective and high-quality products based on clinical studies and scientific research. We are committed to delivering premium supplements to support a healthy lifestyle. Each MD Logic Health supplement is formulated with a specific purpose in mind. We believe that overall health and wellness can be improved by supplementing a healthy diet. MD Logic Health provides options that are gluten-free, vegetarian, dairy, and GMO-free with no artificial colors or flavors. For more information about SmartBRAIN and our other products please visit us at https://www.mdlogichealth.com or call 877-629-8711.
About MD Logic Wellness
MD Logic Health was created and founded by passionate health and wellness advocates. Our mantra is Spirit, Mind, Body, and Planet. Our quality is at the core of who we are and what we offer. Our purity and efficacy come from the superior ingredients used in every MD Logic Health product. Individual dietary and non-dietary ingredients are tested for identity, strength, purity, and composition compliance to ensure maximum effectiveness prior to use.
We currently have three distinct product lines to create a 360-degree ecosystem to link all potential customers. The Professional Line is sold exclusively to Health Care Providers, the MD Logic Health line is sold directly to consumers and the Essential line is sold to retail stores for core nutritional products.
"We believe health and well-being is the foundation to achieve your best life. Our mission is to connect our community to their health through superior dietary supplements, education, and health professional guidance. We believe our customers deserve the highest quality products, service, and support. MD Logic Health connects health care professionals and patients in their mutual pursuit of optimal wellbeing."
Availability
SmartBRAIN by MD Logic Health is now available online at our website https://www.mdlogichealth.com and on Amazon at https://www.amazon.com/MD-Logic-Health-SmartBRAIN/dp/B08NXX36BQ/
Contact
Jyoti Hardat, Director of Marketing
jhardat@mdlogichealth.com
+1(877) 629-8711 x700

We are very proud to introduce SmartBRAIN by MD Logic Health as the newest in our line of cognitive support supplements.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1556
Olive Fertility Centre voted Best Fertility Clinic in Vancouver in the Georgia Straight Best of Vancouver Awards 2020 - for the sixth year in a row - and voted in the top three for Best Local Employer

VANCOUVER, BRITISH COLUMBIA (PRWEB) NOVEMBER 30, 2020
Vancouver Canada-Olive Fertility Centre is proud to announce that they have been voted Best Fertility Clinic in Vancouver in the Georgia Straight Best of Vancouver Awards 2020.
We want to express our gratitude to all our wonderful patients who chose Olive to help them create their families and voted us the Best Fertility Centre in Vancouver for the sixth year in a row. We are also thrilled to have been voted in the top three for Best Local Employer.
"We are absolutely thrilled to have received Best Fertility Centre and Best Local Employer as it recognizes the level of care we provide for our patients and the kind of work environment we want for our staff. We really feel it is only by taking care of the people who work here that we can provide the excellent patient-centered care we are known for," says Olive Fertility co-director, Dr Beth Taylor. "The fact that Olive Fertility has among the best pregnancy success rates in Canada is due to our award-winning lab, internationally acclaimed team of fertility experts, and outstanding staff. Everyone at Olive, from the receptionists at the front desk to the patient care coordinators, nurses, embryologists and doctors, strives to ensure that patients have the best experience possible."
The rate of infertility in Canada has doubled over the last 20 years according to a Stats Canada report, in part because more women are delaying pregnancy until they are in their 30's and even 40's. "Frequently women don't know that fertility declines more quickly after 35 and that a woman over 35 and her partner should have a full fertility workup if they haven't conceived after six months of unprotected intercourse," says Dr Taylor. "The biological clock starts ticking much more quickly at this age. So, the sooner a problem is diagnosed, the more quickly the treatment can start."
Recent advances in fertility treatment and preimplantation genetic testing have improved the chances of achieving a pregnancy and having a healthy baby even for women over the age of 38.
Fertility evaluation and testing is fully covered by MSP in British Columbia with a referral from a family physician or a doctor at a walk-in clinic.
Olive would also like to congratulate Acubalance Wellness Centre for receiving the Georgia Straight Best of Vancouver Acupuncture, Naturopathic and Integrative clinic.
Located in Vancouver, BC, Olive Fertility Centre is one of Canada's leading fertility clinics, offering an award-winning IVF lab, personal care teams, 70+ years of combined experience, and innovative programs including specialized genetic testing, egg freezing, and prenatal NIPT testing.

We are absolutely thrilled to have received Best Fertility Centre and Best Local Employer as it recognizes the level of care we provide for our patients and the kind of work environment we want for our staff.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1557
MarvelXACT PEEKsil can be used in all HPLC/UHPLC applications

ROHNERT PARK, CALIF. (PRWEB) DECEMBER 01, 2020
IDEX Health & Science, industry leader in fluidic connections for life science applications, has launched the new MarvelXACT PEEKsil Connection Systems. Employing patented MarvelXACT connections technology, these new bioinert tubing and fitting connection systems are designed to be compatible with low flow applications at high pressures that require low contamination and minimal flow resistance. The new connection systems have an extremely smooth internal diameter and provide a secure dead volume connection which helps avoid carryover and blockage.
"MarvelXACT PEEKsil can be used in all HPLC/UHPLC applications and as a replacement for PEEK and SST tubing especially where chemical compatibility and low absorption is required" said Audrey Schrock, Sr. Product Manager, Valves and Column Hardware. "We are enabling more robust low-flow analysis data for applications that are highly sensitive and require chemical inertness," continued Schrock.
Other bioinert products supplied by IDEX Health & Science include: MarvelX and MarvelXACT connection technology, 1mm columns, bioinert PEEK-Lined Stainless-Steel Column Hardware and a novel flat film degasser.
About IDEX Health & Science, LLC
IDEX Health & Science, LLC is the global leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, solutions, and expertise. As one of the few companies in the world with component, sub-system, and application level experts, IDEX Health & Science helps instrument developers solve the most demanding fluidic and optical challenges in a wide array of applications. At IDEX Health & Science we believe partnership will change the way the world innovates, leading to new technologies that improve our health, protect our planet, and enrich our lives. For more information visit: http://www.idex-hs.com

MarvelXACT PEEKsil can be used in all HPLC/UHPLC applications and as a replacement for PEEK and SST tubing especially where chemical compatibility and low absorption is required" said Audrey Schrock, Sr. Product Manager, Valves and Column Hardware. "We are enabling more robust low-flow analysis data



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1558
Children's National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids.

SALT LAKE CITY (PRWEB) NOVEMBER 30, 2020
Children's National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids. The innovation, insta-3D imaging from company nView medical, is designed to make 3D images available in the operating room quickly and safely. The 3D images provide surgeons with better visualization, allowing them to continue improving patient care and outcomes.
Matthew Oetgen, M.D., division chief of Orthopaedic Surgery at Children's National, is overseeing the first use of this 3D imaging technology in orthopaedic procedures.
"Having a technology like this available in the operating room will potentially help make our surgeries even more precise with 3D imaging available quickly," says Dr. Oetgen. "We anticipate this improved precision will lead to better outcomes and added value to what we do for our patients."
Cristian Atria, nView medical's CEO, commented for the first case.
"Seeing our imaging technology provide critical information during a kid's surgery reminds us what the purpose of nView medical is all about," says Cristian. "I would like to thank the surgeons, our backers, the team, and our clinical partners for making this first surgery a success. I couldn't be more enthusiastic for what's ahead!"
The potential of nView medical's insta-3D imaging is especially exciting for Children's National as nView medical is a 2019 Winner of the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) competition "Make Your Medical Device Pitch for Kids!" NCC-PDI is led by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National and the A. James Clark School of Engineering at the University of Maryland with support from partners MedTech Innovator, BioHealth Innovation, and design firm Archimedic.
NCC-PDI is one of five members in the FDA's Pediatric Device Consortia Grant Program created to support the development and commercialization of medical devices for children in areas of critical need where innovation can significantly improve children's health care.
"Children deserve to benefit from our most advanced medical technologies and we know that improvements in pediatric care can make a positive difference over the lifetime of a child," says Kolaleh Eskandanian, Ph.D., M.B.A, P.M.P, vice president and chief innovation officer at Children's National and principal investigator of NCC-PDI. "Pediatric hospitals must lead the way in supporting innovation for children's care. That's why, through NCC-PDI and our innovation institute, Children's National helps to provide promising new pediatric devices with resources and expertise that support their journey to the market."
-
About nView medical:
nView medical, based in Salt Lake City, UT, is a startup whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Capital Consortium for Pediatric Device Innovation, MedTech Innovator, HealthTech Arkansas, Dr. Kevin Foley, MD, and Fusion Fund (Palo Alto, CA).
About Children's National Hospital
Children's National Hospital, based in Washington, D.C., celebrates 150 years of pediatric care, research and commitment to community. Volunteers opened the hospital in 1870 with 12 beds for children displaced after the Civil War. Today, 150 years stronger, it is among the nation's top 10 children's hospitals. It is ranked No. 1 for newborn care for the fourth straight year and ranked in all specialties evaluated by U.S. News & World Report. Children's National is transforming pediatric medicine for all children. In 2020, construction will be complete on the Children's National Research & Innovation Campus, the first in the nation dedicated to pediatric research. Children's National has been designated twice as a Magnet hospital, demonstrating the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C., metropolitan area, including the Maryland and Northern Virginia suburbs. Children's National is home to the Children's National Research Institute and Sheikh Zayed Institute for Pediatric Surgical Innovation and is the nation's seventh-highest NIH-funded children's hospital. It is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels.

We anticipate this improved precision will lead to better outcomes and added value to what we do for our patients.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1559
Beginning in March of 2020, older adults were cut off from their families. Senior living companies of all types were caught in the triple bind of no-visitors, worsening worker shortage and the spread of Covid-19 to their residents. The pandemic caused older adults to defer health appointments and interactions with others, resulting in the usage of telehealth and other technologies like Zoom and FaceTime to skyrocket. Many of the technology stopgaps will become part of permanent change in how seniors connect, how businesses serve them, and what innovations matter most. Aging and Health Technology Watch covers these topics in its newest research report , "The Future of Remote Care Technology and Older Adults 2020."

PORT SAINT LUCIE, FLA. (PRWEB) NOVEMBER 30, 2020
The current status and future potential are discussed in the new report The Future of Remote Care Technology and Older Adults 2020 from Aging and Health Technology Watch. The report is based on interviews with experts from 30 organizations across healthcare and technology. Insights and report advice span telehealth, wearables, AI, smart home, and voice products and services.
Says Mary Furlong: "Laurie Orlov continues to deliver thought leadership and guidance that will help shape the longevity market in these difficult times."
Tech industry veteran Laurie M. Orlov launched the market research company in 2009 with a blog, advisory services, and industry information which can be found at http://www.ageinplacetech.com.

The home will be come the hub for life and care.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1560
Prescott's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

PRESCOTT, ARIZ. (PRWEB) DECEMBER 01, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Prescott, AZ for 2021. The informational guide recognizes the top 16 rehab facilities based on cost, treatment options, location, accompanying services and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Prescott, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Prescott with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Prescott. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Prescott, AZ please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-prescott-az/
2021 Best Rehab Facilities in Prescott, AZ (in alphabetical order)
Blueprints for Recovery
225 Grove Avenue
Prescott, AZ 86301
928-723-4600
Canyon Crossing Recovery
819 West Gurley Street
Prescott, AZ 86305
800-651-7254
Compass Recovery Center
711 South Granite Street
Prescott, AZ 86303
800-216-1840
Decision Point Center
505 Whipple Street
Prescott, AZ 86301
928-778-4600
Embark Recovery
3727 Karicio Lane
Prescott, AZ 86303
928-250-0447
Granite Mountain Behavioral Healthcare
8705 East Eastridge Drive
Prescott Valley, AZ 86314
877-389-0412
Holdfast Recover
1470 West Gurley Street
Prescott, AZ 86305
800-680-7738
Northern Arizona Center for Addiction
195 Plaza Drive
Prescott, AZ 86303
928-615-6006
Prescott House
214 North Arizona Avenue
Prescott, AZ 86301
866-425-4673
Recovery In The Pines
919 12th Place, Suite 13
Prescott, AZ 86305
844-762-3748
Reflections Recovery Center
957 Black Drive
Prescott, AZ 86305
866-418-1213
Reflections Recovery Center
957 Black Drive
Prescott, AZ 86305
866-418-1213
Royal Life Centers at Chapter 5
818 W. Gurley Street
Prescott, AZ 86301
877-732-6837
Silver Sand Recovery
3636 Crossings Drive
Prescott, AZ 86305
833-723-0387
StoneRidge Center for Brain and Addiction Treatment
5940 East Copper Hill Drive, Suites B & E
Prescott Valley, AZ 86314
928-583-7799
Viewpoint Dual Recovery
702 W. Hillside Avenue
Prescott, AZ 86301
855-746-3633
West Yavapai Guidance
642 Dameron Drive
Prescott, AZ 86301
928-445-5211
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1561
Even the healthiest of adults are affected by the physical and mental effects of aging because of the inherent nature of the process. With this in mind, Market America | SHOP.COM is here to talk about aging well and two ways to appreciate your second act even more!

GREENSBORO, N.C. (PRWEB) NOVEMBER 30, 2020
The holidays are here and it's the perfect time to give thanks for what's most important in our lives. As we age, certain things take on more meaning and importance. Often, what becomes most important are the very things that money can't buy – the love of family and friends and the time we spend together with the ones we love becomes priceless. American activist, editor and writer, Frances Lear, may have said it best when she said "I believe the second half of one's life is meant to be better than the first half. The first half is finding out how you do it. And the second half is enjoying it." With this in mind, Market America | SHOP.COM is here to talk about aging well and two ways to appreciate your second act even more!
Referred to as the "gray tsunami," the U.S. Census reports that baby boomers (born from 1946 to 1964) have changed the face of our country for more than 70 years and are continuing to do so as they become seniors. An estimated 73 million baby boomers account for the second-largest age group, only to be outnumbered by the millennials (born from 1982 to 2000). By 2030, all boomers will be at least age 65.
No matter what your age, it's important to take care of yourself by eating the right foods, exercising regularly and visiting your personal healthcare physician for an annual checkup. Even the healthiest of adults, however, are affected by the physical and mental effects of aging because of the inherent nature of the process. So, the next time you go in for your annual checkup, consider talking with your doctor about nutrients and what you should be eating to get the right amount of nutrients for your age. Why? Consider this. The National Institute of Health (NIH) has shared research demonstrating that because older adults' abilities to absorb and use many nutrients become less efficient, the nutrient requirements can actually increase. This may mean that while you are focused on maintaining an alert mind and an active body, the level of nutrients it can take to get you there may be more than you realize!
That's where two supplements may help you as you age – Prime Ultimate Longevity Formula by Isotonix and Isotonix Essentials Anti-Aging. Both can help with the physical and mental effects of aging and both are in an isotonic delivery system. More on what an isotonic delivery system is in a moment.
1.    Prime Ultimate Longevity Formula by Isotonix
Prime Ultimate Longevity Formula by Isotonix specifically addresses the select needs of mature adults. While other products might focus on a particular area of aging, Prime Ultimate Longevity Formula by Isotonix is designed for the aging adult who wants to maintain both an alert mind and active body. Prime Ultimate Longevity Formula by Isotonix is formulated with natural ingredients, including huperzine A (which aids in improving and enhancing memory and cognitive function) and branched-chain amino acids (which promote muscle retention). Benefits may include:*

Supporting cognitive performance

Helping to reduce muscle fatigue

Aiding in improving and enhancing memory

Promoting healthy muscle retention and use

2.    Isotonix Essentials Anti-Aging
Although a healthy diet is essential to getting the nutrients the body needs to look and feel well, taking daily supplements can be a good way support optimal health. We too often accept lower energy and strength as we mature, however, supplements can add the needed vitamins and minerals to balance the demands of the body and brain as we get older. Isotonix Essentials Anti-Aging can help you maintain the vitality of your body as you gracefully move up in years. It features a dynamic, custom blend of antioxidants, botanicals and minerals designed to provide the vitamins and minerals you need as your body ages. Our Anti-Aging formula helps support brain and cognitive health, provides a strong antioxidant defense and provides daily nutrients to support healthy aging. It also helps support skeletal and muscular health.* Benefits may include:

Providing daily nutrients to support healthy aging.

Promoting muscle health and strength

Helping with energy and stamina

Helping to support brain/cognitive health

Isotonic, which means "same pressure," bears the same chemical resemblance of the body's blood, plasma and tears. All fluids in the body have a certain concentration, referred to as osmotic pressure. The body's common osmotic pressure, which is isotonic, allows a consistent maintenance of the body's tissues. In order for a substance to be absorbed and used in the body's metabolism, it must be transported in an isotonic state. Both Prime Ultimate Longevity Formula by Isotonix and Isotonix Essentials Anti-Aging are isotonic solutions, meaning that the body has less work to do in obtaining maximum absorption. The isotonic state of the suspension allows nutrients to pass directly into the small intestine and be rapidly absorbed into the bloodstream. With Isotonix products, little nutritive value is lost, making the absorption of nutrients highly efficient while delivering maximum results.*
Finally, when it comes to defeating age, Sophia Loren says each of us already has what we need. "There is a fountain of youth: it is your mind, your talents, the creativity you bring to your life and the lives of people you love. When you learn to tap this source, you will truly have defeated age."
*These statements have not been evaluated by the Food and Drug Administration. This product(s) is not intended to diagnose, treat, cure or prevent any disease.
Market America | SHOP.COM is a global product brokerage and internet marketing company that specializes in one-to-one marketing and is the creator of The Shopping Annuity.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1562
Mediaplanet's Lung Health campaign, found within USA TODAY and online, aims to raise awareness on chronic lung diseases affecting nearly 37 million Americans

NEW YORK (PRWEB) NOVEMBER 30, 2020
Lung disease is the third-leading cause of death in the United States, affecting nearly 37 million Americans living with some form of chronic lung disease. Despite these daunting figures, we are heading toward a brighter future for lung health, due to advancements in early detection and treatment. Mediaplanet's new November edition of the 'Lung Health' campaign will reach both patients and professionals, alerting them to the innovative tools now available.
In partnership with the respiratory community's leaders, this campaign educates readers on some of the most serious lung issues including lung cancer, pulmonary fibrosis, asthma, and cystic fibrosis. It also calls special attention to lung diseases in the age of COVID-19 and how every individual can take preventative measures to protect their lungs.
The print component of "Lung Health" is distributed within the November 25th regional circulation of USA Today with a circulation of approximately 200,000 copies and an estimated readership of 600,000 within the New York, Los Angeles, San Francisco, and Washington D.C./Baltimore markets. The digital component is distributed nationally, through a cast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, click here.
This edition of "Lung Health" was made possible with the support of the American Thoracic Society, Lung Cancer Foundation of America, Go2 Foundation for Lung Cancer, Pulmonary Fibrosis Foundation (PFF), Allergy and Asthma Network, Personalized Medicine Coalition, Cancer Treatment Centers of America, Rock CF, Association of Community Cancer Centers, Bellerophon Therapeutics, GRAIL, Boehringer Ingelheim Pharmaceuticals and SunRADON.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Isabelle Garrity
Isabelle.garrity@mediaplanet.com
646 - 518- 5421



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1563
Mediaplanet and SunRADON have joined forces in advocating for lung health

NEW YORK (PRWEB) NOVEMBER 30, 2020
Mediaplanet is proud to announce the launch of this November's Lung Health campaign. The campaign brings together patients, healthcare providers, advocates to spread awareness of chronic lung disease as well as recent innovation in prevention, diagnostics, and treatment for these devastating respiratory conditions. The campaign also takes a dive into importance of lung cancer prevention, and how some companies are dedicated to helping prevent lung cancer.
One leading company is SunRADON, a top provider of professional Radon Detection and Indoor Air Quality (IAQ) monitors. The company has recently launched lüft, the world's first smart, plug-in Indoor Air Quality and Radon Monitor. This is a welcome innovation in the fight against radon-induced lung cancer.
lüft was created to provide consumers an effective and easy method to track Indoor Air Quality, including detection of Radon, a feature often lacking in today's IAQ monitors yet crucial in protecting lung health. "Radon is the #1 cause of lung cancer among non-smokers, and responsible for more deaths every year than all other home related deaths combined. Yet long term radon measurements are not included in standard IAQ monitors! It's because radon detection requires specialized know-how and technology, which SunRADON has mastered for 30+ years while serving professional radon inspectors and mitigators worldwide," explains SunRADON CEO Dr. Kai Wundke.
Through lüft, SunRADON is helping a wide variety of customers, whether at home, school, the office or a healthcare facility, to accurately monitor indoor air quality on a long-term basis. lüft not only monitors radon levels but also dangerous chemicals such as formaldehyde, carbon dioxide equivalent, temperature, pressure, and humidity. lüft is unique in that it packs state-of-the-art radon detection into an IoT-enabled plug-in device. It also allows users to share data with their indoor air quality professionals to provide expert services should need arise.
"lüft is not just another IAQ monitor, but an integrated, smart IAQ system with the benefit of also detecting radon, the most dangerous Indoor Air Quality problem of them all," adds Dr. Wundke. The lüft monitor is available for purchase on sunradon.com or amazon.com.
The print component of Lung Health is distributed within the November edition of USA TODAY in LA, Boston, New York, Chicago, Houston, Seattle, Las Vegas, D.C Baltimore, and Pittsburgh/Cleveland markets. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: https://www.futureofpersonalhealth.com/campaign/lung-health/
The campaign was made possible with the support of SunRADON, as well as the American Thoracic Society, Lung Cancer Foundation of America, Go2 Foundation for Lung Cancer, Boehringer Ingelheim, Bellerophon Therapeutics and GRAIL.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Isabelle Garrity
Isabelle.garrity@mediaplanet.com
646-518-5421



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1564
Clearwater's leading provider of Cryoskin and Verju fat reduction technologies announces curated event series to give clients safe and local access to even more wellness

CLEARWATER, FLA. (PRWEB) NOVEMBER 30, 2020
Trim Studio is dedicated to helping clients achieve their goals through leading-edge technologies for fat reduction, cellulite treatment and skin toning without painful procedures, side effects or downtime. Their ongoing wellness event series will focus on therapies which support body contouring results and overall well being. For more information, visit their website.
"Throughout this year, we knew we'd need to get creative with how we make wellness resources available to our clients. The 'quarantine 15' joke is all too real for so many of us, and we feel lucky to work in a setting that allows for safe execution of events and one-on-one treatments at a safe social distance," says Corina Froese, co-founder of Trim Studio.
Trim Studio was set to host their second annual Brunch and Yoga event in the spring of 2020 when pandemic-related circumstances made it impossible. After canceling, they shifted gears to smaller pop-up style events with a more intimate feel. Even with smaller events, Trim Studio intends to pack them with a punch of beneficial wellness and science-backed adjunct therapies.
In September, the Clearwater wellness boutique welcomed healthcare providers for vitamin injections and hormone wellness consultations. In November, an ozone sauna was made available to clients during a two day pop-up event which sold out in under 48 hours. In December, the Studio will be in Tampa for a one day event offering discounted body treatments and anti-aging CryoFacials at Femme Akoi Beauty Studio on Nebraska Avenue in Tampa.
"We absolutely love working with local wellness businesses that share our common goal to help clients improve their lifestyle and feel better. Though circumstances limited us a little bit in 2020, it also allowed us time to step back and reflect on how we might help our clients achieve more and better results—this is something that is always top of mind, and we definitely have some exciting news and changes to reveal in the new year!"
Trim Studio's non-invasive Verju laser is FDA-cleared for reduction of cellulite, fat and overall body circumference. Verju is the world's first green body contouring laser of its kind and the only body contouring device on the market with proven efficacy by way of a double-blind, multi-site and placebo-controlled clinical study in which clients saw a four-inch average loss after completion of a treatment program. The Studio also offers Cryoskin 3.0 technology which affords clients the opportunity to spot reduce stubborn body fat through cryolipolysis (fat freezing) as well as to reduce the appearance of cellulite and smooth facial wrinkles.
Trim Studio's technologies are appropriate for body types ranging from athletic to clinically obese. For more information or to request a consultation contact them by calling 727-288-4329.
###
ABOUT TRIM STUDIO
Trim Studio is a wellness boutique located in Clearwater, Florida specializing in non-surgical body sculpting. Utilizing technologies such as Cryoskin 3.0 for cryolipolysis (fat freezing), skin toning, cellulite smoothing and facial rejuvenation as well as Verju (photoporosis) for fat and cellulite reduction, Trim Studio is dedicated to changing the body contouring game with effective tools for real, observable fat loss and improvements to skin's elasticity and tone. For more information, please visit http://www.TrimStudioFL.com or visit the Studio on social media at @TrimStudioFL!
MEDIA CONTACT
Corina Froese
corina@dandelioncreativeco.com
727-441-1711





START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1565
President & Founder of HR Maximizer Inc is now a member of the Forbes Business Council. Forbes Business Council is an Invitation-Only Communities For Successful Executives And Entrepreneurs

HOUSTON (PRWEB) NOVEMBER 30, 2020
Rollis Fontenot III of HR Maximizer Inc accepted into Forbes Business Council
Forbes Business Council Is an Invitation-Only Community for Successful Business Owners and Leaders
Rollis Fontenot III, president & founder of HR Maximizer Inc, a subscription based recruitment services firm serving clients nationwide, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.
Rollis Fontenot III was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors.
"We are honored to welcome Rollis Fontenot III into the community," said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council. "Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world."
As an accepted member of the Council, Rollis has access to a variety of exclusive opportunities designed to help his reach peak professional influence. he will connect and collaborate with other respected local leaders in a private forum and at members-only events. Rollis will also be invited to work with a professional editorial team to share his expert insights in original business articles on Forbes.com, and to contribute to published Q&A panels alongside other experts.
Finally, Rollis will benefit from exclusive access to vetted business service partners, membership-branded marketing collateral, and the high-touch support of the Forbes Councils member concierge team.
"I am very excited about being a part of this global community of business leaders who are looking to offer their expertise to help others grow. In this way, the rising tide will lift all boats, thereby helping all of us attain our individual goals. I look forward to this opportunity for us to make valuable contributions to this group as we grow together."
ABOUT FORBES COUNCILS
Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive.
To learn more about Forbes Councils, visit forbescouncils.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1566
In this free webinar, the featured speakers will discuss the impact of the RACE for Children Act since it went into effect, from a regulatory, health care professional and industry point of view, both in the USA and globally. They will talk about what a pediatric champion is and why they are needed, and a parent and child's experience of a molecularly targeted therapy.

TORONTO (PRWEB) NOVEMBER 30, 2020
After three years of hard work by multiple diverse stakeholders, and with much anticipation, the RACE for Children Act became effective August 18th, 2020. This landmark legislation aims to dramatically shift the global landscape of clinical research in pediatric oncology and intends to bring new molecularly targeted cancer therapeutics to children, who have not been as greatly impacted by precision medicine over the past few decades compared to adults.
Whether the RACE for Children Act leads to the development of more drugs for children with cancer in the USA, and globally, remains to be seen. What can we learn about the global impact of the RACE for Children Act in the first few months since its implementation? What is needed to ensure its ongoing success?
Regulators, researchers, industry and patient advocates have come together to focus on not only curing childhood cancer but reducing long term side effects. Please join us in hearing from them in this webinar on what the early global impact of the RACE for Children Act looks like, and what is needed to ensure its success, including the critical function of pediatric champions.
Join Dr. Gregory Reaman, Associate Director for Pediatric Oncology, Oncology Center of Excellence, Center for Drug Evaluation and Research, US Food and Drug Administration; Prof. Gilles Vassal, Head of Pediatric Research Program, Gustave Roussy/Université Paris-Saclay and President ITCC, Chair of ACCELERATE; Dr. Anjali Sharma, Pediatric Oncology Development Lead and Early Oncology Development Lead, Amgen; and Dr. Beth Anne Baber, Founder & President, TigoHealth, in a live webinar on Thursday, December 17, 2020 at 10am EST (3pm GMT/UK).
For more information, or to register for this event, visit The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1567
In this complimentary webinar, featured speakers from Medpace and MyoKardia will discuss precision medicine approaches for treating cardiovascular disease and its growing role in clinical trials. A case study of MyoKardia's MAVERICK-HCM trial will be presented, highlighting operational challenges, best practices and lessons learned. Future directions, including mitigations during a pandemic will also be disussed.

TORONTO (PRWEB) NOVEMBER 30, 2020
Despite advances in medical therapeutics, cardiovascular disease (CVD) remains the leading cause of death worldwide. Notably, heart failure and coronary disease continue to present an exorbitant burden on patients and health care. Recently, breakthroughs in precision medicine are creating optimism for a field that has historically witnessed few long-term successes in targeted therapeutic approaches.
Indeed, precision-medicine approaches target the subsets of patients that are most likely to benefit from a drug, including approaches based on mechanism of disease and shared patient characteristics. By matching mechanism of a drug action with specific disease etiology, precision-medicine approaches are starting to turn the page in CVD trials.
Investigational drugs like mavacamten, developed by MyoKardia, offer new hope for patients with hypertrophic cardiomyopathy (HCM), an inherited and often lethal primary myocardial disorder without effective pharmacological options. Indeed, the striking positive results found in obstructive and non-obstructive HCM patients are expected to support a New Drug Application (NDA) filing, thus commencing a new promising chapter in the precision-medicine approach to CVD drug discovery.
Join experts from Medpace and MyoKardia in a live webinar on Tuesday, December 15, 2020 at 12pm EST (5pm GMT/UK).
For more information, or to register for this event, visit From Promise to Reality: MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1568
In this free webinar, the featured speakers will discuss when direct-to-patient is applicable for a trial and whatsponsors should plan for if implementing a direct-to-patient strategy.

TORONTO (PRWEB) NOVEMBER 30, 2020
The current pandemic has had a significant impact on clinical development, calling for the implementation of decentralized trials. With this change, it's now more important than ever to ensure the right Investigational Medicinal Product (IMP) reaches the right patient at the right time.
So how do sponsors go about implementing direct-to-patient models and how do they maintain the chain of custody for the life of an IMP? This insightful webinar will take participants through the what, why and how of performing various direct-to-patient models. Participants will gain knowledge of the important areas to consider before executing, such as:

Additional data requirements needed

What information needs to be held in the Interactive Response Technology (IRT)

What steps can be taken to safeguard trials beyond the pandemic

Join expert speakers from Almac Clinical Technologies, Matt Lowrie, ASQ CQA, QA Manager, Quality Assurance; Abby Sener, Manager, Almac ONE, ACS Project Services; and Kat Williams, Manager, Clinical Project Services, in a live webinar on Tuesday, December 15, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Direct-to-Patient: Implementing Models for Continuous Treatment During the Pandemic And Beyond.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1569
In this free webinar, experts from ICON Medical Imaging and Medidata will discuss how AI needs to have focus in specific areas, as past efforts to do everything have failed. The presenters will talk about narrowing down imaging problem statements to generate better results. How AI and ML can function as "guide rails" for radiologists will also be explored, in addition to areas in which AI and ML can increase (thus saving money) and improve quality (thus saving lives).

TORONTO (PRWEB) NOVEMBER 30, 2020
For the first 125 years of medical imaging, technological advances focused primarily on new modes of imaging as technology progressed from the discovery of the X-ray in 1895 to ultrasounds, MRIs, PET and CT scans in the late 20th century. Now, arguably, the most notable advances are being made in how images from those technologies are securely shared, managed, stored and assessed. These advancements are largely due to the application of artificial intelligence (AI) and machine learning (ML) to imaging systems and data platforms.
Automation is improving virtually every stage of the imaging workflow, but there is a lot of hype concerning AI and ML in the marketplace. Companies have underestimated the challenge that complexity presents, and predictions of the end of radiologists have proven false multiple times.
Join experts from ICON Medical Imaging and Medidata for this webinar on the practical applications for AI and ML in clinical trial imaging and what is possible today. Learn what is available today in the current landscape, its applications for building efficiency and what is coming in the near future to help life science companies transform their clinical trial imaging.
Join Paul McCracken, Vice President, Head of Medical Imaging, ICON Medical Imaging; and Dan Braga, VP, Product Management, Acorn AI Product & Ecosystem, Medidata, in a live webinar on Wednesday, December 16, 2020 at 11am EST (8am PST).
For more information, or to register for this event, visit Imaging AI and Machine Learning — Beyond the Hype.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/




START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1570
Prescott's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

PRESCOTT, ARIZ. (PRWEB) DECEMBER 01, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Prescott, AZ for 2021. The informational guide recognizes the top 16 rehab facilities based on cost, treatment options, location, accompanying services and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Prescott, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Prescott with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Prescott. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Prescott, AZ please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-prescott-az/
2021 Best Rehab Facilities in Prescott, AZ (in alphabetical order)
Blueprints for Recovery
225 Grove Avenue
Prescott, AZ 86301
928-723-4600
Canyon Crossing Recovery
819 West Gurley Street
Prescott, AZ 86305
800-651-7254
Compass Recovery Center
711 South Granite Street
Prescott, AZ 86303
800-216-1840
Decision Point Center
505 Whipple Street
Prescott, AZ 86301
928-778-4600
Embark Recovery
3727 Karicio Lane
Prescott, AZ 86303
928-250-0447
Granite Mountain Behavioral Healthcare
8705 East Eastridge Drive
Prescott Valley, AZ 86314
877-389-0412
Holdfast Recover
1470 West Gurley Street
Prescott, AZ 86305
800-680-7738
Northern Arizona Center for Addiction
195 Plaza Drive
Prescott, AZ 86303
928-615-6006
Prescott House
214 North Arizona Avenue
Prescott, AZ 86301
866-425-4673
Recovery In The Pines
919 12th Place, Suite 13
Prescott, AZ 86305
844-762-3748
Reflections Recovery Center
957 Black Drive
Prescott, AZ 86305
866-418-1213
Reflections Recovery Center
957 Black Drive
Prescott, AZ 86305
866-418-1213
Royal Life Centers at Chapter 5
818 W. Gurley Street
Prescott, AZ 86301
877-732-6837
Silver Sand Recovery
3636 Crossings Drive
Prescott, AZ 86305
833-723-0387
StoneRidge Center for Brain and Addiction Treatment
5940 East Copper Hill Drive, Suites B & E
Prescott Valley, AZ 86314
928-583-7799
Viewpoint Dual Recovery
702 W. Hillside Avenue
Prescott, AZ 86301
855-746-3633
West Yavapai Guidance
642 Dameron Drive
Prescott, AZ 86301
928-445-5211
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1571
Even the healthiest of adults are affected by the physical and mental effects of aging because of the inherent nature of the process. With this in mind, Market America | SHOP.COM is here to talk about aging well and two ways to appreciate your second act even more!

GREENSBORO, N.C. (PRWEB) NOVEMBER 30, 2020
The holidays are here and it's the perfect time to give thanks for what's most important in our lives. As we age, certain things take on more meaning and importance. Often, what becomes most important are the very things that money can't buy – the love of family and friends and the time we spend together with the ones we love becomes priceless. American activist, editor and writer, Frances Lear, may have said it best when she said "I believe the second half of one's life is meant to be better than the first half. The first half is finding out how you do it. And the second half is enjoying it." With this in mind, Market America | SHOP.COM is here to talk about aging well and two ways to appreciate your second act even more!
Referred to as the "gray tsunami," the U.S. Census reports that baby boomers (born from 1946 to 1964) have changed the face of our country for more than 70 years and are continuing to do so as they become seniors. An estimated 73 million baby boomers account for the second-largest age group, only to be outnumbered by the millennials (born from 1982 to 2000). By 2030, all boomers will be at least age 65.
No matter what your age, it's important to take care of yourself by eating the right foods, exercising regularly and visiting your personal healthcare physician for an annual checkup. Even the healthiest of adults, however, are affected by the physical and mental effects of aging because of the inherent nature of the process. So, the next time you go in for your annual checkup, consider talking with your doctor about nutrients and what you should be eating to get the right amount of nutrients for your age. Why? Consider this. The National Institute of Health (NIH) has shared research demonstrating that because older adults' abilities to absorb and use many nutrients become less efficient, the nutrient requirements can actually increase. This may mean that while you are focused on maintaining an alert mind and an active body, the level of nutrients it can take to get you there may be more than you realize!
That's where two supplements may help you as you age – Prime Ultimate Longevity Formula by Isotonix and Isotonix Essentials Anti-Aging. Both can help with the physical and mental effects of aging and both are in an isotonic delivery system. More on what an isotonic delivery system is in a moment.
1.    Prime Ultimate Longevity Formula by Isotonix
Prime Ultimate Longevity Formula by Isotonix specifically addresses the select needs of mature adults. While other products might focus on a particular area of aging, Prime Ultimate Longevity Formula by Isotonix is designed for the aging adult who wants to maintain both an alert mind and active body. Prime Ultimate Longevity Formula by Isotonix is formulated with natural ingredients, including huperzine A (which aids in improving and enhancing memory and cognitive function) and branched-chain amino acids (which promote muscle retention). Benefits may include:*

Supporting cognitive performance

Helping to reduce muscle fatigue

Aiding in improving and enhancing memory

Promoting healthy muscle retention and use

2.    Isotonix Essentials Anti-Aging
Although a healthy diet is essential to getting the nutrients the body needs to look and feel well, taking daily supplements can be a good way support optimal health. We too often accept lower energy and strength as we mature, however, supplements can add the needed vitamins and minerals to balance the demands of the body and brain as we get older. Isotonix Essentials Anti-Aging can help you maintain the vitality of your body as you gracefully move up in years. It features a dynamic, custom blend of antioxidants, botanicals and minerals designed to provide the vitamins and minerals you need as your body ages. Our Anti-Aging formula helps support brain and cognitive health, provides a strong antioxidant defense and provides daily nutrients to support healthy aging. It also helps support skeletal and muscular health.* Benefits may include:

Providing daily nutrients to support healthy aging.

Promoting muscle health and strength

Helping with energy and stamina

Helping to support brain/cognitive health

Isotonic, which means "same pressure," bears the same chemical resemblance of the body's blood, plasma and tears. All fluids in the body have a certain concentration, referred to as osmotic pressure. The body's common osmotic pressure, which is isotonic, allows a consistent maintenance of the body's tissues. In order for a substance to be absorbed and used in the body's metabolism, it must be transported in an isotonic state. Both Prime Ultimate Longevity Formula by Isotonix and Isotonix Essentials Anti-Aging are isotonic solutions, meaning that the body has less work to do in obtaining maximum absorption. The isotonic state of the suspension allows nutrients to pass directly into the small intestine and be rapidly absorbed into the bloodstream. With Isotonix products, little nutritive value is lost, making the absorption of nutrients highly efficient while delivering maximum results.*
Finally, when it comes to defeating age, Sophia Loren says each of us already has what we need. "There is a fountain of youth: it is your mind, your talents, the creativity you bring to your life and the lives of people you love. When you learn to tap this source, you will truly have defeated age."
*These statements have not been evaluated by the Food and Drug Administration. This product(s) is not intended to diagnose, treat, cure or prevent any disease.
Market America | SHOP.COM is a global product brokerage and internet marketing company that specializes in one-to-one marketing and is the creator of The Shopping Annuity.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1572
Mediaplanet's Lung Health campaign, found within USA TODAY and online, aims to raise awareness on chronic lung diseases affecting nearly 37 million Americans

NEW YORK (PRWEB) NOVEMBER 30, 2020
Lung disease is the third-leading cause of death in the United States, affecting nearly 37 million Americans living with some form of chronic lung disease. Despite these daunting figures, we are heading toward a brighter future for lung health, due to advancements in early detection and treatment. Mediaplanet's new November edition of the 'Lung Health' campaign will reach both patients and professionals, alerting them to the innovative tools now available.
In partnership with the respiratory community's leaders, this campaign educates readers on some of the most serious lung issues including lung cancer, pulmonary fibrosis, asthma, and cystic fibrosis. It also calls special attention to lung diseases in the age of COVID-19 and how every individual can take preventative measures to protect their lungs.
The print component of "Lung Health" is distributed within the November 25th regional circulation of USA Today with a circulation of approximately 200,000 copies and an estimated readership of 600,000 within the New York, Los Angeles, San Francisco, and Washington D.C./Baltimore markets. The digital component is distributed nationally, through a cast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, click here.
This edition of "Lung Health" was made possible with the support of the American Thoracic Society, Lung Cancer Foundation of America, Go2 Foundation for Lung Cancer, Pulmonary Fibrosis Foundation (PFF), Allergy and Asthma Network, Personalized Medicine Coalition, Cancer Treatment Centers of America, Rock CF, Association of Community Cancer Centers, Bellerophon Therapeutics, GRAIL, Boehringer Ingelheim Pharmaceuticals and SunRADON.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Isabelle Garrity
Isabelle.garrity@mediaplanet.com
646 - 518- 5421



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1573
Mediaplanet and SunRADON have joined forces in advocating for lung health

NEW YORK (PRWEB) NOVEMBER 30, 2020
Mediaplanet is proud to announce the launch of this November's Lung Health campaign. The campaign brings together patients, healthcare providers, advocates to spread awareness of chronic lung disease as well as recent innovation in prevention, diagnostics, and treatment for these devastating respiratory conditions. The campaign also takes a dive into importance of lung cancer prevention, and how some companies are dedicated to helping prevent lung cancer.
One leading company is SunRADON, a top provider of professional Radon Detection and Indoor Air Quality (IAQ) monitors. The company has recently launched lüft, the world's first smart, plug-in Indoor Air Quality and Radon Monitor. This is a welcome innovation in the fight against radon-induced lung cancer.
lüft was created to provide consumers an effective and easy method to track Indoor Air Quality, including detection of Radon, a feature often lacking in today's IAQ monitors yet crucial in protecting lung health. "Radon is the #1 cause of lung cancer among non-smokers, and responsible for more deaths every year than all other home related deaths combined. Yet long term radon measurements are not included in standard IAQ monitors! It's because radon detection requires specialized know-how and technology, which SunRADON has mastered for 30+ years while serving professional radon inspectors and mitigators worldwide," explains SunRADON CEO Dr. Kai Wundke.
Through lüft, SunRADON is helping a wide variety of customers, whether at home, school, the office or a healthcare facility, to accurately monitor indoor air quality on a long-term basis. lüft not only monitors radon levels but also dangerous chemicals such as formaldehyde, carbon dioxide equivalent, temperature, pressure, and humidity. lüft is unique in that it packs state-of-the-art radon detection into an IoT-enabled plug-in device. It also allows users to share data with their indoor air quality professionals to provide expert services should need arise.
"lüft is not just another IAQ monitor, but an integrated, smart IAQ system with the benefit of also detecting radon, the most dangerous Indoor Air Quality problem of them all," adds Dr. Wundke. The lüft monitor is available for purchase on sunradon.com or amazon.com.
The print component of Lung Health is distributed within the November edition of USA TODAY in LA, Boston, New York, Chicago, Houston, Seattle, Las Vegas, D.C Baltimore, and Pittsburgh/Cleveland markets. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: https://www.futureofpersonalhealth.com/campaign/lung-health/
The campaign was made possible with the support of SunRADON, as well as the American Thoracic Society, Lung Cancer Foundation of America, Go2 Foundation for Lung Cancer, Boehringer Ingelheim, Bellerophon Therapeutics and GRAIL.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Isabelle Garrity
Isabelle.garrity@mediaplanet.com
646-518-5421



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1574
Clearwater's leading provider of Cryoskin and Verju fat reduction technologies announces curated event series to give clients safe and local access to even more wellness

CLEARWATER, FLA. (PRWEB) NOVEMBER 30, 2020
Trim Studio is dedicated to helping clients achieve their goals through leading-edge technologies for fat reduction, cellulite treatment and skin toning without painful procedures, side effects or downtime. Their ongoing wellness event series will focus on therapies which support body contouring results and overall well being. For more information, visit their website.
"Throughout this year, we knew we'd need to get creative with how we make wellness resources available to our clients. The 'quarantine 15' joke is all too real for so many of us, and we feel lucky to work in a setting that allows for safe execution of events and one-on-one treatments at a safe social distance," says Corina Froese, co-founder of Trim Studio.
Trim Studio was set to host their second annual Brunch and Yoga event in the spring of 2020 when pandemic-related circumstances made it impossible. After canceling, they shifted gears to smaller pop-up style events with a more intimate feel. Even with smaller events, Trim Studio intends to pack them with a punch of beneficial wellness and science-backed adjunct therapies.
In September, the Clearwater wellness boutique welcomed healthcare providers for vitamin injections and hormone wellness consultations. In November, an ozone sauna was made available to clients during a two day pop-up event which sold out in under 48 hours. In December, the Studio will be in Tampa for a one day event offering discounted body treatments and anti-aging CryoFacials at Femme Akoi Beauty Studio on Nebraska Avenue in Tampa.
"We absolutely love working with local wellness businesses that share our common goal to help clients improve their lifestyle and feel better. Though circumstances limited us a little bit in 2020, it also allowed us time to step back and reflect on how we might help our clients achieve more and better results—this is something that is always top of mind, and we definitely have some exciting news and changes to reveal in the new year!"
Trim Studio's non-invasive Verju laser is FDA-cleared for reduction of cellulite, fat and overall body circumference. Verju is the world's first green body contouring laser of its kind and the only body contouring device on the market with proven efficacy by way of a double-blind, multi-site and placebo-controlled clinical study in which clients saw a four-inch average loss after completion of a treatment program. The Studio also offers Cryoskin 3.0 technology which affords clients the opportunity to spot reduce stubborn body fat through cryolipolysis (fat freezing) as well as to reduce the appearance of cellulite and smooth facial wrinkles.
Trim Studio's technologies are appropriate for body types ranging from athletic to clinically obese. For more information or to request a consultation contact them by calling 727-288-4329.
###
ABOUT TRIM STUDIO
Trim Studio is a wellness boutique located in Clearwater, Florida specializing in non-surgical body sculpting. Utilizing technologies such as Cryoskin 3.0 for cryolipolysis (fat freezing), skin toning, cellulite smoothing and facial rejuvenation as well as Verju (photoporosis) for fat and cellulite reduction, Trim Studio is dedicated to changing the body contouring game with effective tools for real, observable fat loss and improvements to skin's elasticity and tone. For more information, please visit http://www.TrimStudioFL.com or visit the Studio on social media at @TrimStudioFL!
MEDIA CONTACT
Corina Froese
corina@dandelioncreativeco.com
727-441-1711



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1575
President & Founder of HR Maximizer Inc is now a member of the Forbes Business Council. Forbes Business Council is an Invitation-Only Communities For Successful Executives And Entrepreneurs

HOUSTON (PRWEB) NOVEMBER 30, 2020
Rollis Fontenot III of HR Maximizer Inc accepted into Forbes Business Council
Forbes Business Council Is an Invitation-Only Community for Successful Business Owners and Leaders
Rollis Fontenot III, president & founder of HR Maximizer Inc, a subscription based recruitment services firm serving clients nationwide, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.
Rollis Fontenot III was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors.
"We are honored to welcome Rollis Fontenot III into the community," said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council. "Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world."
As an accepted member of the Council, Rollis has access to a variety of exclusive opportunities designed to help his reach peak professional influence. he will connect and collaborate with other respected local leaders in a private forum and at members-only events. Rollis will also be invited to work with a professional editorial team to share his expert insights in original business articles on Forbes.com, and to contribute to published Q&A panels alongside other experts.
Finally, Rollis will benefit from exclusive access to vetted business service partners, membership-branded marketing collateral, and the high-touch support of the Forbes Councils member concierge team.
"I am very excited about being a part of this global community of business leaders who are looking to offer their expertise to help others grow. In this way, the rising tide will lift all boats, thereby helping all of us attain our individual goals. I look forward to this opportunity for us to make valuable contributions to this group as we grow together."
ABOUT FORBES COUNCILS
Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive.
To learn more about Forbes Councils, visit forbescouncils.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1576
In this free webinar, the featured speakers will discuss the impact of the RACE for Children Act since it went into effect, from a regulatory, health care professional and industry point of view, both in the USA and globally. They will talk about what a pediatric champion is and why they are needed, and a parent and child's experience of a molecularly targeted therapy.

TORONTO (PRWEB) NOVEMBER 30, 2020
After three years of hard work by multiple diverse stakeholders, and with much anticipation, the RACE for Children Act became effective August 18th, 2020. This landmark legislation aims to dramatically shift the global landscape of clinical research in pediatric oncology and intends to bring new molecularly targeted cancer therapeutics to children, who have not been as greatly impacted by precision medicine over the past few decades compared to adults.
Whether the RACE for Children Act leads to the development of more drugs for children with cancer in the USA, and globally, remains to be seen. What can we learn about the global impact of the RACE for Children Act in the first few months since its implementation? What is needed to ensure its ongoing success?
Regulators, researchers, industry and patient advocates have come together to focus on not only curing childhood cancer but reducing long term side effects. Please join us in hearing from them in this webinar on what the early global impact of the RACE for Children Act looks like, and what is needed to ensure its success, including the critical function of pediatric champions.
Join Dr. Gregory Reaman, Associate Director for Pediatric Oncology, Oncology Center of Excellence, Center for Drug Evaluation and Research, US Food and Drug Administration; Prof. Gilles Vassal, Head of Pediatric Research Program, Gustave Roussy/Université Paris-Saclay and President ITCC, Chair of ACCELERATE; Dr. Anjali Sharma, Pediatric Oncology Development Lead and Early Oncology Development Lead, Amgen; and Dr. Beth Anne Baber, Founder & President, TigoHealth, in a live webinar on Thursday, December 17, 2020 at 10am EST (3pm GMT/UK).
For more information, or to register for this event, visit The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1577
In this complimentary webinar, featured speakers from Medpace and MyoKardia will discuss precision medicine approaches for treating cardiovascular disease and its growing role in clinical trials. A case study of MyoKardia's MAVERICK-HCM trial will be presented, highlighting operational challenges, best practices and lessons learned. Future directions, including mitigations during a pandemic will also be disussed.

TORONTO (PRWEB) NOVEMBER 30, 2020
Despite advances in medical therapeutics, cardiovascular disease (CVD) remains the leading cause of death worldwide. Notably, heart failure and coronary disease continue to present an exorbitant burden on patients and health care. Recently, breakthroughs in precision medicine are creating optimism for a field that has historically witnessed few long-term successes in targeted therapeutic approaches.
Indeed, precision-medicine approaches target the subsets of patients that are most likely to benefit from a drug, including approaches based on mechanism of disease and shared patient characteristics. By matching mechanism of a drug action with specific disease etiology, precision-medicine approaches are starting to turn the page in CVD trials.
Investigational drugs like mavacamten, developed by MyoKardia, offer new hope for patients with hypertrophic cardiomyopathy (HCM), an inherited and often lethal primary myocardial disorder without effective pharmacological options. Indeed, the striking positive results found in obstructive and non-obstructive HCM patients are expected to support a New Drug Application (NDA) filing, thus commencing a new promising chapter in the precision-medicine approach to CVD drug discovery.
Join experts from Medpace and MyoKardia in a live webinar on Tuesday, December 15, 2020 at 12pm EST (5pm GMT/UK).
For more information, or to register for this event, visit From Promise to Reality: MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1578
In this free webinar, the featured speakers will discuss when direct-to-patient is applicable for a trial and whatsponsors should plan for if implementing a direct-to-patient strategy.

TORONTO (PRWEB) NOVEMBER 30, 2020
The current pandemic has had a significant impact on clinical development, calling for the implementation of decentralized trials. With this change, it's now more important than ever to ensure the right Investigational Medicinal Product (IMP) reaches the right patient at the right time.
So how do sponsors go about implementing direct-to-patient models and how do they maintain the chain of custody for the life of an IMP? This insightful webinar will take participants through the what, why and how of performing various direct-to-patient models. Participants will gain knowledge of the important areas to consider before executing, such as:

Additional data requirements needed

What information needs to be held in the Interactive Response Technology (IRT)

What steps can be taken to safeguard trials beyond the pandemic

Join expert speakers from Almac Clinical Technologies, Matt Lowrie, ASQ CQA, QA Manager, Quality Assurance; Abby Sener, Manager, Almac ONE, ACS Project Services; and Kat Williams, Manager, Clinical Project Services, in a live webinar on Tuesday, December 15, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Direct-to-Patient: Implementing Models for Continuous Treatment During the Pandemic And Beyond.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1579
In this free webinar, experts from ICON Medical Imaging and Medidata will discuss how AI needs to have focus in specific areas, as past efforts to do everything have failed. The presenters will talk about narrowing down imaging problem statements to generate better results. How AI and ML can function as "guide rails" for radiologists will also be explored, in addition to areas in which AI and ML can increase (thus saving money) and improve quality (thus saving lives).

TORONTO (PRWEB) NOVEMBER 30, 2020
For the first 125 years of medical imaging, technological advances focused primarily on new modes of imaging as technology progressed from the discovery of the X-ray in 1895 to ultrasounds, MRIs, PET and CT scans in the late 20th century. Now, arguably, the most notable advances are being made in how images from those technologies are securely shared, managed, stored and assessed. These advancements are largely due to the application of artificial intelligence (AI) and machine learning (ML) to imaging systems and data platforms.
Automation is improving virtually every stage of the imaging workflow, but there is a lot of hype concerning AI and ML in the marketplace. Companies have underestimated the challenge that complexity presents, and predictions of the end of radiologists have proven false multiple times.
Join experts from ICON Medical Imaging and Medidata for this webinar on the practical applications for AI and ML in clinical trial imaging and what is possible today. Learn what is available today in the current landscape, its applications for building efficiency and what is coming in the near future to help life science companies transform their clinical trial imaging.
Join Paul McCracken, Vice President, Head of Medical Imaging, ICON Medical Imaging; and Dan Braga, VP, Product Management, Acorn AI Product & Ecosystem, Medidata, in a live webinar on Wednesday, December 16, 2020 at 11am EST (8am PST).
For more information, or to register for this event, visit Imaging AI and Machine Learning — Beyond the Hype.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1580
The company's latest algorithm enhancements to help radiologists distinguish between Coronavirus and other abnormalities such as common pneumonia on chest CT scans

NEW YORK (PRWEB) NOVEMBER 30, 2020
RADLogics today announced the availability of the latest version of the company's AI-Powered COVID-19 CT algorithm. Building on the company's AI-Powered solution that has processed and analyzed hundreds of thousands of suspected Coronavirus cases globally, the latest update delivers a complex deep learning system consisting of several models utilized to detect, localize and segment regions in the lungs infected with COVID-19. With Coronavirus cases again surging across the U.S. along with hospitalizations, AI-Powered solutions are poised to not only alleviate the increased burden associated with COVID-19, but to help support improved outcomes by reducing burnout and errors.
As part of RADLogics' latest version of its algorithm, three different analyses can now be performed simultaneously on raw chest CT image scans including: 1) a lungs region-of-interest are cropped with lung abnormalities detected; 2) the lung lobes are segmented and; 3) if the nodules plug-in is activated, focal Ground Glass Opacities (GGOs) are detected. According to leading physicians, these measurements are key features in determining patient classification into COVID-19 and non-COVID-19 indications. The overall system produces the decision whether the case is suspected for COVID-19 with a confidence level (in percentages). These measurements along with other features are used by radiologists to distinguish between COVID-19 and other abnormalities such as common pneumonia.
"With the U.S. in the midst of an unprecedented rise in COVID-19 infections, with current hospitalizations at an all-time record of more than 90,000 patients, there is an increasing need for AI solutions in medical imaging," said Moshe Becker, CEO and Co-Founder of RADLogics. "Coronavirus-related infection rates are experiencing a sharp increase in most states – from rural communities to urban areas – that have the potential to overwhelm ER, ICU and radiology teams with a surge of patients, and AI-Powered medical imaging analysis solutions are poised to reduce this pressure through improved patient triage, monitoring and management."
Since the pandemic started earlier this year, RADLogics has responded with the deployment of the company's AI-Powered medical image analysis solution worldwide. In accordance with FDA guidance for imaging systems and software to address the COVID-19 public health emergency, RADLogics has made its FDA cleared CT and X-ray solutions available to hospitals and healthcare systems throughout the U.S. for patient triage and management. Designed for easy installation and integration both on-site and via the cloud, RADLogics' algorithms are supported by the company's patented software platform that enables rapid deployment at multiple hospitals, and seamless integration with existing workflows. All of the company's AI-Powered solutions are available worldwide through major OEM distribution partners including Nuance via the AI Marketplace in the U.S. market.
To further validate the ability of AI to distinguish COVID-19 from other respiratory diseases, the company also highlighted a new research paper in preprint entitled "Automated triage of COVID-19 from various lung abnormalities using chest CT features". Led by Professor Hayit Greenspan from Tel Aviv University and members of the RADLogics' algorithm development team, the paper studied a fully automated AI-based system that takes as input chest CT scans and triages COVID-19 cases.
The study explored multiple descriptive features, including lung and infections statistics, texture, shape and location, to train a machine learning based classifier that distinguishes between COVID-19 and other lung abnormalities (including community acquired pneumonia). The research evaluated the system on a dataset of 2,191 CT cases and demonstrated a robust outcome with 90.8 percent sensitivity at 85.4 percent specificity with 94.0 percent ROC-AUC. Results of this study are available on arXiv.org, and it has been submitted for review and potential publication.
RADLogics will be featured this week as part of the RSNA 2020 Imaging AI in Practice demonstration. In addition, RADLogics will be included in the Nuance virtual booth as part of the company's AI Marketplace display. You can also learn more about RADLogics' COVID-19 solutions on the company's website at https://www.radlogics.com/covid-19.
About RADLogics
RADLogics is a healthcare software company developing AI-Powered solutions that support image analysis to improve radiologists' productivity while enhancing patient outcomes. Based in New York, NY, U.S., and Tel Aviv, Israel, RADLogics is one of the pioneers in using AI & machine learning image analysis and advanced big data analytics to search and analyze imaging data from CTs, MRIs, PET scans, and X-rays to help reduce diagnostics turnaround time from hours to minutes by automating detection and report generation functions. The company's patented AI medical image analysis platform enables rapid development of AI algorithms, and provides seamless integration into existing radiology workflow. Visit http://www.radlogics.com to learn more or follow us on LinkedIn or Twitter. To contact RADLogics to request a demonstration or to sign up for our monthly newsletter, please visit https://www.radlogics.com/contact.
###




START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1581
Introducing the winners of The Scientist's annual Top 10 Innovations competition. From an ID NOW COVID-19 test to a single-cell intracellular proteome, these new products made 2020 a transformative year in both laboratory and clinical life science.

WILMINGTON, DEL. (PRWEB) DECEMBER 01, 2020
Each year The Scientist strives to identify the latest and greatest tools, technologies, and techniques to hit the life science landscape. For more than a decade, our expert panels of independent judges have weighed submissions of innovative products speeding work in laboratories and facilitating biological discovery. This year's crop of entries to The Scientist's Top 10 Innovations contest reflected the fact that the scientific community, like the whole of society, faced a once-in-a-lifetime challenge in the form of a global infectious disease pandemic. "The COVID-19 pandemic birthed a shared scientific purpose and accelerated innovation in 2020," says Editor-in-Chief Bob Grant. "The winners of this year's competition embody the spirit of togetherness and ingenuity marshalled by the research community in the face of this unprecedented challenge."
The winners of The Scientist's Top 10 Innovations of 2020 contest are:
1) CeliumTM (AbCellera) – This AI-powered data visualization tool can rapidly sift through genetic data to identify antibodies that might work best as potential therapies for various diseases, such as COVID-19.
2) ID NOW COVID-19 Test (Abbott) – This toaster-size device can detect RNA from the SARS-CoV-2 virus, reporting results in less than 15 minutes.
3) TotalSeqTM-C Human Universal Cocktail v1.0 (BioLegend) – Comprising a collection of 130 oligo-linked antibodies for massive screening of the cell-surface proteins of individual cells, this tool is designed for use on a single-cell sequencing platform.
3) GRAFTM (Seven Bridges) – This genomic analysis platform attempts to include all possible iterations of genetic sequences at any given locus, with the goal of capturing more variations and boosting the presence of underrepresented groups in genomic research.
4) TESSA (OXGENE) – This research-grade viral vector aims to improve the efficiency of making adeno-associated virus (AAV) for potential use in gene therapies.
5) BioXpTM 3250 System (Codex DNA) – With this desktop gene synthesizer, researchers can assemble DNA sequences of up to 7,000 base pairs long with the push of a button.
6) Single-Cell Intracellular Proteome (IsoPlexis) – This system uses innovative microfluidics to monitor 30 or more protein pathways at the level of single cells.
7) Surge (GigaGen) – This platform helps researchers tease apart the intricacies of the immune system by using single-cell sequencing to capture and recreate libraries of antibodies from blood donors, including people who have recovered from COVID-19.
8) Chromium Single Cell Multiome ATAC + Gene Expression (10X Genomics) – With the goal of opening a window onto cellular functionality, this platform simultaneously profiles the epigenome and transcriptome of single cells.
9) Visium Spatial Gene Expression Solution (10X Genomics) – This technology exposes 55-micrometer areas at 5,000 locations within a tissue sample to mRNA-binding oligonucleotides, and overlays the resulting gene expression data with histological images, yielding high-resolution gene expression data.
9) OnyxTM Digital Genome Engineering Platform (Inscripta, Inc.) – This benchtop device makes CRISPR scalable and high-throughput using fully automated genome-engineered libraries with hundreds of thousands of single edits in microbial genomes.
10) SLIM (MOBILion) – This instrument brings ion mobility separations to the next level, packing a 13-meter ion path length in a device the size of a briefcase, enabling higher resolution, faster analysis, and simpler workflows in characterizing biologic therapeutics, biomarker discovery, and clinical diagnostics.
Congratulations to this year's winners. Be sure to visit https://the-scientist.com/features/2020-top-10-innovations-68176 where you can read more about the products that earned top spots and see comments from our expert judges.
About The Scientist:
The Scientist is a publication for life science professionals that is dedicated to covering a wide range of biological fields. The Scientist provides print and online coverage of the latest developments in the life sciences, including trends in research, new technology, news, business, and careers. It is read by the science-curious public and leading researchers in industry and academia who value penetrating analyses and broad perspectives on life science topics both within and beyond their areas of expertise. Written by prominent scientists and professional journalists, articles in The Scientist are concise, accurate, accessible, and entertaining.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1582
Chill-Pak ramps up mass production of its ISTA-Qualified ultra-cold thermal shippers to meet market demand for upcoming distribution of Covid-19 vaccines.

SPRINGFIELD, MO. (PRWEB) NOVEMBER 30, 2020
Engineered Packaging, Inc. dba Chill-Pak a leading manufacturer and total solutions provider of sustainable cold-chain thermal packaging solutions for specialty pharmaceutical and life sciences applications announces the availability of its ISTA Qualified thermal insulated shippers designed for COVID-19 vaccines that need to be kept at ultra-low (-89ºC to -70ºC) temperatures over long durations (up to 120-hours).
"During these extraordinary times, state Departments of Health and logistics companies have been looking to us for assistance with specialty thermal coolers capable of meeting the rigorous temperature and duration specifications that Covid-19 vaccines require for storage and distribution to vaccine administration sites," said Julie Kilgore, Vice President of Sales at Chill-Pak. "We use proprietary recyclable polyurethane foam in multiple density formulations allowing us to provide solutions with performance-specific results. It is for this very reason we also have solutions for vaccines that require frozen (-20ºC), refrigerated (2-8ºC) and controlled room temperatures (15-30ºC) which span the entire temperature and duration spectrum."
"From a manufacturing standpoint, three major cornerstones of our company identity are at play: our agility, just-in-time delivery, and mass production capabilities, all of which have allowed us to quickly ramp up to meet the unprecedented demand for vaccines shippers in a matter of days," said Stephen Foster, President at Chill-Pak. "With three decades of engineering and manufacturing experience, our team is prepared to deliver exceptional products to protect these lifesaving vaccines. We are honored to be playing a role as we all collectively battle against this disease."
About Chill-Pak
Engineered Packaging, Inc. dba Chill-Pak is a manufacturer and total solutions provider of sustainable cold-chain thermal packaging solutions for specialty pharmaceutical and Life Sciences applications. We create a positive impact for a better and healthier world through aggressive sustainability, diversity, and inclusion initiatives



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1583
In an era where working from home and virtual classrooms have become the norm, indoor air quality is a necessity more than ever before for households throughout the country

CHICAGO (PRWEB) NOVEMBER 30, 2020
Since the COVID-19 pandemic hit the nation, households around the country and beyond have been spending more than 90% of their time indoors. Homes have become our workplaces, classrooms, restaurants, gyms, and everything in between. With the rise of time spent indoors, the rise of harmful pollutants and germs in the air have also skyrocketed and have been recirculating throughout our houses. Now more than ever, the E·Z Breathe Ventilation System is a necessity to transform the entire home into a healthy living environment and to keep families safe by preventing the spread of harmful airborne particles. E·Z Breathe Basement and Crawlspace Ventilation provides complete home air exchange that improves indoor air quality, reduces indoor humidity and lowers allergen and pollutant levels. Air polluted with mold, allergens, pathogens and other toxins and odor-causing pollutants is vented at the lowest level of the home to the outside in a revolutionary way, introducing and circulating fresher, cleaner air throughout the home.
"With our homes being sources to all our recreational activities, we are now breathing in more toxic air than ever before," said E·Z Breathe Vice President Andre Lacroix. "Because this air is trapped within the confines of our four walls, it continues to circulate and we continue to breathe it in on a daily basis, and over time, these are the harmful toxins that get us sick, especially at an early age."
Fighting pollutants and toxins at an early age, in fact, helps lower the chances of children growing up with asthma and allergies. In fact, the U.S. Environmental Protection Agency reports that 60% of homes and buildings are "sick" meaning they are hazardous to your health to occupy. The E·Z Breathe Ventilation System can improve the indoor air quality with up to an 85% reduction in airborne particulates and common indoor air pollutants. This ventilation system has the ability to help alleviate many common homeowner concerns such as mildew odors, mold growth, pet dander, dust mites, humidity and moisture, pollen, chemical smells, leaving your home feeling fresh and allergen-free for both the work from home parents, as well as children with remote learning.
"Our main focus right now are all the households who are consistently breathing in poor air quality without even realizing it, and starting that conversation with them," said E·Z Breathe President Erika Lacroix. "Once people realize this dire need for clean air within our homes, it is then we are able to showcase just what our products can do to help with our overall health during these unprecedented times."
The U.S. Environmental Protection Agency, or EPA, reports that the air in the average American home is a minimum of five times and, in some cases, up to 100 times more polluted than outdoor air, and building science experts agree that more than 20 gallons of water vapor are absorbed into the average home through basements and/or crawlspaces every single day. Even though it is installed in one room, E·Z Breathe achieves whole-home air exchanges six to ten times daily by gently drawing air throughout the home to replace the stale, polluted air being exhausted. As families continue to shelter in place, and adhere to social distancing guidelines outside of their homes, maintaining a safe haven once inside your home is crucial for short, and long term, health benefits, even after the pandemic.
E·Z Breathe products work for up to 7,000 square feet of living space, and operate efficiently at only $2 to $4 a month; the same as a 40-watt light bulb. Known as a set it, then forget it product, E·Z Breathe are low maintenance and do not require extra attention after installation. Now offering self-installation kits for all DIY homeowners, as home improvement has skyrocketed this past year, those who would feel more comfortable setting up the E·Z Breathe on their own have the ability to now do so. With the holidays just around the corner, patrons also have the opportunity to gift good health and purchase an E·Z Breathe product for themselves and their loved ones.
Following in the footsteps of a 2nd generation, family-owned and operated business that has been providing foundation repair in homes with basements and crawlspaces for over 40 years, E·Z Breathe Ventilation Systems was established as an independent company in 2003. The company's core values include offering world-class customer service to every customer, every time. E·Z Breathe Ventilation Systems and E·Z Breathe Healthy Home Solutions supply products to foundation repair contractors, remodelers, indoor air quality professionals and more. They are proud to include over 100,000 homeowners all over North America into their E·Z Breathe family.
For more information on E·Z Breathe and their product benefits, call 1.866.822.7328 or visit http://www.ezbreathe.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1584
CCam focus, powered by Civicom Marketing Research Services, was a Gold Sponsor and Speaker for the recently held IIEX Health, one in a series of this year's virtual GreenBook events, held on November 5th, 2020.

GREENWICH, CONN. (PRWEB) NOVEMBER 30, 2020
CCam focus, powered by Civicom Marketing Research Services, was a Gold Sponsor and Speaker for the recently held IIEX Health, one in a series of this year's virtual GreenBook events, held on November 5th, 2020.
IIEX is a leading global event series that offers programs that discuss valuable insights trends in the healthcare industry. Part of GreenBook's advocacy to bridge the gap between marketers and consumer insight, it provides a platform for thought leaders to share ideas and methods that can help insights professionals innovate their research and keep them ahead of the game.
This year's event was held virtually to adhere to the protocols of the pandemic while offering the same collaborative and enlightening benefits of attending in-person. Participants received cutting edge ideas from major healthcare and pharmaceutical companies as well as leading research strategists in the community.
In support of the event, CCam focus joined alongside experts as a gold sponsor and speaker. CCam focus delivered a case study with New Perspectives Research, entitled "Five Steps to Successful In-Facility Product Testing Right Now," that showcased the value of a unique hybrid approach (combination of in-person and online) for conducting product testing and how it can be accomplished efficiently using CCam focus technology while still following the requirements of the new norm.
Interested parties can view a recording of a presentation by clicking here.
About Civicom CCam focus - HD 360° Focus Groups With Integrated Video Curation Tools
CCam focus is an HD 360º recording and streaming solution for in-person research, ideal for the new safety protocols. The omnidirectional camera with built-in microphones simultaneously captures a panoramic view as well as full-face video that adjusts when the speaker changes, fully capturing body language and sentiment. CCam focus delivers high definition visuals and superior audio even when the participants are wearing masks or are seated behind plexiglass. The result is omnidirectional viewing of all participants.
Integrated video curation tools assure video deliverables are generated within minutes for review of key moments. Civicom provides personalized service and support for set up, troubleshooting, and assistance throughout every session. CCam focus is also portable for plug and play situations, enabling market researchers to record and stream in-person interviews and focus groups from any location.
This quality focus group solution is part of Civicom Marketing Research Services group, the global industry leader in facilitating web-enabled in-depth interviews and focus groups through web-enabled technology.
For more information, email contact(at)ccamfocus.com or visit https://civicommrs.com/ccamfocus.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1585
The potent mint flavor freshens breath while releasing the immune-benefiting properties of HK L-137, a probiotic originally discovered by Japanese immunologists researching health benefits of sushi and fermentation.* Also known as Immuno-LP20, HK L-137 has demonstrated in human clinical studies to benefit the immune system, respiratory health and overall quality of life.*

VENICE, FLA. (PRWEB) NOVEMBER 30, 2020
Enzymedica, a Florida-based company that produces high quality natural digestive products, announces the launch of its innovative Immune Max Immuno-Biotic Defense Mints. These great tasting and refreshing mints dissolve in the mouth to deliver 12 billion cells of HK Lactobacillus plantarum L-137, also known as of Immuno-LP20, a unique probiotic strain that is clinically studied to support immune and respiratory health.* Stress and fatigue can easily lower immunity, and this formula helps boost the immune and digestive systems by increasing natural killer T-cell activity, which are on the front lines to help protect against seasonal threats.*
The probiotic strain L-137 was originally discovered by Japanese immunologists, working at the prestigious Medical Institute of Bioregulation at Kyushu University, who were testing new substances to improve key markers for immune health. By fermenting fish with lactic acid bacteria to create Narezushi, a precursor to modern sushi, the scientists were able to isolate a novel lactic acid bacterium. It became known as probiotic L-137 and it demonstrated beneficial immune boosting properties, made even more robust through a heat-treatment process that converts the strain to HK L-137. *
The heat-treatment process that converts L-137 to HK L-137 locks the structure of the bacterial cells to their shape at the highest point of activity. This allows the beneficial bacterial cells to work in a human's gastric acid, while also promoting the ability for the probiotic bacterial cells to interact with immune cells in the intestine.* The beneficial properties of HK L-137 are most associated with Lipoteichoic acids, components of the cell wall of the probiotic bacterium. These acids provide nutrition for the body's immune system by boosting the production of interleukin-12, a substance secreted by immune cells that strengthens the body's overall immune defense system. *
Following its initial discovery, human clinical studies have demonstrated that HK L-137 benefits the immune system, respiratory health, and overall quality of life.* Each package of Enzymedica's Immune Max Mints contains 30 fast-acting quick melt mints for $19.99 and can be purchased at https://enzymedica.com/products/immune-max-immuno-biotic-defense-mints?variant=32531305889841.
About Enzymedica
Enzymedica is a Florida-based, natural digestive health company since 1998 that sells to over 30,000 stores worldwide and online. Its top-selling enzyme brand is No. 1 in America. In addition to high quality products, Enzymedica also is dedicated to its People & Planet initiative, which is a core pillar within the company's mission - to leave a legacy that will make the world a better place. The company has received more than 50 industry awards including multiple Better Nutrition Magazine's People's Choice Awards, many Best of Supplements Awards and numerous VITY and Nexty Awards. Visit https://enzymedica.com/ for more information.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Media Contact
Ria Romano, Partner
RPR Public Relations, Inc.
Tel. 786-290-6413



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1586
An important milestone on the way to receiving FDA market clearance.

MILLERSVILLE, MD. (PRWEB) NOVEMBER 30, 2020
EndoVigilant, Inc., a privately held company developing an artificial intelligence (AI) enabled medical imaging platform for endoscopy procedures announced that the pivotal clinical study for its first application using the platform is now in progress at multiple sites across the US. The first application focuses on real-time computer aided detection (CADe) assistance for improving polyp detection during colonoscopies.
Colonoscopy is a gold standard screening test for screening of colon cancer, which continues to be one of the leading causes of cancer related deaths in the US. Even though approximately 18 million colonoscopy procedures are performed annually in the US, adenomatous polyp miss rate as high as 26% often results in missed cancers.
EndoVigilant's first application has been developed to assist gastroenterologists in real-time with polyp detection with the goal of reducing adenomatous polyp miss rate and hence, the occurrence of interval colon cancers. EndoVigilant's software has been developed using state of the art deep learning AI algorithms and is trained on images and videos collected from practicing gastroenterologists from multiple academic and private endoscopy centers across the US. It is interoperable with existing endoscopy systems and can be deployed in a plug-and-play manner without requiring changes or costly upgrades to those systems.
Earlier this year, EndoVigilant reached an agreement with the FDA on the design of its pivotal clinical study. The study is a prospective, multi-center, randomized controlled trial with sites and investigators from both academic and community settings. The study is currently being performed to support the company's planned filing to the FDA to obtain market clearance in the US.
Dr. Shai Friedland, Professor of Medicine at Stanford University, the Principal Investigator for the study commented "AI is a rapidly growing field with multiple medical applications in gastrointestinal endoscopy. EndoVigilant's CADe application for colonoscopy procedures has the potential to improve polyp detection rates, decrease adenomas miss rates in colonoscopy and therefore, reduce the occurrence of interval colon cancers."
"The progress of clinical pivotal study highlights our commitment to demonstrate the clinical benefits of EndoVigilant's CADe application and getting it in the hands of gastroenterologists as soon as possible," stated Vineet Sachdev, CEO and Co-Founder of EndoVigilant. "Based on strong results from pilot studies earlier, we are confident that this pivotal study will show increased adenomatous polyp detection without introducing significant risk when our software is used by gastroenterologists while performing colonoscopy procedures. We expect the pivotal clinical study to complete in Q1 2021."
About EndoVigilant
Headquartered in Maryland, home to one of the largest life sciences clusters in the US, EndoVigilant, Inc., is a privately-held company developing an AI enabled medical imaging platform for endoscopy procedures. The platform's first application is focused on improving colon polyp detection during colonoscopies with additional applications planned for the entire digestive tract. For more information, please visit http://www.endovigilant.com .

Dr. Shai Friedland, Professor of Medicine at Stanford University, the Principal Investigator for the study commented "EndoVigilant's CADe application has the potential to decrease adenomas miss rates in colonoscopy and therefore, reduce the occurrence of interval colon cancers."





START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1587
Expansive HTE Catalog Standardizes Quality for Leading and Emerging Cannabis Brands with Unwavering Flavor, Consistency and Testing Standards

IRVINE, CALIF. (PRWEB) NOVEMBER 30, 2020
ABSTRAX, an industry leader in the study and production of cannabis and botanically-derived terpenes, has launched the first standardized cannabis live resin High Terpene Extract (HTE) catalog for the California Cannabis, Vape, and Food/Beverage markets after unparalleled research and development efforts.
"This is a thrilling time for ABSTRAX and our customers," says Max Koby, Founding Partner and Chief Executive Officer. "Beyond offering the largest collection of premium botanically-derived terpenes, we also now offer our California partners the most expansive selection of the highest quality cannabis-derived terpenes and live resin extracts. These are reshaping the way brands are developing their product offerings, by providing them the highest quality, active key flavor ingredients to create the optimal strain specific terpene profiles of the most desirable genetics in California."
ABSTRAX offers a superior product to traditional flavor houses and extraction companies for the following reasons:
1. ABSTRAX product developers and scientists utilize proprietary, groundbreaking technologies to identify rare terpenes and aroma compounds that are hugely responsible for giving each strain its unique flavor and effects, whereas other organizations have access to outmoded technologies that don't reveal the specifics of what makes leading strains so delicious and effective.
2. Other extraction companies lack the resources, technology, and testing capabilities to analyze hundreds of compounds to optimize their extraction processes and standardize product formulations.
3. Flavor companies do not have the proper licensing, facilities or technology for cannabis testing, research, extraction and formulation.
4. Other formulators are unable to develop cannabis products and test them to assure both quality and consistency of product formulations.
5. Flavor and aroma manufacturers do not produce products to the safety compliance specifications required by cannabis regulatory agencies including no residual solvents, heavy metals or pesticides.
6. There is limited access to study and extract the freshest samples of the most popular genetics in the world.
"Thanks to an amazing team of passionate researchers and the combination of our terpene manufacturing facility and state of the art licensed cannabis R&D Manufacturing lab (the only of its kind in the world), we've accomplished the feat of identifying more than 400 cannabis-derived terpenes (aroma and flavor compounds) in every sample we analyze. We use these research capabilities to optimize our cannabis terpene extracts, offer unparalleled terpene analysis, and also recreate any cannabis strain from botanically derived ingredients with an unwavering commitment to quality, consistency, and accuracy," says Koby.
ABSTRAX uses 3D metabolite fingerprinting technology to discover and isolate hidden aroma and fragrance compounds that have been missed in previous efforts by other cannabis researchers and flavor houses. The company combines these advanced testing capabilities with its proprietary extraction process to yield the highest quality natural extracts, assuring they preserve and optimize the full spectrum of the terpene flavor profile.
With every product, ABSTRAX creates standardized product data sheets that map the entire profile of over 400 compounds to determine the specific flavor, aroma, strain balance, gas factor, fruit levels and other desirable qualities that help brands create memorable product experiences. Brands can use this technology and data to better educate consumers on the intended flavor and effects of these natural extracts.
"All of our live resin cannabis derived extracts are produced from the most premium strains and fresh frozen plants selected through our advanced research program, designed to discover and share the best cannabis terpene profiles in the world. We are the modern day Terp Hunters grown out of California, which has the most sought-after cannabis profiles and is the industry trendsetter for the entire world. Our research starts with the cannabis flower, but doesn't end until we can offer the most premium terpene flavors from both cannabis and botanically-derived sources," says Koby.
ABSTRAX also creates botanically derived versions of the best cannabis terpene profiles to help brands reproduce a targeted, repeatable and consistent product experience. The "secret sauce" lies in finding the perfect balance between the major and minor terpenes as well as the hidden aroma and flavor compounds. ABSTRAX does this by studying the cannabis flower and live resin extract to create identical botanically-derived terpenes and entourage-driven mental and physical effects.
"For years, we have specialized in cannabis research and extraction to create the most authentic, botanically derived cannabis profiles in the world. Now we are launching our cannabis derived terpene extracts and offering the next generation of Native Series botanical terpenes to recreate the same live resin experience for companies outside California that do not have access to our cannabis terpenes," continued Koby.
For example, ABSTRAX has perfected a vape-ready Jack Herer blend that couldn't be successfully recreated prior to its technological advancements with 3D metabolite fingerprinting. Other flavor houses had attempted to recreate the strain, but fell short because their analysis didn't go deep enough.
"After partnering with Dan Herer to study and extract the original genetics, we discovered there are a few rare compounds (including ß-phellandrene in high concentration, which plays a crucial role in its unique flavor) that were not easily identified until our groundbreaking technologies made it possible," says Koby.
ABSTRAX was able to bring together the exact aroma and flavor compounds (in their specific amounts) and recreate Jack Herer with unwavering precision and consistency. The company helped the Original Jack Herer Brand develop authenticated products including Live Resin Vapes in CA, Distillate Vape with the Native Series terpenes, terpene-infused rolling papers, and most recently a Jack Herer Beer. Now, the Original Jack Herer Brand has the ability to standardize their cannabis extracts, vape formulations, and CPG product applications across the country with other manufacturing partners.
By bringing together the key terpenes and compounds found in the Jack Herer strain, ABSTRAX's blends also ensure consumers will enjoy similar physiological effects achieved when consuming infused products — such as increased energy and creativeness, followed by a relaxed "chilled" feeling as time progresses. This unique experience, known as the entourage effect, is produced by the terpenes and cannabinoids working together.
"It all comes down to our mastery of mapping cannabis terpene profiles from flower through extraction and developing quality centric testing standards to improve our quality metrics and help further educate consumers and empower the industry with scientifically driven data. Our analytical testing program focuses on: (1) The Gas Factor – the components giving cannabis its quintessentially "skunky" smell, (2) The Fruit Factor – the components that contribute to sweet or fruity flavors, (3) Strain Balance — the dispersal of terpenes in a flower, (4) Sensory Panel — describes the flavor and intended effects, and (5) the specific terpene and aroma compounds found within each cannabis strain ranked by concentration. We've mastered each of these and continue to create new advancements in our testing program so that we can assure unwavering consistency and standards for the most accurate recreation of any strain on the market," says Koby.
For ABSTRAX, the release of its HTE catalog has placed the company in the position of standard-bearer for the production of cannabis terpene profiles for the State of California and beyond. "As legalization expands throughout the country and world, we expect our catalog will set the standard for the industry at large," says Koby.
About ABSTRAX
Leveraging its proven background in cannabis research, ABSTRAX is the leader in the research, development, and production of botanically-derived and cannabis-inspired terpenes that create unforgettable sensorial experiences. Headquartered in California, the company owns and operates a state-of-the-art type 7 licensed research and manufacturing lab where it's award-winning product developers and scientists leverage the most advanced strain analysis technology to extract and study aroma compounds via three-dimensional analysis, allowing for each and every compound within a plant to be named and studied. The company has partnered with many of the best cultivators in the industry to study their cannabis profiles and create the world's most advanced terpene formulations. As a result of its efforts, ABSTRAX offers the largest terpene catalogue of the most popular strains - botanically-derived terpene blends and isolates native to cannabis. These ingredients, also known as functional flavors and aromas, are used in vapes, concentrates, edibles, beer, essential oils, fragrances, cosmetics, topicals, tinctures, alcohol, food and beverage, personal care, and more. The company works with internationally recognized brands and provides unparalleled cannabis research, innovation, and custom formulations to create products that engage and thrill consumers. ABSTRAX also devotes significant resources to developing the highest terpene standards and best practices in the industry. The company has developed a robust quality management system including Gas Chromatography analysis and molecular distillation of natural ingredients to achieve the highest purity standards. Investigating and ensuring that ingredients used in its own products, and products within its industry, are safe for consumption. The terpene industry is a rapidly growing segment of the global flavor and fragrance market, which is expected to grow to $35 billion by 2024. This market segment includes the cannabis, CBD, skincare, cosmetics, health and wellness, food and beverage industries. For more information, visit AbstraxTech.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1588
The pharmaceutical excipient powerhouse will highlight advancements in controlled release and pediatric medicine in addition to efforts to tackle other prevalent industry issues

SHANGHAI (PRWEB) NOVEMBER 30, 2020
DuPont Nutrition & Biosciences (DuPont) will use insights to help manufacturers evolve with the biggest trends in the Asia pharma industry, with highlights to the latest offerings at CPhI China 2020 from December 16–18. Attendees who visit DuPont booth E3D26 will get an exclusive look at solutions to many of the industry's most pressing challenges, including taste-masking for pediatric medicines, pharmaceutical ingredients for acid reflux, and controlled release solutions that can significantly enhance manufacturing processes and much more.
DuPont has continuously supported its pharmaceutical customers with its vital expertise, and broad, unique portfolio that helps formulators succeed in manufacturing, regulatory, product design and beyond. As China's pharmaceutical industry continues to expand in profitability and regulatory complexity, DuPont intends to show customers that it has the products and technical know-how to help them keep pace.
Experts will be available to discuss the offerings which include:

- Ensuring compliance among younger patients. No child likes the taste of medicine, which means taste-masking bitter active pharmaceutical ingredients (APIs) is of utmost importance in pediatric care. DuPont offers several solutions, including colloidal Avicel microcrystalline cellulose (MCC), which is ideal for use in oral suspension; and ETHOCEL and Aquacoat, two superior coating polymers that effectively mask unpleasant tastes.

- Optimal ingredients for controlled release. METHOCEL DC2 is a cellulose ether that achieves superior process control with fewer production steps and less waste. With improved flow, faster and consistent tableting speeds, it greatly enhances overall production efficiency.

- Sustainable ingredients that treat acid reflux. Protanal is a tailored innovative solution highly aligned with market trends and can be used as an API in the treatment of acid reflux. Using a patented and environmentally friendly technology, this brown seaweed extract helps to enable enhanced performance.

- Focus on quality beyond manufacturing. Given quality is paramount for our industry, DuPont will discuss its efforts to broaden its quality focus beyond manufacturing to an organizational priority. Efforts also include an extension of its renowned Avicel to reduce technically unavoidable particles (TUPs).

- A whole new range of innovative delivery forms for dietary supplements industry. We offer a vast range of functional ingredients that works well with nutritional ingredients to make a product that meets consumer demands – from clean label, plant-based, consumer-friendly capsules, great tasting gummies and smaller tablets for consumer convenience. Our SeaGel vegetarian softgel technology outperforms its animal-based counterpart, imparting excellent thermal stability and implementing seamlessly into soft capsule equipment.

At the booth, attendees can attend mini talks and discuss with DuPont experts on how they can enable their goals in the pharma and dietary supplements space, including sharing of best practices for each ingredient, application expertise and regulatory knowledge tailored to the Asian market.
"All of these offerings represent our commitment to delivering strategic, high quality customer service to the Asia's pharma industry," explained Frank Zhao, Sales Leader, APAC, Pharma Solutions, DuPont Nutrition & Biosciences. "It's a reflection of our global implementation of Big Q—a Quality culture. We believe our focus on quality will resonate with visitors at CPhI China, who will come away with practical solutions to create viable pharmaceutical products for this expanding market."
To learn more about the broad product portfolio and expertise areas from DuPont Nutrition & Biosciences, visit pharma.dupont.com.
About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
# # #
12/01/2020
DuPont, the DuPont Oval Logo, and all trademarks and service marks denoted with , SM or are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1589
Global developer of innovative Radiology ultrasound machines invites attendees of the RSNA's 106th Scientific Assembly and Annual Meeting to explore personalized and immersive VR experience

MAHWAH, N.J. (PRWEB) NOVEMBER 30, 2020
Mindray, a global leader in the development of healthcare technologies, will attend the Radiological Society of North America's (RSNA) 106th Scientific Assembly and Annual Meeting, November 29 - December 5. During this year's virtual event, Mindray will highlight their comprehensive portfolio of Radiology ultrasound machines through an immersive and interactive virtual reality (VR) platform.
Throughout the last few years, Mindray has achieved consistent growth in a highly competitive marketplace. Due to an incredible value proposition, advanced technologies and industry-leading warranty, Mindray North America was one of only three companies to achieve double-digit growth in their Radiology ultrasound division in 2019. In addition, Mindray was recently awarded a contract in the ultrasound category for the Pediatric Program at Vizient, and excelled in landing strategic partnerships with the top 10 hospitals in the United States. Mindray continues to provide new and improved ways to enhance patient care and manage costs without sacrificing quality.
"With COVID-19 challenging every aspect of healthcare and forcing many to rethink the 'normal' way of doing things, Mindray's mission has become more important than ever before," said Director of Marketing, Ultrasound, Maher Elhihi. "Mindray was founded on the dream of increasing access to outstanding care by providing accessible, relevant medical devices that exceed clinician's expectations and needs. Our team is determined to ensure our frontline heroes and their patients have the tools they need; and while many things have changed in 2020, Mindray's vision has not - we will continue to drive our vision of better healthcare for all forward."
RSNA Virtual Reality Experience
Mindray will be debuting a one-of-a-kind VR experience at RSNA 2020. This virtual format provides healthcare professionals from around the world the opportunity to safely and conveniently explore Mindray's latest solutions from the comfort of their home or office. Once an attendee enters the experience, they will be transported to a "Mindray Hospital" where they can explore Mindray's Radiology ultrasound solutions in the departments in which they are used: Radiology/Imaging and Interventional Radiology. There is no special technology needed; the VR experience is desktop, laptop, tablet and mobile-friendly. Ultrasound team members and experts will be available throughout the duration of the exhibit to address any questions or comments from attendees.
Featured Systems Include:
•Resona 7 Ultrasound System: Mindray's flagship Radiology Ultrasound System delivers crystal clear imaging capabilities with unrivaled detail resolution and image uniformity that is powered by the industry's first virtual beamforming architecture, ZONE Sonography Technology+ (ZST+).
•ZS3 Ultrasound System: Mindray's ZS3 Ultrasound System is a smaller, lightweight System that combines premium performance and mobility for today's demanding ultrasound environments. This unique portable System allows for rapid transition times resulting in increased exam efficiency and patient throughput.
•DC-90 Ultrasound System: Mindray's DC-90 is a versatile, high-performing System designed for a comprehensive range of clinical applications. Exceptional image clarity, combined with advanced technology, aligns with the financial goals of a wide range of institutions.
Mindray's comprehensive suite of Radiology ultrasound solutions includes an industry-leading five-year warranty and investment protection with software updates to keep customers at the forefront of ultrasound technology. Visit Mindray's virtual exhibit through the RSNA website and learn more about the latest innovation and cutting-edge solutions.
About Mindray
Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.
1.    Harder, B./U.S. News & World Report (July 28, 2020). 2020-21 Best Hospitals Honor Roll and Medical Specialties Rankings Retrieved from https://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1590
Early Studies Indicate up to 20 - 24 Percent of Covid-19 Patients Can Experience Myocardial Injury or Heart Failure

NEWARK, CALIF. (PRWEB) NOVEMBER 30, 2020
Ziosoft, a pioneer in 3D/4D AI medical visualization, is featuring its comprehensive suite of advanced visualization and post-processing applications, on a true vendor neutral platform, at RSNA's virtual 2020 exhibition being held November 29 – December 5. Featured this year on the company's flagship Ziostation2 system are a wide-range of applications, which are well suited in the analysis of pathology caused by the Covid-19 virus as the disease affects multiple anatomy, such as respiratory, pulmonary and cardiovascular sites.
Several studies published earlier this year indicate Covid-19 specifically can cause myocardial injury or heart failure in up to 20 - 24 percent of affected patients. Two of these studies found that between 49-52 percent of patients who died from the disease experienced heart failure.
"In addition to respiratory and pulmonary impact, these recent studies demonstrate significant cardiac injury risk as well," said Rajeev Taitriya, vice president of Business Development and Marketing, Ziosoft. "Our Ziostation2 software provides numerous tools for analyzing these symptoms including pulmonary analysis, virtual bronchoscopy, CT cardiac function and MR coronary analysis, in addition to several other visualization and measurement solutions. All are designed to provide comprehensive analysis capabilities to help support diagnostic confidence and help guide therapeutic endeavors."
Ziosoft's platform provides a robust and clinically validated algorithm, which is driven by both a traditional and new era of machine learning, unlocking the potentials of artificial intelligence (AI) for efficient and repeatable outcomes. The company's flagship Ziostation2 is an economical and scalable multi-departmental solution. A full suite of regulatory cleared 2D, 3D, and 4D analytical tools provides consistent functionality across the enterprise, without compromise.
With over 3,000 installations in 2,000 locations throughout more than 30 countries globally, the company is also highlighting PhyZiodynamics in Vivo, which enables virtual dynamic dissection to support precise therapy for organ targeting analyses and Implantations. PhyZiodynamics in Vivo offers an unprecedented "real-time" journey through the body non-invasively, supporting diagnoses and treatment planning for numerous anatomical targets.
"These unprecedented times call for highly sophisticated and comprehensive solutions for imaging visualization and analysis," said Shusuke Chino, co-founder and president, Ziosoft. "We use 20 plus years of medical imaging expertise with deep learning to enable accurate segmentation with easy-to-use intuitive tools for efficient and customizable workflows. This experience has not only brought outstanding 3D/4D to the radiological community, but several other useful tools to support clinicians during this challenging period."

In addition to respiratory and pulmonary impact, these recent studies demonstrate significant cardiac injury risk as well



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1591
Chugg's goal is to improve accessibility for water challenged communities and outdoor enthusiasts around the world.

TORRANCE, CALIF. (PRWEB) NOVEMBER 30, 2020
With the goal of making clean water technology accessible, Chugg is using easy to use UV-C technology to keep your water free of harmful contaminants and germs. Based in California, Chugg is a purpose-driven family business helping bring clean water to our country's most hard-hit communities.
Clean water is a basic necessity, yet millions of people worldwide lack access, including in the USA. Over 2 million Americans don't have access to clean water. With COVID-19 disproportionately affecting lower-income communities, the water issue has grown exponentially worse and, in some cases, is just an afterthought. Thus Chugg was born with a strong conviction to help fight the clean water issue and provide clean water for all.
While Chugg's goal is big, they have decided to start close to home. Chugg is supporting the Navajo Water Project by donating 5% of profits to help with their goal to provide clean water to 100 families this holiday season. According to The Navajo Water Project, 1 in 3 members of the Navajo tribe do not have access to running water in their home and are forced to pay up to 67X more for the water hauled to them vs. piped water.
The Navajo Water Projects Ultimate Goal Is:

To develop new sources where water is pumped, treated, and stored locally.

Deliver water in food-grade trucks to hundreds of families living close to each source.

Provide home water systems that provide 1200 gallons of hot and cold water.

You can learn more about the cause and how we are helping at https://www.drinkchugg.com/
Chugg pledges to help the Navajo Nation one bottle at a time. Every sale will help create a lasting impact for people in need of safe water. Join the movement and use the hashtag #shareachugg
Product and Technology:
With everyone shifting their thinking and cleanliness habits in 2020, Chugg's goal is to give individuals the tools they need to seamlessly transition into a new reality. A simple press of a button utilizes UV light to sanitize the water in your bottle. Specifically, UV-C light exposure is a proven technique to eradicate microorganisms and dechlorinate drinking water[footnote ref]. With its shorter, more intense wavelengths of light, UV-C has the power to deactivate microbes by destroying the genetic material in their DNA, thus stopping viruses from making copies of themselves. At the same time, its UV-A and UV-B counterparts are merely capable of giving you a nice suntan and sunburn, respectively.
Not only can you begin the clean cycle by activating the Gaia Mode, the Chugg bottle has a Gaia+ mode that will automatically cycle every 6 hours so you can have peace of mind as you continue your busy life on the go.
"Come on this adventure with us!"
– The Chugg Team



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1592
Accreditation bodies like A2LA that meet the FDA's requirements for this new program are granted ASCA Recognition, enabling them to assess testing laboratories seeking ASCA accreditation to perform premarket testing for medical device companies.

FREDERICK, MD. (PRWEB) NOVEMBER 30, 2020
A2LA is proud to announce that it has been granted ASCA Recognition by the FDA, making it among the first accreditation bodies accepted as a participant in the ASCA Pilot program. The ASCA Pilot is a cooperative program that relies on participation from accreditation bodies, testing laboratories, medical device manufacturers and FDA staff. Accreditation bodies like A2LA that meet the FDA's requirements for this new program are granted ASCA Recognition, enabling them to assess testing laboratories seeking ASCA accreditation to perform premarket testing for medical device companies. The Pilot is intended to enhance product reviewers' and device manufacturers' confidence in medical device testing, which in turn helps to ensure the widespread accessibility of safe and effective medical devices.
In addition to supporting the FDA's public health mission by providing increased confidence in testing results from ASCA-accredited testing laboratories, the ASCA Pilot is expected to reduce the burden of individual premarket submissions when manufacturers rely on testing completed by ASCA-accredited testing laboratories. The Pilot relies on international conformity assessment standards and a set of FDA-identified ASCA program specifications to create clear and consistently applied criteria for accreditation, which a limited number of qualified accreditation bodies will be recognized to assess. A2LA is among the largest and most trusted accreditation bodies in the United States and applied for ASCA Recognition at the first opportunity. A2LA's commitment to the value and broad applicability of third-party accreditation aligns closely with the FDA's goals in creating this program, and A2LA is eager to serve the medical device testing companies to which this new program applies.
"A2LA is recognized as a leader in the global accreditation industry. With that reputation to uphold, we continually seek opportunities to expand the services we are able to provide our customers and to find ways to serve our community." Said Terrianne Kohr, Accreditation Supervisor at A2LA, and one of the people most closely involved with this new program. "The launch of this new program and cooperation with the FDA is an exciting opportunity for us to realize both of these missions within the medical device field. It is an honor to be among the first accreditation bodies recognized by the FDA to offer assessment services under this Pilot program. We are looking forward to working closely with the FDA and testing laboratories in this endeavor to improve the efficiency of the premarket review process and instill increased confidence in testing results within the industry."
In the coming weeks, A2LA will be issuing guidance on how to apply for accreditation to this program, and will be providing additional information for both laboratories seeking A2LA accreditation for the first time and those who are already accredited by A2LA and are interested in this new program. For any questions about accreditation with A2LA, please call 301-644-3248 or use this link to reach out by email.
About A2LA
A2LA is a non-profit, non-governmental, third-party accreditation body, offering internationally recognized accreditation services to testing and calibration laboratories, inspection bodies, biobanking facilities, stand-alone sampling organizations, proficiency testing providers, reference material producers and product certifiers.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1593
Veteran Scientist Positioned to Lead Origent's Efforts to Optimize and Rescue Clinical Trials

VIENNA, VA. (PRWEB) DECEMBER 01, 2020
Origent Data Sciences, Inc. today announced that its Board of Directors has appointed Dr. David L. Ennist as President and Chief Executive Officer effective immediately. Dr. Ennist has served continuously as Chief Science Officer since Origent's inception in 2013.
Mike Keymer, who has held the role of President & CEO since 2013, will continue to serve on the Board of Directors and remain actively involved in supporting the Origent leadership team, which includes Dr. Ennist and Chief Data Science Officer Danielle Beaulieu.
"We are fortunate to have someone of Dave's caliber and experience to lead Origent," said Keymer. "I have been grateful for his contributions as Chief Science Officer and his counsel during my own tenure as CEO. He is the perfect leader to execute Origent's move into the drug rescue space, as we work with our partners to bring new therapies to the market to treat neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's Disease, Huntington's Disease, Alzheimer's Disease, and others. I look forward to continuing to support and collaborate with Dave during this exciting next stage of Origent's growth."
Fabian Rosado, Chairman of Origent, said, "Origent is indebted to Mike for his contributions as founding CEO of Origent, and his service and dedication over the last seven years. Mike created a culture of integrity, innovation, and earned trust at Origent, and helped the company push the boundaries of machine learning, AI, and computational science in support of drug development and clinical trials. Dr. Ennist will now build on top of the foundation that Mike created as we pursue our mission of rescuing and bringing to market new drug therapies which failed their initial attempts at registration. Origent's future success will depend on our ability to synthesize complex information across data science, medical science, and drug development. Dr. Ennist is perfectly aligned at the intersection of these domains, and has the right operational, scientific, and managerial experience to lead Origent in our next chapter."
Ennist said, "I believe we have a unique opportunity to rejuvenate therapeutics in multiple neurodegenerative indications that have languished in clinical development. I am honored that the Origent board has selected me to lead Origent into its next chapter and am grateful that Mike Keymer will continue to provide sage advice in his role as Director. With our amazing team, I know Origent will continue to be a leader in the application of machine-learning for improving the efficiency of clinical trials."
About Origent Data Sciences
Origent is dedicated to rescuing failed clinical trials and reducing drug development risks through better foresight. Origent's scientists are experts in the development and application of predictive models that are designed to anticipate and predict the dynamics of individual patients. By modeling patient-level dynamics rather than the characteristics of a population, Origent's tools uncover a deep level of insight that provides greater knowledge from clinical trial data. For additional information about Origent, please visit our website at https://www.origent.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1594
New Feature Enables Integration of Payers' Custom Action Components

GRAFTON, WIS. (PRWEB) DECEMBER 01, 2020
Healthcare interoperability pioneer HealthLX (HLX) announced it has released version 3.3 of its core platform. HealthLX is a managed clinical data exchange solution that drives business agility and advantage for payers and software vendors by enabling healthcare interoperability. With deadlines under the CMS Interoperability and Patient Access Final Rule quickly approaching, HealthLX has seen a sharp increase in focus by health plans on compliance with the mandate. A primary advantage of the HealthLX platform, now version 3.3, is that it enables payers to cross the finish line on compliance without incurring unnecessary costs, spending the time to build their own custom solutions, or replacing legacy systems.
In addition to an enhanced security infrastructure for FHIR/CMS protocols, including OAuth 2.0 and SMART on FHIR, other features new in HealthLX 3.3 include:

An enhanced FHIR server that supports several Da Vinci Payer Data Exchange (PDex) use cases, including those required by new CMS rules. The HealthLX enhanced FHIR Server is designed to support Patient API, Provider Directory, and eventually Payer-to-Payer data exchange, all out of the box. HealthLX 3.3 also gives health plans drag-and-drop capability to configure a FHIR Server via the Workflow Editor. The enhanced FHIR Server is also available in HealthLX's free FHIR Starter Pak (FSP) offering.

A series of Workflow editor enhancements, including CSV templates for USCDI resource types previously available only in FSP. Health plans can now rely on the HealthLX 3.3 platform to import CCD and 837 file formats and process them into FHIR resources.

"One of our guiding principles for development of the HealthLX platform has been to enable interoperability with legacy or custom systems," said HealthLX COO Charlie Provenzano. "We're delivering on that commitment with a HealthLX 3.3 feature that allows technical professionals to import heavily-customized action components directly into our platform through the Workflow Editor. This innovation takes clients another step forward with interoperability without significant investment of their time or dollars."
"HealthLX has been making strides forward in healthcare interoperability for years now through our work with payers and software vendors, and as a founding and active member of the Da Vinci Project," said Will Tesch, CEO of HealthLX. "That's one of the reasons HealthLX was listed as a Vendor by Gartner in its Hype Cycle for U.S. Healthcare Payers, 2020 Report. It is exciting and rewarding for us to see interoperability gain widespread momentum as organizations prepare for compliance with CMS Final Rule mandates. We expect that momentum to ramp up quickly as the July 1, 2021 deadline draws near."
About HealthLX
HealthLX (Healthcare Language Exchange) gives new healthcare software solutions instant access to comprehensive patient information and real-time analytics by linking legacy data, applications and processes with modern approaches to application integration. The HealthLX platform is built around a software integration engine that is specifically designed for the interoperability needs of the healthcare industry, bridging older legacy systems to newly acquired solutions. HealthLX simplifies the effort and cost of new solution integration by configuring application (HL7, X.12, HIPAA) connectors to meet unique client needs. Designed with enhanced levels of transaction monitoring and security, the integration platform ensures message integrity and delivery. HealthLX implementation services are provided through its parent company, TESCHGlobal, an experienced, healthcare-focused professional services firm specializing in enterprise integration and business intelligence. For more information, visit http://www.healthlx.com.
For media inquiries, please contact:
Jennifer Behnke
Director of Marketing, HealthLX
marketing@healthlx.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1595
Layn Natural Ingredients advances innovation, expands botanical extracts portfolio, acquires Wagott, China's largest exporter of green tea extract.

GUILIN, CHINA (PRWEB) DECEMBER 01, 2020
Guilin Layn Natural Ingredient Corp, Ltd. (Layn), one of the world's largest vertically-integrated innovators of natural botanical extract ingredients and solutions, announced it has expanded its botanical extracts portfolio through a majority acquisition of Chengdu Wagott Bio-tech Co.,Ltd. (Wagott), China's largest exporter of green tea extract, and leading producer of tea and resveratrol extracts.
In an agreement finalized October 13, 2020, Layn acquired 51% ownership of Waggot. The purpose of this equity acquisition is to integrate and leverage the industry's leading resources, combining intellectual property and advantages in talent, management, products, processes, and industry relationships to deliver increasing compelling value to customers. Layn provides ingredients and formulation guidance to some of the world's leading brands in food, beverage, flavor, nutraceutical, personal care, animal nutrition and pet health.
"It is exciting to combine our well developed processes & technology to expand opportunities and bring increased value to the marketplace, particularly in bringing tea extracts, including natural polyphenols and L-theanine to market," said Mr Feng Gu, General Manager of Wagott. "Utilizing Layn's formulation and application strengths and proprietary platforms designed to deliver solutions tailored to specific applications and market needs, we anticipate significant product innovation and the introduction of new lines such as white tea and pu'erh tea extracts and organic certified tea extracts." Gu will continue to be Wagott's General Manager and maintain operations independently after the acquisition.
For 25 years, Layn has earned a solid reputation as a leader in agronomy, botanical R&D, testing, manufacturing and innovation. The arrangement with Wagott is in line with Layn's long-term strategic planning and marks a significant milestone in its sustained commitment to innovation and leadership in quality botanical extract production and delivery.
According to published data in 2019, Wagott's green tea extract export value ranks first, and it is a leading company in the field of green tea and resveratrol (from giant knotweed) extract in China.
The Layn and Wagott product lines are highly complementary, and with the integration of advanced capabilities, technology, equipment and world-class talent, Layn will continue to advance its global botanical leadership, particularly in providing scientifically-backed active ingredients including polyphenols(EGCG, theaflavins, resveratrols, etc.), theanine, and others.
"Layn's state-of-the-art facility is optimized for botanical extraction and the production of sweeteners, fruit-based antioxidants and herb-based functional ingredients," said Frank Xie, EVP Layn Corp. "We continuously strive to advance our botanical science and R&D efforts, and unifying this with Wagott's capacity and its leading, complementary ingredient portfolio puts us in a unique position of global leadership in innovation, production, yield, and cost – all focused on providing ultimate value to our customers."
For more information, visit http://www.layncorp.com.
# # #
About Layn Natural Ingredients:
Layn Natural Ingredients is one of the world's largest innovators of natural botanical extract ingredients and solutions serving the biggest brands in food, beverage, flavor, nutraceutical, personal care, animals and pets for over 25 years. Truly vertically integrated, Layn offers nearly three decades of experience in providing a fully secure, manufacturer-direct, transparent and scalable supply chain. From seeds and agronomy, to extraction and formulation, Layn is committed to quality, innovation and sustainability. Its world-class R&D operation includes more than 2.2 million square feet of state-of-the-art extraction, and global innovation centers throughout the world to conduct research, ensure quality, and provide formulation and application guidance. Botanify your product portfolio now with Layn Natural Ingredients – Email botanify@layn-usa.com, or visit: http://www.layncorp.com.
PR Contact:
Heidi Rosenberg
Heidi Rosenberg Communications
mobile: +1-435-841-2171
email: mightymopr@gmail.com
website: http://www.mightymopr.com

Utilizing Layn's formulation expertise, application strengths and proprietary platforms, we anticipate significant innovation and more quality botanical extract ingredient solutions.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1596
Alexandria's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

ALEXANDRIA, VA. (PRWEB) DECEMBER 02, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Alexandria, VA for 2021. The informational guide recognizes the top 4 rehab facilities based on cost, treatment options, location, accompanying services and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Alexandria, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Alexandria with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Alexandria. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Alexandria, VA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-alexandria-va/
2021 Best Rehab Facilities in Alexandria, VA (in alphabetical order)
Aquila Recovery of Virginia
425-B Carlisle Drive
Herndon, VA 20170
703-721-4416
Encore Outpatient Services
4600 Fairfax Drive, Suite 906
Arlington, VA 22203
703-594-9855
Recovery Unplugged at Harrison House
5105Q Backlick Road
Annandale, VA 22003
844-889-9433
Sagebrush Treatment Center
7921 Jones Branch Drive, Suite 400
McLean, VA 22102
866-488-1156
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1597
Omaha's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

OMAHA, NEB. (PRWEB) DECEMBER 02, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Omaha, NE for 2021. The informational guide recognizes the top 16 rehab facilities based on cost, treatment options, location, accompanying services and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Omaha, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Omaha with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Omaha. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Omaha, NE please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-omaha-ne/
2021 Best Rehab Facilities in Omaha, NE (in alphabetical order)
A.R.C.H. O'Hanlon
1502 North 58th Street
Omaha, NE 68104
402-556-6425
Arbor Family Counseling
11605 Arbor Street
Omaha, NE 68144
402-330-0960
BAART Programs Omaha
1941 South 42nd Street, Suite 210
Omaha, NE 68105
402-341-6218
Catholic Charities of Omaha
3300 North 60th Street
Omaha, NE 68104
402-554-0520
Center for Holistic Development, Inc.
6659 Sorensen Parkway
Omaha, NE 68152
402-502-9788
Healing Tree
1011 Leavenworth Street
Omaha, NE 68102
402-614-4870
Heartland Family Service
2101 South 42nd Street
Omaha, NE 68105
402-552-7400
I Got Sober
4905 Dodge Street
Omaha, NE 68132
402-552-8890
Lutheran Family Services
124 South 24th Street
Omaha, NE 68102
402-342-7038
Nebraska Urban Indian Health Coalition Inc.
2240 Landon Court
Omaha, NE 68102
402-346-0902
NOVA Treatment Community
8502 Mormon Bridge Road
Omaha, NE 68152
402-455-8303
OMNI Behavioral Health Eating Disorders Program
5115 F Street
Omaha, NE 68117
402-397-9866
One World Northwest
4229 North 90th Street
Omaha, NE 68134
402-401-6000
Rite of Passage at Uta Halee Academy
10625 Calhoun Road
Omaha, NE 68112
402-905-9600
Siena Francis House
1702 Nicholas Street
Omaha, NE 68102
402-341-1821
Valley Hope of Omaha
7703 Serum Avenue
Omaha, NE 68127
402-991-8824
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1598
Odessa's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

ODESSA, TEXAS (PRWEB) DECEMBER 02, 2020
Odessa, TX – Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Odessa, TX for 2020. The informational guide recognizes the top 3 rehab facilities based on cost, treatment options, location, accompanying services and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Odessa, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Odessa with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Odessa. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Odessa, TX please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-odessa-tx/
2020 Best Rehab Facilities in Odessa, TX (in alphabetical order)
PermiaCare Turning Point
2000 Maurice Road
Odessa, Texas 79763
432-335-9659
The Springboard Center
200 Corporate Drive
Midland, TX 79705
432-620-0255
West Texas Counseling and Rehab (WTCR)
515 N. Golder Avenue
Odessa, TX 79761
432-335-8141
ABOUT HELP.ORG
Help.org Help.org struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1599
American Vision Partners, one of the largest and fastest-growing eye care management organizations in the nation, announced the hire of its new Chief Executive Officer, Randy Dobbs.

PHOENIX (PRWEB) DECEMBER 01, 2020
American Vision Partners ("AVP"), one of the largest and fastest-growing eye care management organizations in the nation, announced the hire of its new Chief Executive Officer, Randy Dobbs.
Mr. Dobbs will focus on strategy, organizational development through process implementation, strategic affiliations, and communication.
Under Mr. Dobbs' leadership, AVP will continue to invest in talent to promote accelerated organic growth, invest in new technologies, open new facilities, and make strategic acquisitions to grow the AVP footprint. AVP will continue to support its affiliated practices in offering the highest quality of patient care across sub-specialties.
Mr. Dobbs joins AVP with more than three decades of executive leadership. He recently served as a Senior Operating Executive within the healthcare industry for Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm.
Prior to his role at WCAS, Randy was the Chief Executive Officer for Matrix Medical Network, a provider of in-home health assessments for Medicare Advantage members across more than thirty states in North America. Mr. Dobbs provided the strategic vision, leadership direction, and organizational execution that enabled Matrix Medical to grow more than three-fold in three years under his leadership.
Over the course of his career, Randy has also served in CEO roles for U.S. Investigation Services, Philips Medical Systems North America, and GE Capital IT Solutions. His career with General Electric spanned 27 years, where he served as a Corporate Officer of the global corporation.
Mr. Dobbs is the author of Transformational Leadership: A Blueprint for Real Organizational Change, which details Randy's proven methods to create a business environment of operational excellence, stellar financial performance and significant growth.
"I am thrilled to partner with the team at AVP and its affiliated practices," commented Mr. Dobbs. "AVP represents a differentiated platform in the eye care industry, driven by the quality of its affiliated practices, the strength of its team and a relentless dedication to patient care. I look forward to building on this foundation to expand AVP in the Southwestern U.S. and beyond."
About American Vision Partners
American Vision Partners ("AVP") is one of the nation's largest and fastest-growing eye care physician practice management organizations. AVP serves communities throughout Arizona, Nevada, and New Mexico with more than 120 nationally recognized doctors, more than 60 locations, including more than 20 ambulatory surgical centers and 20 satellite clinics.
Our partner practices, including Barnet Dulaney Perkins Eye Center, Southwestern Eye Center, Retinal Consultants of Arizona, M&M Eye Institute, Abrams Eye Institute, and Havasu Eye Center have on average been providing comprehensive eye care for more than 35 years.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

#1600
Conroe's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

CONROE, TEXAS (PRWEB) DECEMBER 02, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Conroe, TX for 2021. The informational guide recognizes the top 6 rehab facilities based on cost, treatment options, location, accompanying services and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Conroe, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Conroe with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Conroe. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Conroe, TX please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-conroe-tx/
2021 Best Rehab Facilities in Conroe, TX (in alphabetical order)
Huntsville Clinic, Inc.
829 10th Street
Huntsville, TX 77320
936-291-9172
Lakeview Health Woodlands
2610 Technology Forest Boulevard
The Woodlands, TX 77381
281-784-3842
Memorial Hermann PARC – Prevention and Recovery Center
3043 Gessner Road
Houston, TX 77080
713-939-7272
New Dimensions Day Treatment Centers
1345 Space Park Drive, Suite C
Houston, TX 77058
800-685-9796
Positive Recovery – Conroe
3500 West Davis Street, Suite 300
Conroe, Texas 77304
877-476-2743
Woodland Springs Behavioral Health
15860 Old Conroe Road
Conroe, TX 77384
936-213-5843
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com